Aziridine spinosyn derivative and method for preparing the same

Modified spinosyn derivatives address insect resistance by enhancing activity and resistance profiles, effectively targeting insects, spiders, and nematodes in agricultural and animal health applications.

JP2024167404APending Publication Date: 2024-12-03DOW AGROSCIENCES LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024153573
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2017-01-13
Filing Date
2024-09-06
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing insecticides, including spinosyns, face challenges in maintaining effectiveness due to insect resistance and the complexity of their core structure, which hinders efficient synthesis and development of new compounds.

Method used

Development of spinosyn derivatives with modified sugar moieties and chemical modifications to the spinosyn core structure, enhancing activity against insects, spiders, and nematodes while improving resistance profiles.

Benefits of technology

The modified spinosyn compounds exhibit strong activity and improved resistance profiles compared to natural products, making them effective in agricultural and animal health markets.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024167404000001
    Figure 2024167404000001
  • Figure 2024167404000002
    Figure 2024167404000002
  • Figure 2024167404000003
    Figure 2024167404000003
Patent Text Reader

Abstract

To provide a composition containing a spinosyn derivative for use as an agrochemical, and a method for preparing the spinosyn derivative.SOLUTION: The present invention provides a spinosyn derivative represented by the formula below, where A represents forosamine, B is selected from the group consisting of rhamnose, tri-O-methylrhamnose and a (2R,5S)-5-ethoxy-3,4-dimethoxy-6-methylioxan2-yl group, and C represents O.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] Described herein are spinosyn derivatives for use as pesticides. be. [Background technology]

[0002] Spinosyns are produced from the fermentation of a soil actinomycete species of Saccharopolyspora. The individual components from the fermentation broth are then The compounds were then extracted from the microorganism that produces them, Saccharopolyspora spinos The common name spinosyn was given to associate it with the . The BARs share a core structure with a polyketide-derived tetracyclic macrolide to which two sugars are attached. against many commercially important species that cause extensive damage to crops and other plants. There are many naturally occurring varieties that exhibit strong insecticidal activity. Some of these varieties are It also exhibits activity against important ectoparasites of livestock, companion animals and humans. .

[0003] The fermentation of S. spinosa produces spinosyn A as the major component and spinosyn B as a minor component. The compound contains spinosyn D, producing a natural mixture named spinosad. was determined by NMR, MS and X-ray analysis and the C-9 hydroxyl group with a neutral sugar substituent (2,3,4-tri-O-methyl-α-L-rhamnosyl) on A tetracyclic ring with an amino sugar moiety (β-D-holosaminyl) attached at the C-17 hydroxyl group It contains a polyketide aglycone condensed with a 12-membered lactone and a cis-anti-trans-5 The spinosyn tetracyclic ring system, composed of a 1,6,5-tricyclic moiety, is a unique ring system.

[0004] The second most abundant fermentation component is spinosyn D, which is 6-methyl-spinosyn A Spinosyn D probably functions as an acetate catalyzer at the appropriate stage during polyketide assembly. It is formed by the incorporation of propionate in place of propionate.

[0005] Currently, a large number of structurally related compounds from various spinosyn fermentations have been isolated and characterized. These structures are consistent with a single type of aglycone or sugar in spinosyn A. The changes fall into several general categories.

[0006] Spinosyns have a unique mechanism of action (MOA) that involves destruction of nicotinic acetylcholine receptors. ) compared to many other insecticides. Spinosyns generally have a higher potency against target insects. The structure-activity ratio (SPR) of the 1,2-diaminobutyric acid derivatives is 0.01 to 0.01, and thus exhibits greater selectivity and less activity against many beneficial predators. The correlation between serotonin and acetylcholine (SAR) has been extensively studied, and the semisynthetic second generation derivative, spinetoram, This has led to the development of 3:101~111).

[0007] Previous studies have demonstrated that the mechanism by which spinosyns exert their insecticidal action is different from any other known The cross-resistance between spinosyns and other agents is therefore different. However, other insecticides have been shown to have low or no effects on the efficacy of these drugs. As is well known in the field, continued use probably exerts selective pressure on insects, ultimately leading to induces resistance.

[0008] The unique and highly complex core structure of spinosyns presents challenging synthetic opportunities. In addition, as insect resistance increases, new spinosyn compounds and Methods for their synthesis are needed. Summary of the Invention

[0009] Spinosyn compounds and methods for making and using the spinosyn compounds are provided. The spinosyn compounds described herein are effective in treating insects, spiders and nematodes. and are useful in the agricultural and animal health markets. The spinosyn compounds described have properties comparable to or greater than those of spinosyn-type natural products. They exhibit greater activity and are often accompanied by improved resistance profiles than natural products.

[0010] Spinosyn compounds as described herein include compounds of formula I:

[0011] [ka] or a salt thereof, wherein

[0012] [ka] is a single or double bond; A is a substituted or unsubstituted carbonyl, a substituted or unsubstituted substituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl; B is selected from the group consisting of substituted or unsubstituted heteroaryl; Substituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl C is selected from the group consisting of O or N H;X 1 , X 2 , X 3 , X 4 and X 5 is derived from N, NR, CR and CR2. are independently selected, where X 5 Alternatively, X may be a direct bond. 5 is direct If it is a bond, X 1 , X 2 , X 3 , and X 4 One of the letters is also O or S. each R may be selected from hydrogen, hydroxyl, substituted or unsubstituted amino, substituted or unsubstituted substituted or unsubstituted thio, substituted or unsubstituted alkoxy, substituted or unsubstituted aryloxy, substituted or unsubstituted Substituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or Unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl.

[0013] In some cases, X 1 and X 2 is selected from NR, CR and CR2, X 1 oh And X 2 The R groups in combination are substituted or unsubstituted cycloalkyl, substituted or unsubstituted substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted hetero Cycloalkenyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl In some cases, X 2 and X 3 But from NR, CR and CR2 If selected, X 2 and X 3The R groups in combination form a substituted or unsubstituted cycloalkyl group. alkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocycloalkyl, Substituted or unsubstituted heterocycloalkenyl, substituted or unsubstituted aryl, and substituted or can form an unsubstituted heteroaryl.

[0014] Optionally, A comprises forosamine. Optionally, B comprises rhamnose or (2R, 5S)-5-ethoxy-3,4-dimethoxy-6-methyloxy group. In the formula, A is forosamine, B is rhamnose, C is O, and X1 is N. wherein X2 is C(CH3) and X3 is S. Optionally, the spinosyn compound is , (1S,2R,8R,10S,12S,13R,17R,18S,22S)-18-{ [(2R,5S,6R)-5-(Dimethylamino)-6-methyloxan-2-yl]o 22-ethyl-5,17-dimethyl-10-{[(2R,3R,4R,5S,6 S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy}-23-oxy 6-Thia-4-azapentacyclo[13.10.0.0 2 , 13 .0 3 , 7 .0 8 , 12 ]Pentacosa-3(7),4,14-triene-16,24-dione.

[0015] Formulations are also described herein. The agent comprises at least one spinosyn compound as described herein and Optionally, the formulation comprises at least one additional active ingredient and / or Or at least one plant or plant product treating compound. Another additional active ingredient may be, for example, an insecticide or acaricide (e.g., a contact insecticide). or contact acting acaricides).

[0016] Further described herein are methods for controlling pests. The method for controlling pests as described in the present application comprises administering to the pest an effective amount of a compound as described herein. The method includes contacting the subject with a spinosyn compound or formulation as described in. Optionally, the pest is an insect, arachnid or nematode.

[0017] Methods for making spinosyn compounds are also described herein. A method for making the syn compounds is by reacting the C-5,6 double bond of spinosyn A: forming a spinosyn compound as described herein, Here, the spinosyn compounds are formed via an α-haloketone intermediate.

[0018] The details of one or more embodiments are set forth in the drawings and the description below. Its features, objects, and advantages will be apparent from the description and drawings, and from the claims. . DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0019] Provided herein are spinosyn compounds. The compositions are effective in treating insects, spiders, nematodes, etc. The compounds are active against pests and are useful in the agricultural and animal health markets. A method for doing so is also provided.

[0020] I. Compound The class of spinosyn compounds described herein has formula I:

[0021] [ka] and salts thereof.

[0022] In formula I,

[0023] [ka] is a single bond or a double bond.

[0024] Also in formula I, A is a substituted or unsubstituted carbonyl, a substituted or unsubstituted cycloalkyl, substituted or unsubstituted alkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted aryls. Optionally, A is selected from the group consisting of substituted or unsubstituted heteroaryl. A may be an unsubstituted sugar. For example, A may be forosamine or a forosamine derivative. stomach.

[0025] Additionally, in formula I, B can be substituted or unsubstituted cycloalkyl, substituted or unsubstituted hexaaryl, Heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl. Optionally, B may be a substituted or unsubstituted sugar. For example, B can be rhamnose. Optionally, B can be (2R,5S)-5-ethoxy. It may contain a si-3,4-dimethoxy-6-methyloxan-2-yl group.

[0026] Further, in formula I, C is O or NH.

[0027] Also, in formula I, X 1 , X 2 , X3 , X 4 and X 5 are N, NR, CR and C R2, where X 5 Alternatively, it may be a direct bond. X 5 If is a direct bond, then X 1 , X 2 , X 3 and X 4 One of them is In addition, each R may be selected from O or S, and each R may be selected from hydrogen, hydroxyl, substituted or unsubstituted amino. , substituted or unsubstituted thio, substituted or unsubstituted alkoxy, substituted or unsubstituted aryloxy substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkoxy nyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl.

[0028] In some cases, X 1 and X 2 is selected from NR, CR and CR2, X 1 oh And X 2 The R groups in combination are substituted or unsubstituted cycloalkyl, substituted or unsubstituted substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted hetero Cycloalkenyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl In some cases, X 2 and X 3 But from NR, CR and CR2 If selected, X 2 and X 3 The R groups in combination form a substituted or unsubstituted cycloalkyl group. alkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocycloalkyl, Substituted or unsubstituted heterocycloalkenyl, substituted or unsubstituted aryl, and substituted or can form an unsubstituted heteroaryl.

[0029] Optionally, the C-13, C-14 bond of the compounds of formula I is a double bond. In formula I, the compound of structure IA:

[0030] [ka] It can be expressed as:

[0031] In structure IA, A, B, C, X 1 , X 2 , X 3 , X 4 and X 5 is defined above That is exactly what I did.

[0032] In some cases, X 5 is a direct bond. In these examples, Formula I has the structure IB:

[0033] [ka] It can be expressed as:

[0034] In structure IB, [ka] and A, B, C are as defined above for formula I; X 1 , X 2 , X 3 , and B 4 are each independently selected from O, S, N, NR, CR and CR2, and R is as defined above. As defined.

[0035] In some cases, X 5 is not a direct bond. In these examples, Formula I has the structure IC :

[0036] [ka] It can be expressed as:

[0037] In the structure IC, [ka] and A, B, C are as defined above, and X 1 , X 2 , X 3 , X 4 and X 5 Haso are each independently selected from N, NR, CR and CR2, where R is as defined above. .

[0038] When substituent groups are designated by their conventional chemical formulas written from left to right, These structures are sometimes referred to as chemically identical structures, which would result from writing the structures from right to left. For example, -CH2O- may also be represented as -OCH2-. It is intended.

[0039] The term "alkyl," by itself or as part of another substituent, unless otherwise stated, As long as the alkyl group has the specified number of carbon atoms, it may be fully saturated, mono- or polyunsaturated. (i.e., C1~C 10 means 1 to 10 carbons) Divalent, trivalent and polyvalent linear or branched chain or cyclic hydrocarbon radicals, which may include dialkyls, Examples of saturated hydrocarbon radicals are methyl, ethyl, n-propyl, ethyl, isopropyl, n-butyl, t-butyl, isobutyl, sec-butyl, cyclohexyl, Groups such as (cyclohexyl)methyl, cyclopropylmethyl, and congeners, and e.g. n- Includes but is not limited to isomers such as pentyl, n-hexyl, n-heptyl, and n-octyl. Unsaturated alkyl groups are those that have one or more double or triple bonds. Examples of unsaturated alkyl groups are 2-propenyl, crotyl, 2-isopentenyl, 2 -(butadienyl), 2,4-pentadienyl, 3-(1,4-pentadienyl), ethyl Includes 1- and 3-propynyl, 3-butynyl, and higher homologs and isomers. The term "alkyl" includes, but is not limited to, "heteroalkyl", unless otherwise noted. The term "alkyl" may also include derivatives of alkyl, defined in more detail below, such as "alkyl." Alkyl groups that are limited to hydrocarbon groups are termed "homoalkyl." Exemplary alkyl groups include: The alkyl group is a monounsaturated C 9~10、 Oleoyl chain or diunsaturated C 9~10、12~ 13 Contains linoleyl chains.

[0040] The terms "alkoxy," "alkylamino," and "alkylthio" (or thioalkoxy) The radicals (oxy) are used in their customary sense and represent an oxygen atom, an amino group, or a sulfur atom, respectively. Refers to an alkyl group that is attached to the rest of the molecule through a bond.

[0041] The terms "aryloxy" and "heteroaryloxy" are used in their conventional sense. An aryl or heteroaryl group is used that is attached to the rest of the molecule through an oxygen atom Refers to...

[0042] The term "aryl," unless otherwise specified, refers to groups fused or covalently linked together. Polyunsaturated aromatic rings, which may be monocyclic or polycyclic (preferably 1 to 3 rings) The term "heteroaryl" refers to an aromatic substituent selected from N, O, S, Si and B. 1 to 4 heteroatoms, where the nitrogen and sulfur atoms are optionally oxidized. and the nitrogen atom is optionally quaternized, A heteroaryl group can be attached to the remainder of the molecule through a heteroatom. Non-limiting examples of aryl and heteroaryl groups are phenyl, 1-naphthyl, 2-naphthyl, , 4-biphenyl, 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 3-pyrazolyl, 2- Imidazolyl, 4-imidazolyl, pyrazinyl, 2-oxazolyl, 4-oxazolyl, 2-Phenyl-4-oxazolyl, 5-oxazolyl, 3-isoxazolyl, 4-iso Oxazolyl, 5-isoxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl 4-pyridyl, 2-pyrimidyl, 4-pyrimidyl, 5-benzothiazolyl, purinyl , 2-benzimidazolyl, 5-indolyl, 1-isoquinolyl, 5-isoquinolyl, 2 -quinoxalinyl, 5-quinoxalinyl, 3-quinolyl and 6-quinolyl. Substituents for each of the aryl and heteroaryl ring systems are described below as acceptable substituents. The substituents are selected from the group:

[0043] For the sake of brevity, the term "aryl" when used in combination with other terms (e.g. For example, aryloxy, arylthioxy, arylalkyl), as defined above It includes both aryl and heteroaryl rings. Thus, the term "arylalkyl" refers to any alkyl group having a carbon atom or a carbonyl group. A hydrogen atom (e.g., a methylene group) may be substituted with, for example, an oxygen atom (e.g., phenoxymethyl, 2- pyridyloxymethyl, 3-(1-naphthyloxy)propyl, etc. alkyl groups containing alkyl groups (e.g., benzyl, phenethyl, pyridylmethyl, etc.) , is meant to include a radical having an aryl group attached thereto.

[0044] Each of the above terms (e.g., "alkyl," "heteroalkyl," "aryl" and and "heteroaryl") refer to both substituted and unsubstituted forms of the indicated radical. It is supposed to include more.

[0045] II. Methods for Making Compounds The compounds described herein can be prepared in a variety of ways. The product can be synthesized using a variety of synthetic methods. At least some of these methods are known in the art of synthetic organic chemistry. The compounds described herein are , can be prepared from readily available starting materials. Optimal reaction conditions are determined using Such conditions may vary depending on the particular reactants or solvents, but may be readily understood by one of ordinary skill in the art. This can be determined by routine optimization procedures.

[0046] The variations in formula I are the addition of various components as described for each compound. , reduction or shift. Similarly, if one or more chiral centers are present in a molecule, In addition, compound synthesis involves the selection of various chemical groups, all of which are chiral variants. The use of protection and deprotection, and the selection of appropriate protecting groups, may be Protecting group chemistry is described, for example, in the entirety of this specification, which is incorporated by reference, and can be determined by one of ordinary skill in the art. Wuts, Greene's Protective Groups, incorporated in the book in Organic Synthesis, 5th ed., Wiley & Sons, 2 This can be seen in FIG. 014.

[0047] The reactions for producing the compounds described herein are within the skill of one of ordinary skill in the art of organic synthesis. The reaction can be carried out in a solvent that can be selected according to the conditions under which the reaction is carried out, i.e. , temperature and pressure, substantially non-reactive with starting materials (reactants), intermediates or products The reaction can be carried out in one solvent or a mixture of more than one solvent. Product or intermediate formation can be accomplished by any suitable method known in the art. Thus, product formation can be monitored, for example, by nuclear magnetic resonance spectroscopy (e.g., 1 H or 13 C) infrared spectroscopy, spectrophotometry (e.g., UV-Vis) or mass spectrometry by spectroscopic means such as the HPLC method, or by high performance liquid chromatography (HPLC) or It can be monitored by chromatography, such as thin layer chromatography.

[0048] The compounds described herein are similar to those described in U.S. Pat. No. 5,362,634. Spinosyn precursor, spinosyn or spinosyn analog starting materials, such as those described As used herein, in a synthetic method, The spinosyn precursor, spinosyn or spinosyn analog starting material used is a compound having two sugars. Any tetracyclic spinosyn molecule, including polyketide-derived tetracyclic macrolides having an attached tetracyclic ring, include.

[0049] The methods for making the compounds described herein are carried out on spinosyns. The compound thus formed may include from one to five chemical steps. No purification of the intermediates obtained is necessary.

[0050] The compounds described by Formula I and pharma- ceutically acceptable salts thereof include compounds of Formula I [Formula In the middle, C=O and X 1 , X 2 , X 3 , X 4 , X 5 =CR and R=H] The compounds can be prepared using the method shown in Scheme 1, which depicts

[0051] [ka] In the synthetic method shown above in Scheme 1, the olefin of Spinosyn A is m- The epoxide intermediate can then be oxidized to an amine (this In this example, the ring is opened with aniline, and the amino alcohol intermediate is then treated with DAST. Alternatively, the olefin can be dibrominated and the bromide can be prepared using an amine. One of the groups may be aminated and then ring-closed with a reagent such as DAST.

[0052] Alternatively, the compounds described herein may be modified by directly bridging the C,C double bond. or in multiple chemical steps. Transformations can be used by those skilled in the art to create such compounds. rashar, Chemistry of Heterocyclic Compoun ds, CRC Press, 2014, ISBN-13 978-1466517 and John A. Joule and Keith Mills, Heterocyclic Chemistry, Wiley, 2010, ISBN-13 978-140513 Please refer to 3005.

[0053] Additional modifications can be made to the compounds according to formula I while retaining the desired activity of the compound. For example, the sugar groups (e.g., , forosamine and rhamnose) can be modified by methods known in the art to Forosamine is able to retain some of its antibacterial activity while retaining some of its antibacterial activity. The sugar and non-sugar substituents may be substituted with any of the nitrogen-containing sugar and non-sugar substituents described herein by reference. Incorporated into Gaisser et al. (2002) Chem. Comm. 6:618-61 9; and Gaisser et al. (2009) Org. Biomol. Chem. 7:170 5-1708. Similarly, rhamnose-substituted analogs may be generated. Creamer et al. (2000) J. Antibiotics, 1999, 144:1311-1315, which is incorporated herein by reference. , 53:171-178; Sparks et al. (2001) Pest Manag. Sci. 57:896-905. The activity of spinosyn derivatives is determined by the structure of rhamnose. Changes in the C-2' and C-3' of the tri-O-methyl rhamnose moiety After some modification in the

[0054] Other methods of sugar modification can be performed and are well known in the art. Kirst et al. 02) See Curr.Top.Med.Chem.2:675-699. In some embodiments, one or more of the sugar moieties are replaced with another natural or synthetic sugar. Synthetic sugars include modified sugars. As used herein, "modified sugars" is covalently functionalized with a "modifying group." Useful modifying groups include water-soluble polymers, These include, but are not limited to, therapeutic moieties, diagnostic moieties, biomolecules, etc. Precursors or Substrates Addition or removal of any sugar moieties present on the polypeptide can be accomplished either chemically or enzymatically. It will be carried out.

[0055] In some embodiments, chemical deglycosylation is performed using the compound trifluoromethanesulfonyl. Exposure of the spinosyn compounds described herein to nicotinic acid, or an equivalent compound. This treatment can be used to remove bound sugars (N-acetylglucosamine or results in the cleavage of most or all sugars except N-acetylgalactosamine, while leaving the rest of the molecule intact. Hakimuddin et al. (1987) Arc h. Biochem. Biophys. 259:52 and Edge et al. (1981) A See Nal. Biochem. 118:131. Carbohydrates on Peptide Variants Enzymatic cleavage of the moiety was described by Thotakura et al. (1987) Meth. Enzymol. Various endo- and exoglycosidases as described by 138:350 Chemical addition of the glycosyl moieties can be accomplished by the use of any method known in the art. This can be done by any art-recognized method, see, for example, U.S. Patent No. 5,876,990. No. 80, No. 6,030,815, No. 5,728,554, No. 5,922,57 7 and WO2004 / 99231.

[0056] 1. Synthesis of Compound 1

[0057] [ka]

[0058] A solution of Spinosyn A (20.0 g, 27.3 mmol) in DCM (200 mL) was added at 0 °C. CPBA (12.8 mg, 74.5 mmol) was added. The mixture was allowed to warm to room temperature and stirred for 6 h. Aqueous Na2SO3 solution (300 mL) was added and the mixture was stirred at room temperature overnight. Extracted with CM (500 mL x 2). The combined organic layers were washed with brine and dried over Na2SO4. The residue was purified by column chromatography on silica gel (DCM / MeOH = 20 / 1) to obtain crude product A1 (13.0 g, containing approximately 15% A2 according to HNMR and LC-MS). 300 mg of crude A1 was purified by prep HP Further purification by LC gave pure compounds A1 (120 mg) and A2 (20 mg) as white solids. Ta. A1: Partial 1 H NMR (CDCl3, 400 MHz):δ6.58 (s, 1H), 4.85 (s, 1H), 4.67 (m, 1H) , 4.41 (d, J = 7.2 Hz, 1H), 4.23 (m, 1H), 3.25-3.10 (m, 3H), 2.61-2.54 (m, 1H), 2.44 (dd, J = 13.6, 3.2 Hz, 1H), 0.82 (t, J = 7.2 Hz, 3H); LC-MS: m / z 748.4 [M+ H] + . A2: Partial 1 H NMR (CDCl3, 400 MHz):δ6.70 (s, 1H), 4.84 (s, 1H), 4.70 (m, 1H) , 4.42 (d, J = 8.4 Hz, 1H), 4.28 (m, 1H), 3.63-3.42 (m, 16H), 3.27-3.06 (m, 6H) , 2.57-2.42 (m, 2H), 2.24-2.07 (m, 6H), 0.82 (t, J = 14.8 Hz, 3H); LC-MS: m / z 7 48.4 [M+H] +

[0059] A solution of crude compound A1 (0.5 g, 0.65 mmol) in aniline (3 mL) was added with ZrCl4 (7.5 mg, 0.03 3 mmol) was added. The mixture was stirred at 80° C. under microwave for 1 hour. The mixture was purified by silica gel column (DCM / MeOH = 20:1 to 10:1) followed by prep HPLC to give white eluate. A mixture of compounds 1-1 and 1-2 (165 mg, 30.3% yield) was obtained as a white solid. -1 (20 mg) and 1-2 (12 mg) were separated by chiral prep HPLC. LCMS: m / z 841.2 [ M+H] + .

[0060] A solution of a mixture of compounds 1-1 and 1-2 (50 mg, 0.059 mmol) in DCM (5 mL) was added to -78 At −78° C., DAST (28.7 mg, 0.18 mmol) was added. The mixture was stirred at −78° C. for 0.5 h under N2 pressure. The reaction mixture was then diluted with saturated NaHCO3 solution (5 mL) and extracted with DCM (5 mL x 2) The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was The product was purified by HPLC to give compound 1 as a white solid (20 mg, 40.8% yield). 1 H NMR (CDCl3, 400 MHz): δ7.22 (d, J = 7.6 Hz, 2H), 7.03 (d, J = 7.2 Hz, 1H), 6.96 (t, J = 7.2 Hz, 1H), 6.75 (s, 1H), 4.89 (d, J = 0.8 Hz, 1H), 4.73-4.68 (m, 1H), 4.4 2-4.40 (m, 1H), 4.33-4.32 (m, 1H), 3.67-3.44 (m, 16H), 3.32-3.26 (m, 2H), 3.14-3 .09 (m, 2H), 2.58-2.49 (m, 2H), 2.41-2.39 (m, 1H), 2.24 (brs, 10H), 2.00-1.97 (m , 1H), 0.80 (t, J = 7.2 Hz, 3H). LCMS: m / z 823.2 [M+H] + .

[0061] 2. Synthesis of Compound 2

[0062] [ka]

[0063] A solution of compound A1 (0.5 g, 0.65 mmol) in 2-chloroaniline (3 mL) was added with ZrCl4 (7.5 mg, 0 0.033 mmol) was added. The mixture was stirred at 80° C. in a microwave for 0.5 h. Purification by silica gel column (DCM / MeOH = 20:1 to 10:1) followed by prep HPLC gave a white solid A mixture of compounds 2-1 and 2-2 (132 mg, yield 24.2%) was obtained as a chromatogram. LCMS: m / z 875.1 [M+ H] + .

[0064] A solution of a mixture of compounds 2-1 and 2-2 (50 mg, 0.057 mmol) in DCM (5 mL) was added to -78 At −78° C., DAST (28.0 mg, 0.17 mmol) was added. The mixture was stirred at −78° C. for 0.5 h under N2 pressure. The reaction mixture was diluted with saturated NaHCO3 solution (15 mL) and extracted with DCM (15 mL x 2). The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by prep HPLC. The compound 2 was obtained as a white solid (15 mg, yield 30.7%). 1 H NMR (CDCl3 , 400 MHz): δ7.31 (d, J = 6.8 Hz, 1H), 7.17-7.13 (m, 1H), 6.97-6.90 (m, 2H), 6. 76 (s, 1H), 4.88 (s, 1H), 4.71-4.69 (m, 1H), 4.44-4.42 (m, 1H), 4.34-4.32 (m, 1H) ), 3.30-3.22 (m, 2H), 3.17-3.09 (m, 2H), 2.61-2.58 (m, 1H), 2.46-2.44 (m, 1H), 1 .99-1.97 (m, 1H), 0.84 (t, J = 7.6 Hz, 3H). LCMS: m / z 857.1 [M+H] + .

[0065] 3. Synthesis of Compound 3

[0066] [ka]

[0067] Compound A1 (500 mg, 0.65 mmol) and 4-chloroform in 1,4-dioxane (5 mL) To a solution of diphenylamine (340 mg, 2.68 mmol), ZrCl4 (156 mg, 0.65 mmol) was added. The mixture was stirred at 80 °C under N2 for 4 h. The mixture was quenched with H2O and extracted with DCM. The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by silica gel column (DCM / MeOH = 20:1 to 10:1) followed by prep HPLC. This gave a mixture of compounds 3-1 and 3-2 (150 mg, 27.5% yield) as a yellow solid. LCMS: m / z 875.1 [M+H] + .

[0068] A solution of a mixture of compounds 3-1 and 3-2 (150 mg, 0.17 mmol) in DCM (5 mL) was added under N DAST (0.2 mL) was added at -78°C. The mixture was stirred at -78°C for 1 hour under N2 pressure. The mixture was quenched with aqueous NaHCO3 and extracted with DCM (30 mL x 3). The mixture was dried over Na2SO4, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. Compound 3 was obtained (20 mg, yield 13.7%). 1 H NMR (CDCl3, 300 MHz):δ7.23 (d, J = 20.4 Hz, 2H), 6.95 (d, J = 8.4 Hz, 2H), 6.76 (s, 1H), 4.89 (s, 1H), 4.75-4.6 5 (m, 1H), 4.48-4.41 (m, 1H), 4.36-4.29 (m, 1H), 3.68-3.41 (m, 15H), 3.34-3.25 ( m, 2H), 3.17-3.08 (m, 2H), 2.58-2.45 (m, 2H), 2.40-2.35 (m,1H), 0.86 (t, J = 7.5 Hz, 3H); LC-MS: m / z 857.1 [M+H] + .

[0069] 4. Synthesis of Compound 4

[0070] [ka]

[0071] A solution of compound A1 (400 mg, 0.53 mmol) in 2-fluoro-6-methylaniline (3 mL) was added to ZrC l4 (6.0 mg, 0.026 mmol) was added. The mixture was stirred at 80° C. in a microwave for 1 h. The mixture was purified by silica gel column (DCM / MeOH = 20:1 to 10:1) followed by prep HPLC. The mixture of compounds 4-1 and 4-2 (210 mg, yield 45.3%) was obtained as a white solid. Compounds 4-1 (25 mg) and 4-2 (10 mg) were separated by chiral prep HPLC. LCMS: m / z 874.2 [M+H] + .

[0072] A solution of a mixture of compounds 4-1 and 4-2 (88 mg, 0.1 mmol) in DCM (5 mL) was added to -7 DAST (50.0 mg, 0.3 mmol) was added at 8°C. The mixture was stirred under N2 pressure at -78°C for 0.5 h. The reaction mixture was diluted with saturated NaHCO3 solution (10 mL) and extracted with DCM (15 mL x 2). The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by prep HPLC. The compound 4 was obtained as a white solid (20 mg, yield 22.6%). 1 H NMR (CDCl3 , 400 MHz): δ6.90-6.74 (m, 4H), 4.88 (s, 1H), 4.75-4.66 (m, 1H), 4.44-4.40 (m, 1H), 4.33-4.29 (m, 1H), 3.31-3.21 (m, 2H), 3.17-3.11 (m, 2H), 2.61-2.51 (m, 2H), 0.84 (t, J = 7.2 Hz, 3H). LCMS: m / z 856.2[M+H] + .

[0073] 5. Synthesis of Compound 5

[0074] [ka]

[0075] Compound A1 (500 mg, 0.65 mmol) and 4-methoxyphenyl To a solution of dimethylamine (95.9 mg, 0.78 mmol) was added ZrCl4 (60.6 mg, 0.26 mmol). The mixture was stirred at 80 °C under N2 overnight. The mixture was quenched with H2O and Extracted (30 mL x 3). The combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by prep HPLC to give products 5-1 and 5-2 (125 mg, 22.9 yield) as yellow solids. %) mixture was obtained. LC-MS: m / z 871.2 [M+H] + .

[0076] A solution of a mixture of compounds 5-1 and 5-2 (125 mg, 0.14 mmol) in DCM (5 mL) was added under N DAST (0.1 mL) was added at -78°C. The mixture was stirred at -78°C for 1 hour under N2 pressure. The mixture was quenched with aqueous NaHCO3 and H2O. The mixture was extracted with DCM (30 mL x 3). The combined organic layers were dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by PrepHP Purification by LC gave compound 5 as a yellow solid (30 mg, 20.7% yield). 1 H NMR (CDC l3, 300 MHz): δ7.01-6.82 (m, 4H), 6.75 (s, 1H), 4.90 (s, 1H), 4.79-4.68 (m, 1H) , 4.48-4.26 (m, 1H), 3.91 (s, 3H), 3.70-3.44 (m, 16H), 3.35-3.06 (m, 4H), 2.67-2 .51 (m, 2H), 2.43-2.36 (m, 1H), 2.26-2.14 (m, 10H), 2.10-1.94 (m, 2H), 0.85 (t, J = 7.2 Hz, 3H); LC-MS: m / z 853.2 [M+H] + .

[0077] 6. Synthesis of Compound 6

[0078] [ka]

[0079] Compound A1 (300 mg, 0.4 mmol) and 2-methoxy-4-methyl- To a solution of 164.6 mg, 1.2 mmol of phenylamine was added ZrCl4 (93.2 mg, 0.4 mmol). The mixture was stirred at 80 °C under N2 overnight. The mixture was quenched with H2O and extracted with DCM. The combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by prep HPLC to give a crude mixture of products 6-1 and 6-2 (200 mg) as a yellow solid. LC-MS: m / z 886.2 [M+H] + .

[0080] A solution of a mixture of compounds 6-1 and 6-2 (100 mg, 0.11 mmol) in DCM (5 mL) was added under N DAST (87.3 mg, 0.54 mmol) was added at -78°C. The mixture was stirred at -78°C for 1 hour under N2 pressure. The mixture was quenched with aqueous NaHCO3 and H2O. The mixture was extracted with DCM ( 30 mL x 3). The combined organic layers were dried over anhydrous Na2SO4, filtered and concentrated. The residue The residue was purified by prep HPLC to give compound 6 (14.3 mg, 16.4% yield) as a yellow solid. al 1 H NMR (CDCl3, 300 MHz): δ6.82-6.74 (m, 2H), 6.68-6.62 (m, 2H), 4.90 (s, 1H) , 4.78-4.69 (m, 1H), 4.46-4.41 (m, 1H), 4.36-4.29 (m, 1H), 3.89 (s, 3H), 3.68-3. 43 (m, 15H), 3.33-3.07 (m, 4H), 2.64-2.49 (m, 2H), 0.85 (t, J = 7.8 Hz, 3H); LC- MS: m / z 868.2 [M+H] + .

[0081] 7. Synthesis of Compound 7

[0082] [ka]

[0083] Compound A1 (500 mg, 0.65 mmol) and 3-fluoro-phenyl To a solution of dimethylamine (222.8 mg, 2.0 mmol) was added ZrCl4 (156.1 mg, 0.65 mmol). The mixture was stirred at 80 °C under N2 for 4 h. The mixture was quenched with H2O and extracted with DCM (3 0 mL x 3). The combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by pretreatment. Purification by top-up HPLC gave a crude mixture of products 7-1 and 7-2 (150 mg) as a yellow solid. LC-MS: m / z 886.2 [M+H] + .

[0084] A solution of a mixture of compounds 7-1 and 7-2 (150 mg, 0.17 mmol) in DCM (5 mL) was added under N DAST (0.1 mL) was added at -78°C. The mixture was stirred at -78°C for 1 hour under N2 pressure. The mixture was quenched with aqueous NaHCO3 and H2O and extracted with DCM (30 mL x 3). The organic layer was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. Compound 7 was obtained as a yellow solid (40 mg, 28% yield). 1 H NMR (CDCl3, 300 MHz): δ 7.22-7.14 (m, 1H), 6.64-6.62 (m, 4H), 4.89 (s, 1H), 4.75-4.64 (m, 1H), 4.46-4.40 (m, 1H), 4.37-4.29 (m, 1H), 3.68-3.42 (m, 16H), 3.34-3.07 (m, 4H), 2.59-2.39 (m , 3H), 0.90-0.75 (m, 4H); LC-MS: m / z 841.2 [M+H] + .

[0085] 8. Synthesis of Compound 8

[0086] [ka]

[0087] Compound A1 (400 mg, 0.53 mmol) and 2,6-dimethyl- To a solution of phenylamine (129 mg, 1.07 mmol), Ti(O-iPr)4 (156 mg, 0.67 mmol) was added. The mixture was stirred at 120 °C under N2 overnight. The mixture was quenched with H2O and extracted with DCM. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give the crude products 8-1 and 8-2 (200 mg) as yellow solids. Obtained. LC-MS: m / z 869.5 [M+H] + .

[0088] A solution of a mixture of compounds 8-1 and 8-2 (200 mg, 0.23 mmol) in DCM (10 mL) was subjected to N DAST (74 mg, 0.46 mmol) was added at −78° C. under N2 pressure. The mixture was stirred at −78° C. for 1 hour. The mixture was quenched with aqueous NaHCO3 and H2O, then extracted with DCM (30 mL The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by HPLC. Purification by rep HPLC gave compound 8 as a yellow solid (40 mg, 20.5% yield). 1 H NMR (CDCl3, 400 MHz): δ6.98-6.92 (m, 2H), 6.83-6.75 (m, 2H), 4.88 (s, 1H), 4.75 -4.65 (m, 1H), 4.44-4.40 (m, 1H), 4.37-4.29 (m, 1H), 3.31-3.08 (m, 4H), 2.65-2.6 0 (m, 1H), 2.56-2.50 (m, 1H), 2.42-2.33 (m, 7H), 1.64 (s, 3H), 1.29-1.16 (m, 12H) ), 0.89-0.80 (m, 4H); LC-MS: m / z 851.5 [M+H] + .

[0089] 9. Synthesis of Compound 9

[0090] [ka]

[0091] Compound A1 (300 mg, 0.4 mmol) and 2-methoxy-phenyl To a solution of diphenylamine (117.6 mg, 0.8 mmol) was added Ti(O-iPr)4 (113.6 mg, 0.4 mmol). The mixture was stirred at 120 °C under N2 overnight. The mixture was quenched with H2O and extracted with DCM. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give crude products 9-1 and 9-2 (100 mg) as yellow solids. LC-MS: m / z 871.2 [M+H] + .

[0092] A solution of a mixture of compounds 9-1 and 9-2 (100 mg, 0.11 mmol) in DCM (10 mL) was subjected to N DAST (37 mg, 0.22 mmol) was added at −78° C. under N2 pressure. The mixture was stirred at −78° C. for 1 hour. The mixture was quenched with aqueous NaHCO3 and H2O, then extracted with DCM (30 mL The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by HPLC. Purification by rep HPLC gave compound 9 as a yellow solid (40 mg, 46% yield). 1 H.N.M. R (CDCl3, 400 MHz):δ6.97-6.81(m, 4H), 6.75 (s, 1H), 4.89 (s, 1H), 4.76-4.68 (m, 1H), 4.46-4.39 (m, 1H), 4.35-4.27 (m, 1H), 3.90 (s, 3H), 3.67-3.40 (m, 17H), 3. 32-3.18 (m, 2H), 3.14-3.07 (m, 2H), 2.63-2.50 (m, 2H), 2.40-2.36 (m,1H), 0.87-0. 78 (m, 4H); LC-MS: m / z 853.2 [M+H] + .

[0093] 10. Synthesis of Compound 10

[0094] [ka]

[0095] Compound A1 (400 mg, 0.53 mmol) and p-tolylamine ( To a solution of Ti(O-iPr)4 (114.4 mg, 1.06 mmol), Ti(O-iPr)4 (150.5 mg, 0.53 mmol) was added. The mixture was stirred at 120 °C under N2 overnight. The mixture was quenched with H2O and extracted with DCM (30 mL The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by HPLC. Purification by rep HPLC gave crude products 10-1 and 10-2 (100 mg) as yellow solids. S: m / z 855.2 [M+H] + .

[0096] A solution of a mixture of compounds 10-1 and 10-2 (100 mg, 0.11 mmol) in DCM (10 mL) was subjected to N DAST (32 mg, 0.19 mmol) was added at −78° C. under N2 pressure for 1 h. The mixture was quenched with aqueous NaHCO3 and H2O, then extracted with DCM (30 ml The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was Purification by prep HPLC gave compound 10 as a white solid (15 mg, 16.2% yield). 1 H NMR (CDCl3, 400 MHz):δ6.97-6.81(m, 4H), 6.75 (s, 1H), 4.89 (s, 1H), 4.76-4.6 8 (m, 1H), 4.46-4.39 (m, 1H), 4.35-4.27 (m, 1H), 3.00 (s, 3H), 3.32-3.18 (m, 2H) , 3.14-3.07 (m, 2H), 2.63-2.50 (m, 2H), 2.40-2.36 (m,1H), 2.28-2.13 (m, 10H), 0. 87-0.78 (m, 4H); LC-MS: m / z 853.2 [M+H] + .

[0097] 11. Synthesis of Compound 11

[0098] [ka]

[0099] Compound A1 (500 mg, 0.65 mmol) and 4-ethoxy-phenyl-2-(2-methyl-1,3-diphenyl-2-propanediol) in 1,4-dioxane (10 mL) To a solution of nylamine (184 mg, 1.33 mmol), Ti(O-iPr)4 (190.3 mg, 0.65 mmol) was added. The mixture was stirred at 120 °C under N2 overnight. The mixture was quenched with H2O and extracted with DCM. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give crude products 11-1 and 11-2 (250 mg) as yellow solids. LC-MS: m / z 885.2 [M+H] + .

[0100] A solution of a mixture of compounds 11-1 and 11-2 (250 mg, 0.28 mmol) in DCM (10 mL) was subjected to N DAST (5 mg, 0.28 mmol) was added at −78° C. under N2 pressure for 1 h. The mixture was quenched with aqueous NaHCO3 and H2O, then extracted with DCM (30 ml The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was Purification by prep HPLC gave compound 11 as a white solid (25 mg, 10.3% yield). 1 H NMR (CDCl3, 400 MHz):δ6.98-6.92 (m, 2H), 6.81-6.73 (m, 2H), 4.89 (s, 1H), 4. 76-4.64 (m, 1H), 4.48-4.40 (m, 1H), 4.36-4.28 (m, 1H), 3.96 (q, J = 6.9 Hz, 2H), 3.35-3.24 (m, 2H), 3.17-3.08 (m, 2H), 2.61-2.47 (m, 2H), 0.90-0.72 (m, 4H); LC- MS: m / z 867.2 [M+H] + .

[0101] 12. Synthesis of Compound 12

[0102] [ka]

[0103] Compound A1 (400 mg, 0.53 mmol) and 2,4-dichloro- A solution of phenylamine (172 mg, 1.06 mmol) was added with Ti(O-iPr)4 (152 mg, 0.53 mmol). The mixture was stirred at 120 °C under N2 overnight. The mixture was quenched with H2O (100 mL). The combined organic layers were dried over potassium carbonate and filtered. The residue was purified by prep HPLC to give crude products 12-1 and 12-2 as yellow solids. (350 mg) was obtained. LC-MS: m / z 909.1 [M+H] + .

[0104] A solution of a mixture of compounds 12-1 and 12-2 (300 mg, 0.4 mmol) in DCM (15 mL) was added under N DAST (96.8 mg, 0.6 mmol) was added at 78° C. The mixture was stirred at −78° C. for 2 hours. The mixture was quenched with aqueous NaHCO3 and H2O, then extracted with DCM (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. Purification gave compound 12 as a white solid (20 mg, 5.6% yield).

[0105] Partial 1 H NMR (CDCl3, 400 MHz): δ 7.34-7.31 (m, 1H), 7.15-7.09 (m, 1H), 6.92-6 .87 (m, 2H), 6.76 (s, 1H), 4.73-4.65 (m, 1H), 4.47-4.41 (m, 1H), 4.36-4.28 (m, 1 H), 3.33-3.22 (m, 2H), 3.18-3.08 (m, 2H), 2.65-2.53 (m, 2H), 2.46-2.41 (m,1H), 2 .28-2.16 (m, 10H); LC-MS: m / z 891.1 [M+H] + .

[0106] 13. Synthesis of Compound 13

[0107] [ka]

[0108] Compound A1 (400 mg, 0.53 mmol) and 4-phenoxy-phenylalanine in toluene (10 mL) To a solution of amine (197.8 mg, 1.07 mmol) was added Ti(O-iPr)4 (150.5 mg, 0.53 mmol). The mixture was quenched with H2O (100 mL) and extracted with DCM (30 mL x 3). The layer was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. The crude products 13-1 and 13-2 (300 mg) were obtained as solids. LC-MS: m / z 933.2 [M+H] + .

[0109] A solution of a mixture of compounds 13-1 and 13-2 (300 mg, 0.32 mmol) in DCM (15 mL) was added under N DAST (51.7 mg, 0.32 mmol) was added at -78°C. The mixture was stirred at -78°C for 2 hours. The mixture was quenched with aqueous NaHCO3 and H2O, then extracted with DCM (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. to give compound 13 (20 mg, 6.8% yield) as a yellow solid.

[0110] Partial 1 H NMR (CDCl3, 300 MHz): δ 7.33-7.28 (m, 2H), 7.08-6.99 (m, 3H), 6.95-6 .91 (m, 4H), 6.76 (s, 1H), 4.89 (s, 1H), 4.73-4.65 (m, 1H), 4.47-4.41 (m, 1H), 4 .37-4.29 (m, 1H), 3.70-3.62 (m, 1H), 3.35-3.24 (m, 2H), 2.60-2.47 (m, 2H), 2.42- 2.38 (m, 1H), 0.85 (t, J = 7.5 Hz, 3H); LC-MS: m / z 915.2 [M+H] + .

[0111] 14. Synthesis of Compound 14

[0112] [ka]

[0113] Compound A1 (500 mg, 0.65 mmol) and 4-fluoro-phenylalanine in toluene (20 mL) To a solution of amine (168 mg, 1.33 mmol) was added Ti(O-iPr)4 (189.8 mg, 0.66 mmol). The mixture was quenched with H2O (100 mL) and extracted with DCM (30 mL x 3). The combined organic layers The mixture was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. The crude products 14-1 and 14-2 (250 mg) were obtained as condensed forms. LC-MS: m / z 860.2 [M+H] + .

[0114] A solution of a mixture of compounds 14-1 and 14-2 (250 mg, 0.28 mmol) in DCM (10 mL) was added under N DAST (46 mg, 0.28 mmol) was added at -78°C. The mixture was stirred at -78°C for 2 hours. The mixture was quenched with aqueous NaHCO3 and H2O, then extracted with DCM (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. Purification gave compound 14 as a yellow solid (20 mg, 8.5% yield). 1 H NMR (CDCl3, 400 MHz):δ7.01-6.88 (m, 4H), 6.75 (s, 1H), 4.89 (s, 1H), 4.73-4.65 (m, 1H), 4.4 5-4.40 (m, 1H), 4.35-4.29 (m, 1H), 3.67-3.61 (m, 1H), 3.32-3.24 (m, 2H), 3.16-3. 08 (m, 2H), 2.58-2.46 (m, 2H), 2.39-2.35 (m, 1H), 2.02-1.96 (m, 1H), 1.87-1.78 ( m, 2H); LC-MS: m / z 842.2 [M+H]+.

[0115] 15. Synthesis of Compound 15

[0116] [ka]

[0117] Compound A1 (400 mg, 0.53 mmol) and 1-(4-amino-phenyl)- To a solution of ethanone (197.8 mg, 1.07 mmol) was added Ti(O-iPr)4 (150.5 mg, 0.53 mmol). The mixture was stirred at 120 °C under N2 overnight. The mixture was quenched with H2O (100 mL) and DC The combined organic layers were dried over potassium carbonate, filtered and purified by HPLC. The residue was purified by prep HPLC to give crude products 15-1 and 15-2 (25 0 mg). LC-MS: m / z 983.5 [M+H] + .

[0118] A solution of a mixture of compounds 15-1 and 15-2 (200 mg, 0.22 mmol) in DCM (10 mL) was added to the flask with N DAST (36.4 mg, 0.22 mmol) was added at −78° C. The mixture was stirred at −60° C. under N2. The mixture was stirred at -78 °C for 2 h. The mixture was quenched with aqueous NaHCO3 and H2O. It was then extracted with DCM (30 mL x 3). The combined organic layers were dried over potassium carbonate. The residue was purified by prep HPLC to give compound 15 (30 mg, yield 15.7%). 1 H NMR (CDCl3, 300 MHz): δ7.91-7.86 (m, 2H), 7.09-7.0 5 (m, 2H), 6.76 (s, 1H), 4.89 (s, 1H), 4.75-4.65 (m, 1H), 4.47-4.41 (m, 1H), 4.3 8-4.32 (m, 1H), 3.69-3.62 (m, 1H), 3.58-3.45 (m, 16H), 3.34-3.27 (m, 2H), 3.18-3 .12 (m, 2H), 2.57-2.53 (m, 4H); LC-MS: m / z 865.5 [M+H]+.

[0119] 16. Synthesis of Compound 16

[0120] [ka]

[0121] Compound A1 (500 mg, 0.65 mmol) and m-tolylamine (143 mg To a solution of Ti(O-iPr)4 (190 mg, 0.66 mmol) was added Ti(O-iPr)4 (1.33 mmol). The mixture was heated under N2 The mixture was quenched with HO (100 mL) and extracted with DCM (30 mL x 3) The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by pretreatment. The crude products 16-1 and 16-2 (180 mg) were obtained as yellow solids after purification by step-HPLC. LC-MS: m / z 855.2 [M+H] + .

[0122] A solution of a mixture of compounds 16-1 and 16-2 (170 mg, 0.19 mmol) in DCM (10 mL) was added to the flask with N DAST (32 mg, 0.20 mmol) was added at −78° C. After stirring at −78° C. for 1 h, the mixture was diluted with NaH It was quenched with aqueous CO3 and H2O, then extracted with DCM (30 mL x 3). The organic layer was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. Compound 16 was obtained as a yellow solid (30 mg, 18.8% yield). 1 H NMR (CDCl3, 300 MHz ): δ7.17-7.09 (m, 1H), 6.87-6.75 (m, 4H), 4.90 (s, 1H), 4.75-4.67 (m, 1H), 4.74 -4.41 (m, 1H), 4.37-4.30 (m, 1H), 3.69-3.62 (m, 1H), 3.59-3.44 (m, 14H), 3.33-3. 25 (m, 2H), 2.41-2.15 (m, 14H), 2.03-1.97 (m, 1H), 1.32-1.16 (m, 13H), 0.90-0.79 (m, 4H); LC-MS: m / z 837.2 [M+H]+.

[0123] 17. Synthesis of Compound 17

[0124] [ka]

[0125] Compound A1 (500 mg, 0.65 mmol) and 3-chloro-phenylamine in toluene (10 mL) To a solution of 170.5 mg, 1.33 mmol of tetrahydrofuran was added Ti(O-iPr)4 (190 mg, 0.66 mmol). The mixture was stirred under N2 at 120 °C overnight. The mixture was quenched with H2O (100 mL) and extracted with DCM. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give crude products 17-1 and 17-2 (120 mg) as yellow solids. LC-MS: m / z 875.1 [M+H] + .

[0126] A solution of a mixture of compounds 17-1 and 17-2 (120 mg, 0.14 mmol) in DCM (10 mL) was added to the flask with N DAST (32 mg, 0.20 mmol) was added at −78° C. After stirring at −78° C. for 2 h, the mixture was diluted with NaH It was quenched with aqueous CO3 and H2O, then extracted with DCM (30 mL x 3). The organic layer was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. Compound 17 was obtained as a white solid (40 mg, 34.1% yield). 1 H NMR (CDCl3, 300 MHz ): δ7.18-7.12 (m, 1H), 6.99-6.92 (m, 3H), 6.75 (s, 1H), 4.89 (s, 1H), 4.73-4.65 (m, 1H), 4.44-4.41 (m, 1H), 4.36-4.29 (m, 1H), 3.68-3.61 (m, 1H), 3.31-3.24 (m, 2H), 2.58-2.47 (m, 2H), 2.41-2.39 (m, 1H), 2.28-2.15 (m, 10H), 2.01-1.96 (m, 1H) ), 0.89-0.76 (m, 4H); LC-MS: m / z 857.1 [M+H]+.

[0127] 18. Synthesis of Compound 18

[0128] [ka]

[0129] Compound A1 (500 mg, 0.65 mmol) and 3-methoxy-phenylalanine in toluene (10 mL) To a solution of amine (164 mg, 1.31 mmol) was added Ti(O-iPr)4 (190 mg, 0.66 mmol). The mixture was stirred under N2 at 120 °C overnight. The mixture was quenched with H2O (100 mL) and extracted with DCM. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give crude products 18-1 and 18-2 (120 mg) as yellow solids. LC-MS: m / z 871.2 [M+H] + .

[0130] A solution of a mixture of compounds 18-1 and 18-2 (120 mg, 0.13 mmol) in DCM (10 mL) was added to the flask with N DAST (32 mg, 0.20 mmol) was added at −78° C. After stirring at −78° C. for 2 h, the mixture was diluted with NaH It was quenched with aqueous CO3 and H2O, then extracted with DCM (30 mL x 3). The organic layer was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. Compound 18 was obtained as a yellow solid (30 mg, 27% yield). 1 H NMR (CDCl3, 400 MHz): δ7.15 (d, J = 8.0 Hz, 1H), 6.75 (s, 1H), 6.66 (d, J = 7.2 Hz, 1H), 6.59 (s, 1H) , 6.52 (dd, J = 8.0,1.6 Hz, 1H), 4.89 (s, 1H), 4.73-4.65 (m, 1H), 4.46-4.40 (m, 1H), 4.36-4.28 (m, 1H), 3.78 (s, 3H), 3.67-3.60 (m, 1H), 3.32-3.24 (m, 2H), 3.14 -3.08 (m, 2H), 2.59-2.47 (m, 2H), 2.41-2.37 (m, 1H), 2.02-1.96 (m, 1H), 0.89-0.7 5 (m, 4H); LC-MS: m / z 853.2 [M+H] + .

[0131] 19. Synthesis of Compound 19

[0132] [ka]

[0133] Compound A1 (500 mg, 0.65 mmol) and 2,4-dimethoxy-phenyl To a solution of diphenylamine (203.5 mg, 1.33 mmol) was added Ti(O-iPr)4 (190 mg, 0.66 mmol). The mixture was stirred under N2 at 120 °C overnight. The mixture was quenched with H2O (100 mL) and diluted with DCM. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and The residue was purified by prep HPLC to give crude products 19-1 and 19-2 (20 0 mg). LC-MS: m / z 901.2 [M+H] + .

[0134] A solution of a mixture of compounds 19-1 and 19-2 (200 mg, 0.22 mmol) in DCM (10 mL) was added to the flask with N DAST (53.6 mg, 0.33 mmol) was added at −78° C. After stirring at −78° C. for 2 h, the mixture was The mixture was quenched with aqueous aHCO3 and H2O, then extracted with DCM (30 mL x 3). The organic layer was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. Compound 19 was obtained as a yellow solid (15 mg, 7.7% yield). 1 H NMR (CDCl3, 300 MH z):δ6.85-6.72 (m, 1H), 6.45 (s, 1H), 6.39-6.32 (m, 2H), 4.89 (s, 1H), 4.78-4.68 (m, 1H), 4.47-4.39 (m, 1H), 4.36-4.26 (m, 1H), 3.88 (s, 3H), 3.77 (s, 3H), 3.56 -3.43 (m, 15H), 3.35-3.04 (m, 4H), 2.64-2.46 (m, 3H), 2.36-2.13 (m, 10H), 2.05-1 .93 (m, 2H), 0.91-0.73 (m, 4H); LC-MS: m / z 883.2 [M+H] + .

[0135] 20. Synthesis of Compound 20

[0136] [ka]

[0137] Compound A1 (500 mg, 0.65 mmol) and 2,4-dimethoxy-phenyl To a solution of diphenylamine (203.5 mg, 1.33 mmol) was added Ti(O-iPr)4 (190 mg, 0.66 mmol). The mixture was stirred under N2 at 120 °C overnight. The mixture was quenched with H2O (100 mL) and diluted with DCM. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and The residue was purified by prep HPLC to give crude products 20-1 and 20-2 (20 0 mg). LC-MS: m / z 869.2 [M+H] + .

[0138] A solution of a mixture of compounds 20-1 and 20-2 (200 mg, 0.23 mmol) in DCM (10 mL) was added to the flask with N DAST (53.6 mg, 0.33 mmol) was added at −78° C. After stirring at −78° C. for 2 h, the mixture was The mixture was quenched with aqueous aHCO3 and H2O, then extracted with DCM. The combined organic layers were The mixture was dried over O3, filtered and concentrated. The residue was purified by prep HPLC to give compound 1 as a yellow solid. Compound 20 was obtained (16 mg, 8.2% yield). 1 H NMR (CDCl3, 300 MHz):δ6.76 (s, 1H), 6 .63 (s, 2H), 6.61 (s, 1H), 4.89 (s, 1H), 4.74-4.66 (m, 1H), 4.46-4.38 (m, 1H), 4 .36-4.29 (m, 1H), 3.69-3.63 (m, 1H), 3.32-3.24 (m, 2H), 2.29-2.13 (m, 18H), 2.01 -1.96 (m, 1H), 0.89-0.75 (m, 4H); LC-MS: m / z 851.2 [M+H] + .

[0139] 21. Synthesis of Compound 21

[0140] [ka]

[0141] Compound A1 (500 mg, 0.65 mmol) and (4-amino-phenyl)- A solution of tert-butyl carbamate (278 mg, 1.33 mmol) was added to Ti(O-iPr)4 (190 mg, 0.66 mmol) was added. The mixture was stirred under N2 at 120 °C overnight. The mixture was diluted with H2O (100 mL ) and extracted with DCM (30 mL x 3). The combined organic layers were washed with potassium carbonate It was dried, filtered and concentrated. The residue was purified by prep HPLC to give the crude product as a yellow solid. 21-1 and 21-2 (300 mg) were obtained. LC-MS: m / z 956.6 [M+H] + .

[0142] A solution of a mixture of compounds 21-1 and 21-2 (220 mg, 0.22 mmol) in DCM (10 mL) was added to the flask with N DAST (52 mg, 0.32 mmol) was added at −78° C. After stirring at −78° C. for 2 h, the mixture was diluted with NaH It was quenched with aqueous CO3 and H2O, then extracted with DCM (30 mL x 3). The organic layer was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. Compound 21 was obtained as a white solid (12 mg, 5.9% yield). 1 H NMR (CDCl3, 400 MHz) :δ7.23-7.19 (m, 2H), 6.94 (d, J = 8.4 Hz, 2H), 6.75 (s, 1H), 6.34 (s, 1H), 4.88 (s, 1H), 4.72-4.66 (m, 1H), 4.48-4.43 (m, 1H), 4.34-4.29 (m, 1H), 3.68-3.62 (m, 1H), 3.56-3.42(m, 17H), 3.30-3.24 (m, 2H), 3.14-3.07 (m, 1H), 0.85 (t, J = 7.6 Hz, 3H); LC-MS: m / z 938.6 [M+H]+ .

[0143] 22. Synthesis of Compound 22

[0144] [ka]

[0145] Compound A1 (500 mg, 0.65 mmol) and 3-fluoro-2-methyl- To a solution of phenylamine (166 mg, 1.33 mmol), Ti(O-iPr)4 (190 mg, 0.66 mmol) was added. The mixture was stirred at 120 °C under N2 overnight. The mixture was quenched with H2O and extracted with DCM. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by column chromatography on silica gel (DCM / MeOH = 20 / 1) to give a yellow The crude products 22-1 and 22-2 (350 mg) were obtained as solids, which were carried out without further purification. Used in next step. LC-MS: m / z 873.5 [M+H] + .

[0146] A solution of a mixture of compounds 22-1 and 22-2 (350 mg, 0.4 mmol) in DCM (10 mL) was added under N DAST (64.5 mg, 0.4 mmol) was added at -78°C. After stirring at -78°C for 2 hours, the mixture was diluted with NaHC It was quenched with aqueous O3 and H2O, then extracted with DCM (30 mL x 3). The organic layer was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. Compound 22 was obtained as a yellow solid (100 mg, 29.2% yield). 1 H NMR (CDCl3, 400 MH z):δ7.05-6.99 (m, 1H), 6.76 (s, 1H), 6.71-6.64 (m, 2H), 4.88 (s, 1H), 4.73-4.67 (m, 1H), 4.45-4.41 (m, 1H), 4.35-4.31 (m, 1H), 3.67-3.62 (m, 1H), 3.30-3.25 (m, 2H), 3.18-3.09 (m, 2H), 2.62-2.55 (m, 1H), 2.51-2.47 (m, 1H), 2.39-2.35 (m, 1H) , 2.29 (s, 3H), 0.88-0.80 (m, 4H); LC-MS: m / z 855.2 [M+H]+.

[0147] 23. Synthesis of compound 23

[0148] [ka]

[0149] Compound A1 (500 mg, 0.65 mmol) and 2,3-dimethoxy-phenyl To a solution of diphenylamine (203.5 mg, 1.33 mmol) was added Ti(O-iPr)4 (190 mg, 0.66 mmol). The mixture was stirred under N2 at 120 °C overnight. The mixture was quenched with H2O (100 mL) and diluted with DCM. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and The residue was purified by column chromatography on silica gel (DCM / MeOH = 20 / 1 ), to give crude products 23-1 and 23-2 (300 mg) as yellow solids, which were purified further by purification. Used in next step without purification. LC-MS: m / z 901.2 [M+H] + .

[0150] A solution of a mixture of compounds 23-1 and 23-2 (300 mg, 0.33 mmol) in DCM (10 mL) was added to the flask with N DAST (107.2 mg, 0.66 mmol) was added at −78° C. After stirring at −78° C. for 2 hours, the mixture was It was quenched with aqueous NaHCO3 and H2O, then extracted with DCM (30 mL x 3). The combined organic layer was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. Compound 23 was obtained as a white solid (40 mg, 13.7% yield). 1 H NMR (CDCl3, 400 MHz): δ6.92 (d, J = 8.0 Hz, 1H), 6.75 (s, 1H), 6.59-6.54 (m, 2H), 4.89 (s, 1H) , 4.77-4.68 (m, 1H), 4.45-4.39 (m, 1H), 4.36-4.28 (m, 1H), 3.93 (s, 3H), 3.85 (s , 3H), 3.71-3.59 (m, 1H), 3.31-3.08 (m, 4H), 2.74-2.68 (m, 1H), 2.64-2.56 (m, 1H) ), 2.39-2.34 (m, 1H), 2.01-1.94 (m, 1H); LC-MS: m / z 883.2 [M+H]+.

[0151] 24. Synthesis of compound 24

[0152] [ka]

[0153] Compound A1 (500 mg, 0.65 mmol) and 3,4,5-trifluoro- A solution of phenylamine (196.5 mg, 1.33 mmol) was added with Ti(O-iPr)4 (190 mg, 0.66 mmol). The mixture was stirred under N2 at 120 °C overnight. The mixture was quenched with H2O (100 mL) and Extracted with DCM (30 mL x 3). The combined organic layers were dried over potassium carbonate and filtered. The residue was purified by column chromatography on silica gel (DCM / MeOH = 20 / 1), the crude products 24-1 and 24-2 (300 mg) were obtained as yellow solids, which were further purified by Used in next step without purification. C-MS: m / z 895.5 [M+H] + .

[0154] A solution of compounds 24-1 and 24-2 (300 mg, 0.33 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (54 mg, 0.33 mmol) was added. After stirring at -78 °C for 2 h, the mixture was diluted with NaHCO3 aqueous solution. and H2O, then extracted with DCM (30 mL x 3). The combined organic layers were Dry over potassium carbonate, filter and concentrate. The residue was purified by prep HPLC to give a white solid Compound 24 was obtained as a partial elution product (30 mg, yield 10.3%). 1 H NMR (CDCl3, 400 MHz): δ 6.73 (s, 1H), 6.63-6.59 (m, 2H), 4.88 (s, 1H), 4.71-4.64 (m, 1H), 4.47-4.41 (m, 1H), 4.35-4.29 (m, 1H), 3.67-3.61 (m, 1H), 3.57-3.40 (m, 1H), 3.67-3.61 (m, 1H), 3.5 7-3.40 (m, 14H), 3.33-3.23 (m, 2H), 3.15-3.08 (m, 2H), 0.90-0.75 (m, 4H); LC-MS: m / z 877.5 [M+H] + .

[0155] 25. Synthesis of compound 25

[0156] [ka]

[0157] Compound A1 (500 mg, 0.65 mmol) and 3-fluoro-2-methyl- To a solution of methoxy-phenylamine (186 mg, 1.32 mmol), ZrCl4 (230 mg, 0.99 mmol) was added. The mixture was stirred at room temperature under N2 for 1 h. The mixture was then cooled with NaHCO3 aq. and H2O. The mixture was quenched and extracted with DCM (30 mL x 3). The combined organic layers were dried over potassium carbonate. The residue was purified by column chromatography on silica gel (DCM / MeOH = 20 / 1) to give crude products 25-1 and 25-2 (350 mg) as yellow solids, which were , used in the next step without further purification. LC-MS: m / z 889.5 [M+H] + .

[0158] A solution of compounds 25-1 and 25-2 (350 mg, 0.39 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (95 mg, 0.59 mmol) was added. After stirring at -78 °C for 2 h, the mixture was diluted with NaHCO3 aqueous solution. and H2O, then extracted with DCM (30 mL x 3). The combined organic layers were Dry over potassium carbonate, filter and concentrate. The residue was purified by prep HPLC to give a white solid Compound 25 was obtained as a partial elution product (40 mg, yield 11.7%). 1 H NMR (CDCl3, 400 MHz): δ 6.92 -6.83 (m, 1H), 6.77-6.67 (m, 3H), 4.89 (s, 1H), 4.76-4.70 (m, 1H), 4.49-4.44 (m, 1H), 4.36-4.29 (m, 1H), 3.99 (s, 3H), 3.67-3.61 (m, 1H), 3.59-3.44 (m, 18H), 3. 30-3.09 (m, 4H), 0.89-0.78 (m, 4H); LC-MS: m / z 871.5 [M+H] + .

[0159] 26. Synthesis of compound 26

[0160] [ka]

[0161] Compound A1 (500 mg, 0.65 mmol) and 3,5-difluoro- To a solution of phenylamine (172 mg, 1.33 mmol) was added ZrCl4 (230 mg, 0.99 mmol). The mixture was stirred at room temperature under N2 for 1 h. The mixture was quenched with aqueous NaHCO3 and H2O. The combined organic layers were dried over K2CO3, filtered and extracted with DCM (30 mL x 3). The residue was purified by column chromatography on silica gel (DCM / MeOH = 20 / 1 ), to give crude products 26-1 and 26-2 (300 mg) as yellow solids, which were purified further by purification. Used in next step without purification. LC-MS: m / z 889.5 [M+H] + .

[0162] A solution of compounds 26-1 and 26-2 (300 mg, 0.34 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (82.6 mg, 0.5 mmol) was added. After stirring at -78 °C for 2 h, the mixture was diluted with NaHCO3 The mixture was quenched with HO and then extracted with DCM (30 mL x 3). The combined organic layers The mixture was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a white solid. Compound 26 was obtained as a partial elution product (15 mg, yield 5.1%). 1 H NMR (CDCl3, 400 MHz): δ 6.74 (s, 1H), 6.54-6.51 (m, 2H), 6.44-6.37 (m, 1H), 4.88 (s, 1H), 4.73-4.65 (m, 1H), 4.48-4.34 (m, 1H), 4.35-4.28 (m, 1H), 3.67-3.612 (m, 1H), 3.56-3.41 (m, 19H), 3 .32-3.23 (m, 2H), 3.14-3.09 (m, 2H), 0.91-0.77 (m, 4H); LC-MS: m / z 860.1 [M+H] + .

[0163] 27. Synthesis of compound 27

[0164] [ka]

[0165] Compound A1 (500 mg, 0.65 mmol) and 5-fluoro-2-methylaniline in MeCN (10 mL) To a solution of 167 mg (1.32 mmol) of tetrahydrofuran, Ti(O-iPr)4 (190 mg, 0.66 mmol) was added. The mixture was stirred under N2 at 80 °C overnight. The mixture was quenched with H2O (50 mL) and extracted with DCM. (20 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by column chromatography on silica gel (DCM / MeOH = 20 / 1) to give a yellow solid. The crude products 27-1 and 27-2 (300 mg) were obtained as 27-1 and 27-2. LC-MS: m / z 873.2 [M+H] + .

[0166] A solution of compounds 27-1 and 27-2 (250 mg, 0.29 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (82.6 mg, 0.5 mmol) was added. After stirring at -78 °C for 2 h, the mixture was diluted with NaHCO3 The mixture was quenched with HO and then extracted with DCM (30 mL x 3). The combined organic layers The mixture was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a white solid. Compound 27 was obtained as a partial ester (79 mg, yield 32.4%). 1 H NMR (CDCl3, 400 MHz): δ7. 04 (t, J = 8 Hz, 1H), 6.76 (s, 1H), 6.63-6.55 (m, 2H), 4.88 (s, 1H), 4.70 (d, J = 4 Hz, 1H), 4.43 (d, J = 8 Hz, 1H), 4.36-4.31 (m, 1H), 3.67-3.62 (m, 1H), 3.30- 3.24 (m, 2H), 3.16-3.09 (m, 2H), 2.59 (m, 1H), 2.50 (m, 1H), 2.34 (s, 3H), 2.24- 2.12 (m, 12H), 1.99 (d, J = 9.6 Hz, 1H), 1.87-1.43 (m, 18H), 1.31-1.18 (m, 17H), 0.89-0.79 (m, 3H). LC-MS: m / z 855.2 [M+H] + .

[0167] 28. Synthesis of compound 28

[0168] [ka]

[0169] Compound A1 (400 mg, 0.53 mmol) and 2,4,6-trimethylaniline in toluene (10 mL) To a solution of 144 mg (1.07 mmol) of tetrahydrofuran was added Ti(O-iPr)4 (151.6 mg, 0.53 mmol). The mixture was stirred under N2 at 120 °C overnight. The mixture was quenched with H2O (50 mL) and extracted with DCM. (20 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by column chromatography on silica gel (DCM / MeOH = 15 / 1) to give a yellow The crude products 28-1 and 28-2 (280 mg) were obtained as solids. LC-MS: m / z 883.6 [M+H] + .

[0170] A solution of compounds 28-1 and 28-2 (280 mg, 0.32 mmol) in DCM (5 mL) was heated to -78 °C under N2. Then, DAST (51 mg, 0.32 mmol) was added. After stirring at -78 °C for 2 h, the mixture was diluted with NaHCO3 aqueous solution. and H2O, then extracted with DCM (30 mL x 3). The combined organic layers were Dry over potassium carbonate, filter and concentrate. The residue was purified by prep HPLC to give a yellow solid Compound 28 was obtained as a partial elution product (65 mg, 23% yield). 1 H NMR (CDCl3, 400 MHz):δ6.77 ( m, 3H), 4.87 (s, 1H), 4.87 (s, 1H), 4.75-7.70 (m, 1H), 4.43 (d, J = 7.6 Hz, 1H), 4.34-4.29 (m, 1H), 3.30-3.21 (m, 2H), 3.16-3.09 (m, 2H), 2.65-2.60 (m, 1H), 2.5 5-2.50 (m, 1H), 2.36 (s, 6H), 2.02-1.95 (m, 1H),;LC-MS: m / z 865.6 [M+H] + .

[0171] 29. Synthesis of Compound 29

[0172] [ka]

[0173] Compound A1 (400 mg, 0.53 mmol) and 5-fluoro-2-methoxyphenyl To a solution of aniline (150.7 mg, 1.07 mmol), Ti(O-iPr)4 (151.6 mg, 0.53 mmol) was added. The mixture was stirred under N2 at 120 °C overnight. The mixture was quenched with H2O (50 mL) and (20 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and The residue was purified by column chromatography on silica gel (DCM / MeOH = 15 / 1 ), to obtain crude products 29-1 and 29-2 (320 mg) as yellow solids. LC-MS: m / z 889.4 [M+H] + .

[0174] A solution of compounds 29-1 and 29-2 (310 mg, 0.35 mmol) in DCM (5 mL) was heated to -78 °C under N2. Then, DAST (56.2 mg, 0.35 mmol) was added. After stirring at -78 °C for 2 h, the mixture was diluted with NaHCO3 The mixture was quenched with HO and then extracted with DCM (30 mL x 3). The combined organic layers The mixture was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a white solid. Compound 29 was obtained as a partial ester (53 mg, yield 17.5%). 1 H NMR (CDCl3, 400 MHz): δ6. 75-6.71 (m, 2H), 6.64-6.59 (m, 2H), 4.89 (s, 1H), 4.76-4.72 (m, 1H), 4.43 (d, J = 8.0 Hz, 1H), 4.34-4.30 (m, 1H), 3.87 (s, 3H), 2.59-2.50 (m, 2H), LC-MS: m / z 87 1.4 [M+H] + .

[0175] 30. Synthesis of Compound 30

[0176] [ka]

[0177] Compound A1 (0.5 g, 0.65 mmol) and 4-isopropoxyaniline in toluene (10 mL) To a solution of tetrahydrofuran (202 mg, 1.34 mmol) was added Ti(O-iPr)4 (190 mg, 0.66 mmol). The mixture was stirred at 120° C. overnight. The mixture was quenched with H2O (50 mL) and extracted with DCM (20 mL). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was The product was purified by column chromatography on silica gel (DCM / MeOH = 15 / 1) to give a brown solid. The crude products 30-1 and 30-2 (140 mg) were obtained. LC-MS: m / z 899.2 [M+H] + .

[0178] A solution of compounds 30-1 and 30-2 (137 mg, 0.15 mmol) in DCM (5 mL) was heated to -78 °C under N2. Then, DAST (24.5 mg, 0.15 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with NaHCO3 The mixture was quenched with HO and then extracted with DCM (30 mL x 3). The combined organic layers The mixture was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. Compound 30 was obtained as a partial elution product (19 mg, yield 14%). 1 H NMR (CDCl3, 400 MHz): δ 6.93 (d, J =8.8 Hz, 2H), 6.78-6.75 (m, 3H), 4.88 (s, 1H), 4.71-4.66 (m, 1H), 4.46-4. 33 (m, 2H), 4.32-4.29 (m, 1H), 3.66-3.63 (m, 1H), 3.29-3.26 (m, 2H), 3.13-3.09 ( m, 2H), 3.56-2.33 (m, 3H); LC-MS: m / z 881.2 [M+H] + .

[0179] 31. Synthesis of Compound 31

[0180] [ka]

[0181] Compound A1 (0.4 g, 0.53 mmol) and 3,5-dichloroaniline (1 To a solution of Ti(O-iPr)4 (71.7 mg, 1.06 mmol), Ti(O-iPr)4 (150.5 mg, 0.53 mmol) was added. The mixture was stirred under N2 at 120 °C overnight. The mixture was quenched with H2O (30 mL) and extracted with EA. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to obtain crude products 31-1 and 31-2 (100 mg) as yellow solids. LC-MS: m / z 909.1 [M+H] + .

[0182] A solution of compounds 31-1 and 31-2 (75 mg, 0.08 mmol) in DCM (5 mL) was added at −78 °C under N DAST (13.3 mg, 0.08 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with NaHCO3 aq. and H2O, then extracted with DCM (30 mL x 3). The combined organic layers were Dry over potassium carbonate, filter and concentrate. The residue was purified by prep HPLC to give a white solid Compound 31 was obtained as a partial elution product (18 mg, yield 25%). 1 H NMR (CDCl3, 400 MHz):δ6.95 ( s, 1H), 6.88 (s, 2H), 6.74 (s, 1H),4.89 (s, 1H), 4.71-4.65 (m, 1H), 4.43 (d, J = 7.6 Hz, 1H), 4.38-4.32 (m, 1H), 3.65 (m, 1H), 3.31-3.25 (m, 2H), 3.14-3.09 (m, 2H), 2.54-2.39 (m, 3H), 2.00-1.84 (m, 3H); LC-MS: m / z 891.1 [M+H] + .

[0183] 32. Synthesis of compound 32

[0184] [ka]

[0185] Compound A1 (0.5 g, 0.65 mmol) and 3,5-dimethoxyaniline in toluene (10 mL) (205 mg, 1.34 mmol) was added to a solution of Ti(O-iPr)4 (190 mg, 0.67 mmol). The mixture was stirred at 120 °C overnight. The mixture was quenched with H2O (30 mL) and extracted with EA (30 mL x 3) The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by pretreatment. The crude products 32-1 and 32-2 (110 mg) were obtained as yellow solids by HPLC. -MS: m / z 901.5 [M+H] + .

[0186] A solution of compounds 32-1 and 32-2 (110 mg, 0.12 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (19.1 mg, 0.12 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with NaHCO3 The mixture was quenched with HO and then extracted with DCM (30 mL x 3). The combined organic layers The mixture was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. Compound 32 was obtained as a partial ester (12 mg, yield 11%). 1 H NMR (CDCl3, 400 MHz): δ 6.74 (s, 1H), 6.22 (d, J = 2.0 Hz, 2H), 6.10 (t, J = 2.0 Hz, 1H), 4.88 (s, 1H), 4.42 (d, J = 7.2 Hz, 1H), 4.31 (m, 1H), 3.78 (s, 6H), 3.66-3.61 (m, 1H), 3.27 (dd, J = 12.8, 4.8 Hz, 2H), 3.11 (t, J = 9.6 Hz, 2H), 2.52-2.46 (m, 2H), 2.39-2.37 (m, 1H), 0.84 (t, J = 7.2 Hz, 3H); LC-MS: m / z 883.5 [M+H] + .

[0187] 33. Synthesis of Compound 33

[0188] [ka]

[0189] Compound A1 (0.4 g, 0.53 mmol) and ethyl 4-aminobenzoate in toluene (10 mL) To a solution of tetrahydrofuran (176.5 mg, 1.07 mmol) was added Ti(O-iPr)4 (152 mg, 0.535 mmol). The mixture was stirred at 120° C. overnight. The mixture was quenched with H2O (30 mL) and extracted with EA. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to obtain crude products 33-1 and 33-2 (240 mg) as yellow solids. LC-MS: m / z 913.2 [M+H] + .

[0190] A solution of compounds 33-1 and 33-2 (240 mg, 0.26 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (42.3 mg, 0.26 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with NaHCO3 The mixture was quenched with HO and then extracted with DCM (30 mL x 3). The combined organic layers The mixture was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. Compound 33 was obtained as a partial ester (34 mg, yield 14%). 1 H NMR (CDCl3, 300 MHz): δ7.93 (d, J = 8.4 Hz, 2H), 7.05 (d, J = 8.4 Hz, 2H), 6.76 (s, 1H), 4.90 (s, 1H), 4.74 -4.68 (m, 1H), 4.46-4.31 (m, 4H), 3.35-3.29 (m, 2H), 3.16-3.09 (m, 2H), 2.61-2.4 5 (m, 3H), 0.87 (t, J = 19.2 Hz, 3H); LC-MS: m / z 895.2 [M+H] + .]

[0191] 34. Synthesis of compound 34

[0192] [ka]

[0193] Compound A1 (0.5 g, 0.65 mmol) and 2-fluoroaniline (148 To a solution of Ti(O-iPr)4 (190 mg, 0.66 mmol) was added Ti(O-iPr)4 (1.33 mmol). The mixture was stirred at 20° C. overnight. The mixture was quenched with H2O (30 mL) and extracted with EA (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was prepped. Purification by HPLC gave the crude products 34-1 and 34-2 (240 mg) as yellow solids. LC-MS: m / z 859.2 [M+H] + .

[0194] A solution of compounds 34-1 and 34-2 (235 mg, 0.27 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (44.1 mg, 0.27 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with NaHCO3 The mixture was quenched with HO and then extracted with DCM (30 mL x 3). The combined organic layers The mixture was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. Compound 34 was obtained as a partial ester (30 mg, yield 13%). 1 H NMR (CDCl3, 400 MHz): δ7.34 -6.99 (m, 4H), 6.75 (s, 1H), 4.89 (s, 1H), 4.71 (m, 1H), 4.44 (d, J = 7.2 Hz, 1H ), 4.33 (m, 1H), 3.28-3.23 (m, 2H), 3.15-3.09 (m, 2H), 2.61-2.53 (m, 2H), 2.43 ( m, 1H), 2.21-2.17 (m, 10H), 0.85 (t, J = 7.2 Hz, 3H); LC-MS: m / z 841.2 [M+H] + .

[0195] 35. Synthesis of Compound 35

[0196] [ka]

[0197] Compound A1 (0.4 g, 0.53 mmol) and 3-(trifluoromethyl) To a solution of aniline (172 mg, 1.07 mmol) was added Ti(O-iPr)4 (152 mg, 0.53 mmol). The mixture was stirred at 120° C. overnight. The mixture was quenched with H2O (30 mL) and extracted with EA. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to obtain crude products 35-1 and 35-2 (160 mg) as yellow solids. LC-MS: m / z 909.2 [M+H] + .

[0198] A solution of compounds 35-1 and 35-2 (160 mg, 0.18 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (28.3 mg, 0.18 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with NaHCO3 The mixture was quenched with HO and then extracted with DCM (30 mL x 3). The combined organic layers The mixture was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. Compound 35 was obtained as a partial elution product (70 mg, yield 45%). 1 H NMR (CDCl3, 400 MHz): δ7.36 -7.33 (m, 1H), 7.22-7.18 (m, 3H), 6.75 (s, 1H), 4.90 (s, 1H), 4.69 (m, 1H), 4.43 (d, J = 8.4 Hz, 1H), 4.34 (m, 1H), 3.33-3.28 (m, 2H), 3.14-3.10 (m, 2H), 2.56-2 .43 (m, 2H), 0.86 (t, J = 7.6 Hz, 3H); LC-MS: m / z 891.2 [M+H] + .

[0199] 36. Synthesis of Compound 36

[0200] [ka]

[0201] Compound A1 (0.5 g, 0.65 mmol) and 4-aminophenylacetate in toluene (10 mL) To a solution of tetrahydrofuran (172 mg, 1.07 mmol) was added Ti(O-iPr)4 (190 mg, 0.66 mmol). The mixture was stirred at 120° C. overnight. The mixture was quenched with H2O (30 mL) and extracted with EA (30 The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was Purification by prep HPLC gave crude products 36-1 and 36-2 (210 mg) as yellow solids. LC-MS: m / z 857.2 [M+H] + .

[0202] A solution of compounds 36-1 and 36-2 (210 mg, 0.24 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (51.5 mg, 0.31 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with NaHCO3 The mixture was quenched with HO and then extracted with DCM (30 mL x 3). The combined organic layers The mixture was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. Compound 36 was obtained as a partial elution product (80 mg, yield 39%). 1 H NMR (CDCl3, 400 MHz): δ 6.91 (d, J = 8.4 Hz, 2H), 6.75 (s, 1H), 6.71 (d, J = 8.4 Hz, 2H), 4.88 (s, 1H), 4.69 (m, 1H), 4.43 (d, J = 7.2 Hz, 1H), 4.31 (m, 1H), 3.31-3.26 (m, 2H), 3.14-3.09 ( m, 2H), 0.85 (t, J = 7.2 Hz, 3H); LC-MS: m / z 839.2 [M+H] + .

[0203] 37. Synthesis of compound 37

[0204] [ka]

[0205] Compound A1 (0.5 g, 0.65 mmol) and o-toluidine (143 mg, 1 To a solution of Ti(O-iPr)4 (190 mg, 0.66 mmol) was added Ti(O-iPr)4 (190 mg, 0.66 mmol). The mixture was heated at 120 °C. The mixture was stirred overnight. The mixture was quenched with H2O (30 mL) and extracted with EA (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. After purification, the crude products 37-1 and 37-2 (140 mg) were obtained as yellow solids. LC-MS: m / z 8 55.5 [M+H] + .

[0206] A solution of compounds 37-1 and 37-2 (140 mg, 0.16 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (26.4 mg, 0.16 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with NaHCO3 The mixture was quenched with HO and then extracted with DCM (30 mL x 3). The combined organic layers The mixture was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. Compound 37 was obtained as a partial elution product (14 mg, 10% yield). 1 H NMR (CDCl3, 400 MHz): δ7.12 -7.08 (m, 2H), 6.92-6.85 (m, 2H), 6.77 (s, 1H), 4.88 (s, 1H), 4.69 (m, 1H), 4.43 (d, J = 7.6 Hz, 1H), 4.33 (m, 1H), 3.30-3.24 (m, 2H), 3.16-3.09 (m, 2H), 0.84 ( t, J = 7.2 Hz, 3H); LC-MS: m / z 837.5 [M+H]+ .

[0207] 38. Synthesis of compound 38

[0208] [ka]

[0209] Compound A1 (0.5 g, 0.65 mmol) and 3,4-difluoroaniline in toluene (10 mL) (172.0 mg, 1.34 mmol) was added to a solution of Ti(O-iPr)4 (190 mg, 0.66 mmol). After stirring at rt overnight, the mixture was quenched with H2O (30 mL) and extracted with EA (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by Prep HP Purification by LC gave the crude products 38-1 and 38-2 (240 mg) as brown solids. LC-MS: m / z 877.2 [M+H] + .

[0210] A solution of compounds 38-1 and 38-2 (240 mg, 0.27 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (44.5 mg, 0.27 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with NaHCO3 The mixture was quenched with HO and then extracted with DCM (30 mL x 3). The combined organic layers The mixture was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. Compound 38 was obtained as a partial elution product (40 mg, yield 28%). 1 H NMR (CDCl3, 400 MHz): δ7.03 -6.99 (m, 1H), 6.85-6.78 (m, 1H), 6.75-6.72 (m, 2H), 4.90 (s, 1H), 4.68 (m, 1H), 4.47 (d, J =8.8 Hz, 1H), 4.32 (m, 1H), 3.66-3.62 (m, 1H), 3.33-3.22 (m, 2H), 3. 15-3.11 (m, 2H), 2.37 (m, 1H), 0.85 (t, J = 7.6 Hz, 3H); LC-MS: m / z 859.2 [M+H] + .

[0211] 39. Synthesis of compound 39

[0212] [ka]

[0213] Compound A1 (0.5 g, 0.65 mmol) and 2,3-difluoroaniline in toluene (10 mL) (172.0 mg, 1.34 mmol) was added to a solution of Ti(O-iPr)4 (190 mg, 0.66 mmol). After stirring at rt overnight, the mixture was quenched with H2O (30 mL) and extracted with EA (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by Prep HP Purification by LC gave the crude products 39-1 and 39-2 (150 mg) as brown solids. LC-MS: m / z 877.2 [M+H] + .

[0214] A solution of compounds 39-1 and 39-2 (150 mg, 0.17 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (28 mg, 0.17 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with NaHCO3 aqueous solution. and H2O, then extracted with DCM (30 mL x 3). The combined organic layers were Dry over potassium carbonate, filter and concentrate. The residue was purified by prep HPLC to give a yellow solid Compound 39 was obtained as a partial elution product (20 mg, 14% yield). 1 H NMR (CDCl3, 400 MHz):δ6.95-6 .91 (m, 1H) 6.79-6.75 (m, 3H), 4.88 (s, 1H), 4.70 (m, 1H), 4.43 (d, J = 7.6 Hz, 1H), 4.33 (m, 1H), 3.30-3.23 (m, 2H), 3.16-3.09 (m, 2H), 2.62-2.50 (m, 2H), 2.4 7-2.44 (m, 1H), 0.85 (t, J = 7.2 Hz, 3H); LC-MS: m / z 859.2 [M+H] + .

[0215] 40. Synthesis of Compound 40

[0216] [ka]

[0217] Compound A1 (0.5 g, 0.65 mmol) and 2,4-difluoroaniline in toluene (10 mL) (172.0 mg, 1.34 mmol) was added to a solution of Ti(O-iPr)4 (190 mg, 0.66 mmol). After stirring at rt overnight, the mixture was quenched with H2O (30 mL) and extracted with EA (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by Prep HP Purification by LC gave the crude products 40-1 and 40-2 (210 mg) as brown solids. LC-MS: m / z 877.2 [M+H] + .

[0218] A solution of compounds 40-1 and 40-2 (210 mg, 0.24 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (38 mg, 0.24 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with NaHCO3 aqueous solution. and H2O, then extracted with DCM (30 mL x 3). The combined organic layers were Dry over potassium carbonate, filter and concentrate. The residue was purified by prep HPLC to give a yellow solid Compound 40 was obtained as a partial elution product (40 mg, yield 20.5%). 1 H NMR (CDCl3, 400 MHz): δ 6.94 -6.93 (m, 1H), 6.81-6.74 (m, 3H), 4.88 (s, 1H), 4.69 (m, 1H), 4.44 (d, J = 6.8 H z 1H), 4.32 (m, 1H), 3.30-3.24 (m, 2H), 3.18-3.09 (m, 2H); LC-MS: m / z 859.2 [M +H] + .

[0219] 41. Synthesis of Compound 41

[0220] [ka]

[0221] A solution of compound A1 (0.5 g, 0.65 mmol) in toluene (10 mL) was added Ti(O-iPr)4 (190 mg, 0.66 mmol) and 2-methoxy-6-methylaniline (188 mg, 1.33 mmol). After stirring at °C overnight, the mixture was quenched with H2O (30 mL) and extracted with EA (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was flash-coated. The crude products 41-1 and 41-2 (300 mg, 51% yield) were obtained as yellow solids. This was used in the next step without further purification. LC-MS: m / z 886.4 [M+H] + .

[0222] A solution of compounds 41-1 and 41-2 (300 mg, 033 mmol) in DCM (10 mL) was heated to -78 °C under N2. Then, DAST (54 mg, 0.33 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with NaHCO3 aqueous solution. and H2O, then extracted with DCM (30 mL x 3). The combined organic layers were Dry over potassium carbonate, filter and concentrate. The residue was purified by prep HPLC to give a yellow solid Compound 41 was obtained as a partial elution product (20 mg, 7% yield). 1 H NMR (CDCl3, 400 MHz):δ6.84 (t , J = 7.6 Hz, 1H), 6.77 (s, 1H), 6.72 (d, J = 7.6 Hz, 2H), 4.88 (s, 1H), 4.76-4. 73 (m, 1H), 4.43 (d, J = 9.6 Hz, 1H), 4.32-4.30 (m, 1H), 3.85 (s, 3H), 3.30-3.20 (m, 2H), 3.14-3.09 (m, 2H), 2.62-2.56 (m, 2H), 2.36 (s, 3H); LC-MS: m / z 868.4 [ M+H] + .

[0223] 42. Synthesis of Compound 42

[0224] [ka]

[0225] A solution of compound A1 (400 mg, 0.53 mmol) in 2,4-dimethylaniline (5 mL) was added with ZrCl4( 6.0 mg, 0.026 mmol) was added. The mixture was stirred at 80° C. for 1 hour under microwave. The mixture was purified by silica gel column (DCM / MeOH = 20:1 to 10:1) followed by prep HPLC. The mixture of compounds 42-1 and 42-2 (180 mg) was obtained as a white solid. LCMS: m / z 869.2 [M +H] + .

[0226] A solution of a mixture of compounds 42-1 and 42-2 (173 mg, 0.2 mmol) in DCM (5 mL) was subjected to N DAST (99 mg, 0.6 mmol) was added at −78° C. under N2 pressure for 0.5 h at −78° C. The reaction mixture was quenched with saturated NaHCO3 solution (10 mL) and extracted with DCM (15 mL x 2) The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was The product was purified by HPLC to give compound 42 (20 mg, 11.7% yield) as a white solid. 1 H NMR (CDCl3, 400 MHz):δ6.94 (s, 1H), 6.88 (d, J = 9.2 Hz, 1H), 6.77-6.73 (m, 2H), 4 .88 (s, 1H), 4.69 (s, 1H), 4.42 (d, J = 11.2 Hz, 1H), 4.31 (s, 1H), 2.36 (s, 3H) , 0.84 (t, J = 7.6 Hz, 3H)., LCMS: m / z 851.2 [M+H] +

[0227] Synthesis of compounds A3, A4, and 43

[0228] [ka]

[0229] The epoxide compound A (A1 / A2 = 5 / 1, 3.0 g, 4.0 mmol) and trimethylsilyl ether were dissolved in toluene (30 mL). A solution of trimethylsilyl azide (923 mg, 8.0 mmol) was added to Ti(O-iPr)4 (1.14 g, 4.0 mmol). The mixture was stirred at 120 °C overnight. After cooling to room temperature, the mixture was quenched with H2O. The mixture was thawed and extracted with DCM (30 mL x 3). The combined organic layers were dried over potassium carbonate and The mixture was filtered and concentrated to give a mixture of compounds N1 and N2 (2.9 g), which was further treated with Used in next step without purification.

[0230] To a solution of compounds N1 and N2 (2.9 g, 3.6 mmol) in THF (30 mL) was added PPh3 (961 mg, 3.6 The mixture was heated to reflux for 3 h. The mixture was concentrated and the residue was Purify by column chromatography on gel (DCM / MeOH = 15 / 1) to obtain the crude product. This was further purified by prep HPLC to give compounds A3 (930 mg) and A4 as white solids. (116 mg) was obtained.

[0231] A3 (AG-733): Partial 1 H NMR (CDCl3, 400 MHz): δ6.72 (s, 1H), 4.85 (s, 1H), 4.70 -4.66 (m, 1H), 4.43-4.41 (m, 1H), 4.29-4.25 (m, 1H), 3.29-3.18 (m, 3H), 3.14-3.0 7 (m, 2H), 2.49-2.45 (m, 2H), 2.16-2.07 (m, 3H), 1.99-1.97 (m, 1H), 0.82 (t, J = 7.2 Hz, 3H). LCMS: m / z 747.2 [M+H] +

[0232] A4: Partial 1 H NMR (CDCl3, 300 MHz):δ6.57 (s, 1H), 4.86 (s, 1H), 4.67-4.62 (m, 1H), 4.40-4.41 (m, 1H), 4.25-4.18 (m, 1H), 3.67-3.63 (m, 3H), 3.36-3.08 (m, 4H), 2.57-2.49 (m, 2H), 2.43-2.37 (m, 1H, 0.82 (t, J = 7.8 Hz, 3H). LCMS: m / z 747.2 [M+H] + .

[0233] 4-Trifluoromethylphenylboronic acid (151 mg, 0.79 mmol) in toluene (20 mL) and Cu(OAc)2 (10 mg, 0.05 mmol) were added to a solution of 2,6-lutidine (57.4 mg, 0.5 mmol). 3 mmol), lauric acid (21.2 mg, 0.1 mmol), and compound A3 (400 mg, 0.53 mmol) was added. The mixture was stirred at room temperature under air for 2 days. The residue was purified by column chromatography on silica gel (MeOH / DCM = 1 / 20) and precipitation. The mixture was purified by step HPLC to give compound 43 (40 mg, 8.5% yield) as a white solid. 1 H NMR (CDCl3, 400 MHz):δ7.47 (d, J = 8.4 Hz, 2H), 7.08 (d, J = 8.4 Hz, 2H), 6.95 (s, 1H), 4.89 (s, 1H), 4.74-4.65 (m, 1H), 4.47-4.41 (m, 1H), 4.38-4.28 (m, 1H), 3.69-3.61 (m, 1H), 3.35-3.23 (m, 2H), 3.17-3.07 (m, 2H), 2.60-2.41 (m, 3H), 2.28 -2.13 (m, 10H), 2.04-1.94 (m, 1H), 0.90-0.74 (m, 4H). LCMS: m / z 891.4 [M+H] + .

[0234] 43. Synthesis of compound 44

[0235] [ka]

[0236] 4-Biphenylboronic acid (119 mg, 0.6 mmol) and Cu(OAc)2(1 5.9 mg, 0.08 mmol) was added to a solution of 2,6-lutidine (42.8 mg, 0.4 mmol), lauric acid (8.0 mg, 0.04 mmol), and compound A3 (300 mg, 0.4 mmol) were added. The mixture was stirred in an air atmosphere. The mixture was stirred at room temperature under atmospheric pressure for 2 days. The mixture was concentrated, and the residue was purified by column chromatography on silica gel. Compound 4 was purified by chromatography (MeOH / DCM = 1 / 20) and prep HPLC as a white solid. 4 was obtained (30 mg, 8.3% yield). 1 H NMR (CDCl3, 400 MHz):δ7.54 (d, J = 8.8 H z, 2H), 7.47 (d, J = 8.8 Hz, 2H), 7.41 (t, J = 8.0 Hz, 2H), 7.29-7.26 (m, 1H), 7 .09 (d, J = 8.4 Hz, 2H), 6.76 (s, 1H), 4.89 (s, 1H), 4.75-4.66 (m, 1H), 4.46-4.4 0 (m, 1H), 3.37-3.30 (m, 1H), 3.69--3.61 (m, 1H), 3.34-3.25 (m, 2H), 3.18-3.08 ( m, 2H), 2.61-2.50 (m, 2H), 2.45-2.41 (m, 1H), 2.26-2.16 (m, 9H), 0.90-0.79 (m, 4 H). LCMS: m / z 899.4 [M+H] + .

[0237] 44. Synthesis of compound 45

[0238] [ka]

[0239] 3-(morpholino)phenylboronic acid (124 mg, 0.6 mmol) in toluene (10 mL) and A solution of 2,6-lutidine (42.8 mg, 0.4 mmol), La (15.6 mg, 0.08 mmol) and Cu(OAc)2 (15.6 mg, 0.08 mmol) was added. Urinary acid (8.0 mg, 0.04 mmol) and compound A3 (300 mg, 0.4 mmol) were added. The mixture was stirred at room temperature under air for 2 days. The mixture was concentrated, and the residue was precipitated on silica gel. Purification by column chromatography (MeOH / DCM = 1 / 20) and prep HPLC gave a white solid. Compound 45 was obtained as a partial elution product (40 mg, yield 11.2%). 1 H NMR (CDCl3, 400 MHz): δ7. 94-7.89 (m, 2H), 7.48 (dd, J = 8.8 Hz, 2H) 7.27-7.20 (m, 2H), 6.78 (s, 1H), 4.91 (s, 1H), 4.76-4.67 (m, 1H), 4.47-4.42 (m, 1H), 4.39-4.31 (m, 1H), 3.69-3.62 (m, 1H), 3.58-3.44 (m, 15H), 3.36-3.25 (m, 2H), 3.21-3.09 (m, 2H), 2.70 (s, 3H), 2. 64-2.49 (m, 3H), 2.34-2.17 (m, 11H), 1.33-1.16 (m, 2H), 0.91-0.80 (m, 4H). LCMS: m / z 888.4 [M+H] + .

[0240] 46. ​​Synthesis of Compound 46

[0241] [ka]

[0242] A solution of compound A1 (0.5 g, 0.65 mmol) in toluene (15 mL) was added to Ti(O-iPr)4 (190 mg, 0.67 mmol) and benzo[b]thiophene-5-amine (200 mg, 1.34 mmol). After stirring at ℃ overnight, the mixture was concentrated, and the residue was diluted with EA (30 ml) and washed with water. The organic layer was dried over Na2SO4, filtered and concentrated. The residue was purified by flash to give a brown The crude products 46-1 and 46-2 (236 mg, 39% yield) were obtained as solids, which were further purified by Used in next step without purification. LC-MS: m / z 897.4 [M+H] + .

[0243] A solution of a mixture of compounds 46-1 and 46-2 (225 mg, 0.25 mmol) in DCM (5 mL) was subjected to N DAST (82 mg, 0.5 mmol) was added at −78° C. under N2 pressure for 1 h. The reaction mixture was quenched with saturated NaHCO3 solution (10 mL) and extracted with DCM (15 mL x 2 The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was prepped. Purification by HPLC gave compound 46 as a yellow solid (18 mg, 8.1% yield). 1 H NMR (C DCl3, 400 MHz):δ7.71 (d, J = 8.8 Hz, 1H), 7.42 (d, J = 5.2 Hz, 1H), 7.38 (s, 1H ), 7.24 (d, J = 5.2 Hz, 1H), 7.12 (d, J = 8.8 Hz, 1H), 6.77 (s, 1H), 4.90 (s, 1H) ), 4.72-4.70 (m, 1H), 4.43 (d, J =7.2 Hz, 1H), 4.35-4.33 (m, 1H), 3.33-3.27 (m, 2H), 3.16-3.10 (m, 2H), 2.58-2.53 (m, 2H), 2.22-2.18 (m, 10H), 0.87 (t, J = 7.2 Hz, 3H); LC-MS: m / z 879.4 [M+H] + .

[0244] 47. Synthesis of compound 47

[0245] [ka]

[0246] A solution of compound A1 (0.2 g, 0.26 mmol) in toluene (10 mL) was added to Ti(O-iPr)4 (76 mg, 0.26 mmol) and quinolin-6-amine (77 mg, 0.53 mmol) were added. The mixture was stirred at 120° C. overnight. After that, the mixture was concentrated, and the residue was diluted with EA (30 ml) and washed with water. The organic layer was washed with Na2SO4 The mixture was dried over ice, filtered and concentrated. The residue was purified by flash to give crude hexane as a brown solid. The crude products 47-1 and 47-2 (90 mg, 38% yield) were obtained and used in the following step without further purification. Used in step 2. LC-MS: m / z 899.2 [M+H] + .

[0247] A solution of a mixture of compounds 47-1 and 47-2 (90 mg, 0.1 mmol) in DCM (5 mL) was added under N DAST (33 mg, 0.2 mmol) was added at -78°C. The mixture was stirred at -78°C for 1 hour under N2 pressure. The reaction mixture was quenched with saturated NaHCO3 solution (10 mL) and extracted with DCM (15 mL x 2). The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by PrepHP Purification by LC gave compound 47 as a white solid (10 mg, 11% yield). 1 H NMR (CDCl 3, 400 MHz):δ8.77-8.75 (m, 1H), 8.04-7.89 (m, 2H), 7.53-7.51 (m, 1H), 7.35-7.33 (m, 1H), 7.24 (m, 1H), 6.77 (s, 1H), 4.91 (s, 1H), 4.71 (s, 1H), 4.44 (d, J = 8 .0 Hz, 1H), 4.37-4.34 (m, 1H), 3.35-3.32 (m, 2H), 3.15-3.13 (m, 2H), 2.58-2.54 ( m, 3H), 2.34-2.19 (m, 12H); LC-MS: m / z 881.2 [M+H] + .

[0248] 48. Synthesis of compound 48

[0249] [ka]

[0250] A solution of compound A3 (100 mg, 0.13 mmol) in DIEA (5 mL) was added with 2-chloro-benzothiazo To the mixture was added 115° C. (45.3 mg, 0.27 mmol), and the resulting mixture was stirred at 115° C. for 3 h under N2. The mixture was quenched with water (50 mL) and extracted with DCM (30 mL x 3). The combined organic layers The extract was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a white solid. Compound 48 was obtained as a partial elution product (20 mg, yield 17.5%). 1 H NMR (CDCl3, 400 MHz): δ7. 74 (d, J = 8.0 Hz, 1H), 7.69 (d, J = 7.6 Hz, 1H), 7.41-7.36 (m, 1H), 7.26-7.22 ( m, 1H), 6.75 (s, 1H), 4.88 (s, 1H), 4.75-4.68 (m, 1H), 3.31-3.22 (m, 2H), 3.19-3 .08 (m, 3H), 2.75 (d, J = 6.4 Hz, 1H), 2.67-2.59 (m, 1H), 2.56-2.50 (m, 1H), 0.9 2-0.78 (m, 5H); LC-MS: m / z 880.2 [M+H] + .

[0251] 49. Synthesis of Compound 49

[0252] [ka]

[0253] A solution of compound A3 (200 mg, 0.26 mmol) in DIEA (5 mL) was added with 2,5-dichloro-benzothiazolidinium chloride. azole (110 mg, 0.54 mmol) was added. The resulting mixture was stirred at 115° C. for 3 h under N2. The reaction was quenched with water (50 mL) and extracted with DCM (20 mL x 3). The layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give a yellow solid. Compound 49 was obtained as a solid (17 mg, 7.1% yield). 1 H NMR (CDCl3, 400 MHz): δ7 .65-7.63 (m, 2H), 7.33 (dd, J = 2.4, 2.0 Hz, 1H), 6.74 (s, 1H), 5.36-5.33 (m, 1H ), 4.88 (s, 1H), 4.75-4.67 (m, 1H), 4.44-4.41 (m, 1H), 4.36-4.31 (m, 1H), 3.68-3 .60 (m, 1H), 3.29-3.22 (m, 2H), 3.18-3.09 (m, 3H), 2.77 (d, J = 6.0 Hz, 1H), 2.6 5-2.49 (m, 2H), 2.04-1.96 (m, 3H), 0.89-0.78 (m, 5H); LC-MS: m / z 914.4 [M+H] + .

[0254] 50. Synthesis of Compound 50

[0255] [ka]

[0256] To a solution of compound A3 (200 mg, 0.27 mmol) in DIEA (5 mL), 2-chloro-5-methoxy- Benzothiazole (107 mg, 0.53 mmol) was added, and the resulting mixture was heated under nitrogen at 115 °C for 4 h. The reaction was quenched with water (50 mL) and extracted with DCM (20 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. Compound 50 was obtained as a yellow solid (10 mg, yield 4.0%). 1 H NMR (CDCl3, 40 0 MHz): 7.63 (d, J = 7.2 Hz, 1H), 7.17 (d, J = 2.4 Hz, 1H), 6.98-6.96 (m, 1H), 6 .74 (s, 1H), 4.88 (s, 1H), 4.73-4.68 (m, 1H), 4.45-4.40 (m, 1H), 4.35-4.32 (m, 1 H), 3.84 (s, 3H), 3.66-3.61 (m, 2H), 3.57-3.42 (m, 29H), 3.29-3.22 (m, 3H), 3.18 -3.08 (m, 3H), 2.75-2.72 (m, 1H); LC-MS: m / z 910.4 [M+H] + .

[0257] 51. Synthesis of Compound 51

[0258] [ka]

[0259] A solution of compound A3 (200 mg, 0.26 mmol) in DIEA (5 mL) was added with 2-chloro-5-methyl- Zothiazole (99.4 mg, 0.54 mmol) was added, and the resulting mixture was heated under nitrogen at 115 °C for 3 h. The reaction was quenched with water (50 mL) and extracted with DCM (20 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC. Compound 51 was obtained as a yellow solid (15 mg, yield 6.0%). 1 H NMR (CDCl3, 40 0 MHz):δ7.50 (d, J = 5.6 Hz, 1H), 7.20-7.12 (m, 2H), 6.75 (s, 1H), 4.89 (s, 1H) , 4.75-4.68 (m, 1H), 4.45-4.41 (m, 1H), 4.37-4.30 (m, 1H), 3.67-3.42 (m, 20H), 3 .31-3.08 (m, 6H), 2.75 (d, J = 6.8 Hz, 1H), 2.62 (s, 3H), 2.55-2.49 (m, 1H), 0.8 9-0.82 (m, 6H); LC-MS: m / z 895.4 [M+H] + .

[0260] 52. Synthesis of Compound 52

[0261] [ka]

[0262] A solution of compound A3 (200 mg, 0.26 mmol) in DIEA (10 mL) was added with 2,5-dichloro-benzothiamine. Azole (110 mg, 0.54 mmol) was added, and the resulting mixture was stirred under nitrogen at 115° C. for 3 h. The reaction was quenched with water (50 mL) and extracted with DCM (20 mL x 3). The organic layer was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give Compound 52 was obtained as a yellow solid (17 mg, 7.1% yield).1 H NMR (CDCl3, 400 MHz) :δ7.72 (s, 1H) 7.57 (d, J = 9.6 Hz, 1H), 7.22 (d, J = 6.8 Hz, 1H), 6.74 (s, 1H) , 4.88 (s, 1H), 4.71 (m, 1H), 4.42 (d, J = 7.6 Hz, 1H), 4.33 (m, 1H), 3.27-3.24 (m, 2H), 2.76 (d, J = 6.4 Hz, 1H), 0.85 (t, J = 7.6 Hz, 3H); LC-MS: m / z 916.3 [M +H] + .

[0263] 53. Synthesis of Compound 53

[0264] [ka]

[0265] A solution of compound A3 (200 mg, 0.26 mmol) in DIEA (10 mL) was added with 2,7-dichloro-benzothiamine. Azole (110 mg, 0.54 mmol) was added, and the resulting mixture was stirred under nitrogen at 115° C. for 3 h. The reaction was quenched with water (50 mL) and extracted with DCM (20 mL x 3). The organic layer was dried over potassium carbonate, filtered and concentrated. The residue was purified by prep HPLC to give Compound 50 was obtained as a yellow solid (20 mg, 8.3% yield). 1 H NMR (CDCl3, 400 MHz) :δ7.63 (d, J = 8.0 Hz, 1H), 7.32-7.23 (m, 2H), 6.74 (s, 1H), 4.88 (s, 1H), 4.75 -4.70 (m, 1H), 4.45-4.38 (m, 1H), 4.36-4.31 (m, 1H), 3.68-3.41 (m, 17H), 3.30-3. 09 (m, 6H), 2.80 (d, J = 6.0 Hz, 1H), 2.67-2.51 (m, 2H), 2.32-2.13 (m, 10H), 0.8 5 (t, J = 7.2 Hz, 3H); LC-MS: m / z 914.3 [M+H] + .

[0266] 54. Synthesis of Compound 54

[0267] [ka]

[0268] Compound A3 (100 mg, 0.13 mmol) and DIEA (86 mg, 0.67 mmol) in EtOH (2 mL) To the solution was added 4-chloropyrimidine hydrochloride (40 mg, 0.26 mmol). The mixture was heated at 85° C. for 20 h. The mixture was purified by prep HPLC to give compound 54 (26 mg, yield rate 23.6%). Partial 1 H NMR (CDCl3, 300 MHz):δ7.73 (s, 1H), 7.33 (d, J = 8.1 Hz, 1H), 6.67 (s, 1H), 6.23 (d, J = 7.2 Hz, 1H), 4.86 (s, 1H), 4.65-4.61 (m, 1H), 4. 43-4.35 (m, 2H), 4.01-3.96 (m, 1H), 3.89-3.85 (m, 1H), 3.81-3.68 (m, 1H), 2.93-2 .86 (m, 1H), 2.60-2.46 (m, 3H). LC-MS: m / z 825.5 [M+H] + .

[0269] 55. Synthesis of Compound 55

[0270] [ka]

[0271] Compound A3 (250 mg, 0.33 mmol) and 2-chloropyrimidine hydrochloride in MeCN (10 mL) To a solution of 1,2-dichloromethane (77 mg, 0.67 mmol) was added K2CO3 (138 mg, 1.0 mmol). The mixture was heated at 85° C. for 20 h. The reaction mixture was concentrated and the residue was diluted in EA (60 mL). The mixture was washed with water (30 mL), dried over anhydrous Na2SO4, filtered and concentrated. The product was purified by HPLC to give compound 55 (50 mg, 18% yield). 1 H NMR (CDCl3, 400 MHz ): δ8.51 (d, J = 4.8 Hz, 2H), 6.90 (t, J = 4.8 Hz, 1H), 6.76 (s, 1H), 4.88 (s, 1 H), 4.76-4.70 (m, 1H), 4.43-4.41 (m, 1H), 4.35-4.30 (m, 1H), 3.66-3.62 (m, 1H), 3.30-3.19 (m, 3H), 3.11 (t, J = 9.6 Hz, 1H), 2.83-2.80 (m, 1H), 2.72 (d, J = 6.4 Hz, 1H), 2.70-2.61 (m, 2H), 2.34-2.29 (m, 1H), 0.81 (t, J = 7.6 Hz, 3H). LCMS: m / z 825.5 [M+H] + .

[0272] 56. Synthesis of Compound 56

[0273] [ka]

[0274] Indole-6-boronic acid (96 mg, 0.6 mmol) and Cu(OAc)2(1 5.6 mg, 0.08 mmol) was added to a solution of 2,6-lutidine (42.8 mg, 0.4 mmol), lauric acid (8.0 mg, 0.04 mmol), and compound A3 (300 mg, 0.4 mmol) were added. The mixture was stirred in an air atmosphere. The mixture was stirred at room temperature under atmospheric pressure for 2 days. The mixture was concentrated, and the residue was purified by column chromatography on silica gel. Compound 5 was purified by chromatography (MeOH / DCM = 1 / 20) and prep HPLC as a white solid. 6 was obtained (40 mg, 11.6% yield). 1 H NMR (CDCl3, 400 MHz):δ8.05 (s, 1H), 7.4 7 (d, J = 8.4 Hz, 1H), 7.11 (s, 1H), 7.03 (s, 1H), 6.89 (d, J = 4.0 Hz, 1H), 6.7 7 (s, 1H), 6.46 (s, 1H), 4.90 (s, 1H), 4.75-4.67 (m, 1H), 4.46-4.41 (m, 1H), 3.3 7-3.29 (m, 1H), 3.70--3.42 (m, 19H), 3.36-3.25 (m, 2H), 3.18-3.07 (m, 2H), 2.62- 2.52 (m, 2H), 2.46-2.41 (m, 1H), 2.30-2.13 (m, 12H), 2.03-1.95 (m, 1H), 0.91-0.7 7 (m, 5H). LCMS: m / z 862.4 [M+H] + .

[0275] 57. Synthesis of Compound 57

[0276] [ka]

[0277] N-Methylindole-5-boronic acid (105 mg, 0.6 mmol) and Cu in toluene (10 mL) A solution of (OAc)2 (15.6 mg, 0.08 mmol) was added with 2,6-lutidine (42.8 mg, 0.4 mmol) and lauryl chloride. carboxylic acid (8.0 mg, 0.04 mmol), and compound A3 (300 mg, 0.4 mmol) were added to this mixture. The mixture was stirred at room temperature under air for 2 days. The mixture was concentrated, and the residue was columned on silica gel. The product was purified by column chromatography (MeOH / DCM = 1 / 20) and prep HPLC to give a white solid. Compound 57 was obtained (15 mg, yield 4.2%). 1 H NMR (CDCl3, 400 MHz):δ7.85 (s , 1H), 7.25-7.21 (m, 2H), 6.77 (s, 1H), 4.90 (s, 1H), 4.76-4.67 (m, 1H), 4.46-4. 41 (m, 1H), 4.03 (s, 3H), 3.69-3.62 (m, 1H), 3.59-3.43 (m, 15H), 3.35-3.25 (m, 2 H), 3.19-3.08 (m, 2H), 2.63-2.52 (m, 2H), 2.46-2.42 (m, 1H), 2.30-2.16 (m, 10H), 2.03-1.95 (m, 1H), 1.32-1.16 (m, 16H), 0.91-0.79 (m, 6H). LCMS: m / z 877.4 [M+H] + .

[0278] 58. Synthesis of Compound 58

[0279] [ka]

[0280] Isoquinoline-5-boronic acid (103.8 mg, 0.6 mmol) and Cu(OAc A solution of 2,6-lutidine (42.8 mg, 0.4 mmol) and lauric acid was added to the solution of 2 (15.6 mg, 0.08 mmol). (8.0 mg, 0.04 mmol), and compound A3 (300 mg, 0.4 mmol) were added to the mixture. The mixture was stirred at room temperature for 2 days under air atmosphere. The mixture was concentrated, and the residue was purified by column chromatography on silica gel. Purification by chromatography (MeOH / DCM = 1 / 20) and prep HPLC gave a white solid. Compound 58 was obtained (40 mg, yield 11.5%). 1 H NMR (CDCl3, 400 MHz):δ9.22 (s, 1 H), 8.56 (dd, J = 6.0 Hz, 1H), 8.17 (d, J = 6.0 Hz, 1H), 7.61(d, J = 8.0 Hz, 1H) ,7.46 (t, J = 7.6 Hz, 1H), 7.16 (d, J = 7.6 Hz, 1H), 6.79 (s, 1H), 4.92 (s, 1H), 4.81-4.72 (m, 1H), 4.47-4.43 (m, 1H), 4.42-4.34 (m, 1H), 3.67-3.79 (m, 1H), 3.7 0-3.44 (m, 16H), 3.35-3.23 (m, 2H), 3.19-3.10 (m, 2H), 2.73-2.65 (m, 1H), 2.61-2 .55 (s, 1H), 2.52-2.45 (m, 1H), 2.33-2.45 (m, 1H), 2.33-2.21 (m, 10H), 0.98-0.85 (m, 4H). LCMS: m / z 874.4 [M+H] + .

[0281] 59. Synthesis of Compound 59

[0282] [ka]

[0283] Dibenzothiophene-4-boronic acid (136.8 mg, 0.6 mmol) in toluene (10 mL) and A solution of Cu(OAc)2 (15.6 mg, 0.08 mmol) was added with 2,6-lutidine (42.8 mg, 0.4 mmol) and lauric acid. Phosphoric acid (8.0 mg, 0.04 mmol) and compound A3 (300 mg, 0.4 mmol) were added to this mixture. The mixture was stirred at room temperature under air for 2 days. The mixture was concentrated and the residue was precipitated on silica gel. Purification by column chromatography (MeOH / DCM = 1 / 20) and prep HPLC gave a white solid Compound 59 was obtained as a partial elution product (45 mg, yield 10.9%). 1 H NMR (CDCl3, 400 MHz): δ8.17 -8.11 (m, 1H), 7.88-7.80 (m, 2H), 7.48-7.41 (m, 2H), 7.37 (t, J = 7.6 Hz, 2H), 7 .02 (d, J = 7.6 Hz, 1H), 6.80 (s, 1H), 4.94 (s, 1H), 4.83-4.76 (m, 1H), 4.46-4.3 4 (m, 2H), 3.79-3.73 (m, 1H), 3.68-3.47 (m, 17H), 3.34-3.10 (m, 4H), 2.78-2.60 ( LCMS: m / z 930. 4 [M+H] + .

[0284] 60. Synthesis of Compound 60

[0285] [ka]

[0286] 3-Thiopheneboronic acid (134 mg, 1.05 mmol) and Cu(OAc)2( A solution of 2,6-lutidine (75 mg, 0.7 mmol) and lauric acid (14 mg, Compound A3 (500 mg, 0.7 mmol) was added to the mixture. The mixture was stirred at room temperature for 2 days under reduced pressure. The mixture was concentrated and purified by column chromatography on silica gel. (MeOH / DCM = 1 / 20) followed by purification by prep HPLC gave compound 60 as a white solid. (35 mg, 6% yield). 1 H NMR (CDCl3, 400 MHz):δ7.17 (dd, J = 5.2, 2.8 Hz, 1H), 6.92 (dd, J = 5.2, 1.2 Hz, 1H), 6.74 (s, 1H), 6.53 (dd, J = 2.8, 1.2 Hz, 1H ), 4.87 (s, 1H), 4.72-4.63 (m, 1H), 4.45-4.40 (m, 1H), 3.31-3.21 (m, 2H),3.16-3. 08 (m, 2H), 2.60-2.35 (m, 6H), 2.28-2.11 (m, 11H), 2.01-1.94 (m, 1H),1.32-1.16 (m, 4H). LCMS: m / z 829.4 [M+H] + .

[0287] 61. Synthesis of Compound 61

[0288] [ka]

[0289] Quinolin-3-ylboronic acid (103.8 mg, 0.6 mmol) and Cu(OAc A solution of 2,6-lutidine (42 mg, 0.4 mmol) and lauric acid (7. Compound A3 (300 mg, 0.4 mmol) was added to the mixture. The mixture was stirred at room temperature under atmospheric pressure for 2 days. The mixture was concentrated and purified by column chromatography on silica gel. Compound 61 was obtained as a white solid by purification using preparative HPLC followed by purification using MeOH / DCM = 1 / 20. (30 mg, yield 8.6%). 1 H NMR (CDCl3, 400 MHz):δ8.80 (d, J = 2.4 Hz , 1H), 8.03 (d, J = 8.4 Hz, 1H), 7.71 (d, J = 8.0 Hz, 1H), 7.57-7.26 (m, 3H), 6 .77 (s, 1H), 4.91 (s, 1H), 4.76-4.67 (m, 1H), 4.46-4.41 (m, 1H), 4.40-4.32 (m, 1 H), 3.36-3.26 (m, 2H), 3.22-3.08 (m, 2H), 2.66-2.50 (m, 3H), 2.35-2.18 (m, 10H), 2.02-1.95 (m, 1H); LCMS: m / z 874.3[M+H] + .

[0290] 62. Synthesis of Compound 62

[0291] [ka]

[0292] 6-Bromo-2-methyl-quinoline (89 mg, 0.4 mmol) in toluene (30 mL) and compound A solution of A3 (300 mg, 0.4 mmol) was added with Pd2(dba)3 (14.1 mg, 0.02 mmol) and BINAP (17 Cs2CO3 (190.3 mg, 0.03 mmol) and Cs2CO3 (190.5 mg, 0.6 mmol) were added. The mixture was stirred at °C overnight. The reaction was quenched with water (50 mL) and extracted with DCM (30 mL x 3). The combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by column chromatography on silica gel. Purification by column chromatography (MeOH / DCM = 1 / 20) and prep HPLC gave a white solid Compound 62 was obtained as a partial elution product (40 mg, yield 11.3%). 1 H NMR (CDCl3, 400 MHz): δ7.94 -7.89 (m, 2H), 7.51-7.45 (m, 1H),7.26-7.18 (m, 2H), 6.77 (s, 1H), 4.91 (s, 1H), 4.76-4.67 (m, 1H), 4.46-4.41 (m, 1H), 4.38-4.31 (m, 1H), 3.69-3.63 (m, 1H), 3.36 -3.26 (m, 3H), 2.70 (s, 3H), 2.03-1.96 (m, 1H). LCMS: m / z 888.4 [M+H] + .

[0293] 63. Synthesis of Compound 63

[0294] [ka]

[0295] In a 25 mL round bottom flask containing a magnetic stir bar, CuI (15 mg, 0.08 mmol) was added followed by L- Hydroxyproline (21 mg, 0.16 mmol), 3-iodopyridine (165 mg The flask was flushed with N2 and charged with K3PO4 (256 mg, 1.2 mmol). A solution of compound A3 (300 mg, 0.40 mmol) in anhydrous DMSO (10 mL) was then added. The mixture was stirred at 60 °C under N for 24 h. After cooling to room temperature, the mixture was diluted with EA and 5% aqueous NH3.H2O The organic layer was washed with water (30 mL x 2) and brine. The residue was dried over anhydrous Na2SO4, filtered and concentrated. Prep TLC (MeOH / DCM = 1 / 15) showed Further purification gave compound 63 as a white solid (19 mg, 5.7% yield). 1 H NMR (C DCl3, 300 MHz):δ8.39-8.37 (m, 1H), 8.26-8.22 (m, 1H), 7.35-7.33 (m, 1H), 7.19-7 .14 ​​(m, 1H), 6.76 (s, 1H), 4.90 (s, 1H), 4.72-4.67 (m, 1H), 4.47-4.44 (m, 1H), 4 .374-4.32 (m, 1H), 3.33-3.26 (m, 2H), 3.17-3.10 (m, 2H), 2.59-2.44 (m, 3H), 2.24 -2.18 (m, 3H), 0.86 (t, J = 7.5 Hz, 3H). LCMS: m / z 824.3 [M+H]+ .

[0296] 64. Synthesis of Compound 64

[0297] [ka]

[0298] Compound A3 (300 mg, 0.4 mmol) and 2-chlorobenzo[d]oxazo in MeCN (5 mL) To a solution of 1,2-dichloropropane (62 mg, 0.4 mmol) was added K2CO3 (111 mg, 0.8 mmol). The mixture was heated at room temperature. The mixture was stirred at rt overnight. The mixture was filtered, and the filtrate was purified by silica gel column chromatography (DCM / Me OH = 20 / 1) to give compound 60 as a white solid (125 mg, 36.0% yield). l 1 H NMR (CDCl3, 400 MHz):δ7.52-7.50 (m, 1H), 7.40-7.38 (m, 1H), 7.25-7.19 (m, 2H), 6.74 (s, 1H), 4.88 (s, 1H), 4.77-4.71 (m, 1H), 4.43-4.41 (m, 1H), 4.36-4.30 (m, 1H), 3.66-3.61 (m, 2H), 3.31-3.21 (m, 4H), 3.11 (t, J = 9.6 Hz, 2H), 2.84 ( d, J = 6.8 Hz, 1H), 2.67-2.62 (m, 2H), 0.84 (t, J = 7.6 Hz, 3H); LCMS: m / z 864.4 [M+H] + .

[0299] 65. Synthesis of Compound 65

[0300] [ka]

[0301] A solution of compound A1 (400 mg, 0.53 mmol) in propan-2-amine (10 mL) was added with ZrCl4 (6. 0 mg, 0.026 mmol) was added. The mixture was stirred at 80° C. in a microwave for 1 hour. The mixture was purified by silica gel column (DCM / MeOH = 100:1 to 10:1) followed by prep HPLC to give white eluate. A mixture of compounds 65-1 and 65-2 (210 mg, yield 45.3%) was obtained as a colored solid. LCMS: m / z 8 07.2 [M+H] + .

[0302] A solution of a mixture of compounds 65-1 and 65-2 (200 mg, 0.25 mmol) in DCM (5 mL) was subjected to N DAST (50.0 mg, 0.3 mmol) was added at −78° C. under N2 pressure for 1 h at −78° C. The reaction mixture was quenched with saturated NaHCO3 solution (10 mL) and extracted with DCM (15 mL x 2) The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was The product was purified by HPLC to give compound 65 as a white solid (20 mg, 10.2% yield). 1 H NMR (CDCl3, 400 MHz):δ6.70 (s, 1H), 4.83 (s, 1H), 4.64 (s, 1H), 4.42 (d, J = 7.2 H z, 1H), 4.26 (s, 1H), 3.27-3.03 (m, 6H), 2.48-2.40 (m, 2H), 0.82 (t, J = 7.6 Hz, 3H); LCMS: m / z 789.2 [M+H] + .

[0303] 66. Synthesis of Compound 66

[0304] [ka]

[0305] A solution of compound A1 (1.0 g, 1.3 mmol) in cyclopentanamine (10 mL) was added to ZrCl4 (1 6 mg, 0.07 mmol) was added. The mixture was stirred at 80° C. in a microwave for 1 hour. The mixture was purified by silica gel column (DCM / MeOH = 100:1 to 10:1) followed by prep HPLC to give white eluate. A mixture of compounds 66-1 and 66-2 (250 mg, 23% yield) was obtained as a yellow solid. LCMS: m / z 833 .2 [M+H] + .

[0306] A solution of a mixture of compounds 66-1 and 66-2 (167 mg, 0.2 mmol) in DCM (5 mL) was subjected to N DAST (50.0 mg, 0.3 mmol) was added at −78° C. The mixture was stirred at −78° C. for 1 h under N2. The reaction mixture was quenched with saturated NaHCO3 solution (10 mL) and extracted with DCM (15 mL x 2). The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by PrepHP Purification by LC gave compound 66 as a white solid (55 mg, 34% yield). 1 H NMR (CDCl 3, 400 MHz):δ6.67 (s, 1H), 4.81 (s, 1H), 4.63 (s, 1H), 4.39 (d, J = 7.2 Hz, 1H) , 4.24 (s, 1H), 3.28-3.01 (m, 5H), 2.23 (s, 6H), 2.48-2.43 (m, 2H), 0.79 (t, J = 7.6 Hz, 3H), 0.65 (m, 1H); LCMS: m / z 815.2 [M+H] + .

[0307] 67. Synthesis of Compound 67

[0308] [ka]

[0309] A solution of compound A1 (1.0 g, 1.3 mmol) in 2-methylpropan-1-amine (10 mL) was added to ZrC l4 (63 mg, 0.26 mmol) was added. The mixture was heated at 80 °C under N2 pressure in a microwave for 1 h. The mixture was purified by silica gel column (DCM / MeOH = 100:1 to 10:1) to give a white A mixture of compounds 63-1 and 63-2 (410 mg, 38% yield) was obtained as a solid. LCMS: m / z 821.2 [M+H] + .

[0310] A solution of compounds 63-1 and 63-2 (350 mg, 0.42 mmol) in DCM (20 mL) was added at −78 °C under N DAST (99 mg, 0.6 mmol) was added. After stirring at -78 °C for 1 h, the mixture was diluted with aqueous NaHCO3 (30 After stirring for 15 min, the mixture was extracted with DCM (20 mL x 3). The combined organic layers were washed with brine, dried over Na2SO4, filtered and concentrated. The residue was prepped. Purification by HPLC gave compound 63 as a white solid (80 mg, 24% yield). 1 H NMR (CD Cl3, 400 MHz):δ6.70 (s, 1H), 4.83 (s, 1H), 4.67 (m, 1H), 4.39 (d, J = 8.8 Hz, 1 H), 4.26 (m, 1H), 3.64(m, 1H),3.26-3.04 (m, 6H), 0.98-0.94 (m, 6H), 0.79 (t, J = 7.2 Hz, 3H)., LCMS: m / z 803.2 [M+H] +

[0311] 68. Synthesis of Compound 68

[0312] [ka]

[0313] A solution of compound A1 (0.5 g, 0.65 mmol) in 2-methoxyethanamine (5 mL) was added to ZrCl4 (16 mg, 0.07 mmol) was added. The mixture was heated at 80 °C under N2 pressure in a microwave for 1 h. The mixture was purified by silica gel column chromatography (DCM / MeOH = 100:1 to 10:1). and purified by prep HPLC to give compounds 68-1 and 68-2 (100 mg, yield: 18.6%) mixture was obtained. LCMS: m / z 823.2 [M+H] + .

[0314] A solution of compounds 68-1 and 68-2 (50 mg, 0.06 mmol) in DCM (5 mL) was added at −78 °C under N DAST (20 mg, 0.12 mmol) was added. After stirring at -78 °C for 1 h, the mixture was warmed to room temperature and NaHCO3 (30 mL). After stirring for 15 min, the mixture was extracted with DCM (20 The combined organic layers were washed with brine, dried over Na2SO4, filtered and concentrated. The residue was purified by prep HPLC to give compound 68 as a white solid (20 mg, 40% yield). Partial 1H NMR (CDCl3, 400 MHz): 6.70 (s, 1H), 4.84 (s, 1H), 4.69 (m, 1H), 4.4 3 (d, J = 7.2 Hz, 1H), 4.24 (m, 1H), 3.39 (s, 3H), 2.76-2.72 (m, 1H), 2.48-2.42 (m, 2H), 0.82 (t, J = 7.6 Hz, 3H)., LCMS: m / z 805.1 [M+H] + .

[0315] 69. Synthesis of Compound 69

[0316] [ka]

[0317] Dissolve compound A1 (0.5 g, 0.65 mmol) in 2-(pyrrolidin-1-yl)ethanamine (5 mL). To the solution was added ZrCl4 (63 mg, 0.26 mmol). The mixture was heated for 8 h in a microwave oven under N2 pressure. The mixture was stirred at 0°C for 1 hour. The mixture was purified by flash (MeCN / H2O = 50:50 to 95:5). A mixture of compounds 69-1 and 69-2 (200 mg, 35% yield) was obtained. LCMS: m / z 863.2 [M+H] +

[0318] A solution of compounds 69-1 and 69-2 (200 mg, 0.23 mmol) in DCM (20 mL) was heated to -78 °C under N2. Then DAST (5 mL) was added. After stirring at -78 °C for 30 min, the mixture was warmed to room temperature and diluted with NaHCO3 aqueous solution. After stirring for 15 min, the mixture was extracted with DCM (20 mL x 3 The combined organic layers were washed with brine, dried over Na2SO4, filtered and concentrated. The residue was purified by prep HPLC to give compound 69 (15 mg, 7.7% yield) as a white solid. al 1 H NMR (CDCl3, 400 MHz):δ6.70 (s, 1H), 4.84 (s, 1H), 4.67 (m, 1H), 4.41 (d, LCMS: m / z 845.2 [M+H] +

[0319] 70. Synthesis of Compound 70

[0320] [ka]

[0321] A solution of compound A1 (0.6 g, 0.8 mmol) in phenylmethanamine (4 mL) was added with ZrCl4 (93. 2 mg, 0.4 mmol) was added. The mixture was stirred overnight at 80° C. under N2 pressure. It was quenched with water and extracted with DCM. The organic layer was washed with water, dried over Na2SO4, filtered and concentrated. The residue was purified by flash (MeCN / H2O = 50:50 to 95:5) to give crude compound 70-1 and and 70-2 (487 mg, 71% yield). LCMS: m / z 855.2 [M+H] +

[0322] A stirred solution of compounds 70-1 and 70-2 (487 mg, 0.57 mmol) in DCM (10 mL) was placed under a N DAST (184 mg, 1.14 mmol) was added at −78° C. under atmospheric pressure. The resulting mixture was stirred at −78° C. for 30 minutes. The reaction mixture was allowed to warm to room temperature and quenched with aqueous NaHCO3 (10 mL). The combined organic layers were dried over anhydrous Na2SO4, filtered and extracted with CM (10 mL x 3). The residue was purified by prep HPLC to give compound 70 as a white solid (58 mg, yield: rate 12.2%). Partial 1 H NMR (CDCl3, 400 MHz):δ7.39-7.32 (m, 4H), 7.26-7.23 (m, 1H) , 6.71 (s, 1H), 4.84 (s, 1H), 4.72-4.66 (m, 1H), 4.42 (d, J = 8.8 Hz, 1H), 4.30- 4.23 (m, 1H), 3.54 (s, 2H), 3.39-3.32 (m, 1H), 2.53-2.48 (m, 1H), 2.38-2.34 (m, 1H), 2.24 (s, 6H), 2.17-2.10 (m, 1H), 0.83 (t, J = 7.2 Hz, 3H), 0.78-0.68 (m, 1H ). LCMS: m / z 837.2 [M+H] + .

[0323] 71. Synthesis of Compound 71

[0324] [ka]

[0325] Compound A1 (500 mg, 0.65 mmol) and 2,5-dichloro- To a solution of zirconium amine (467.3 mg, 2.67 mmol) was added ZrCl4 (155 mg, 0.67 mmol). The mixture was stirred at 80° C. overnight. The mixture was quenched with water and extracted with DCM. The layers were washed with water, dried over Na2SO4, filtered and concentrated. The residue was washed with flash (MeCN / H2O = 50:50 to 95:5) to give crude compounds 71-1 and 71-2 (250 mg, yield 21-2) as yellow solids. 41.5%) was obtained. LC-MS: m / z 925.5 [M+H] + .

[0326] A solution of compounds 71-1 and 71-2 (250 mg, 0.27 mmol) in DCM (10 mL) was added to -78 under N2 pressure. At ℃, DAST (87.3 mg, 0.54 mmol) was added. The mixture was stirred at -78 ℃ under N2 pressure for 1 hour. The mixture was quenched with aqueous NaHCO3 (10 mL) and extracted with DCM (30 mL x 3). The combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by prep HPLC. Compound 71 was obtained as a yellow solid (50 mg, 20.4% yield). 1 H NMR (CDCl3, 3 00 MHz):δ7.71 (d, J = 8.1 Hz, 1H), 7.37-7.30 (m, 2H), 6.73 (s, 1H), 4.86 (s, 1H) ), 4.75-4.65 (m, 1H), 4.47-4.40 (m, 1H), 4.34-4.24 (m, 1H), 3.85 (d, J = 16.2 Hz , 1H), 3.67-3.06 (m, 22H), 2.57-2.46 (m, 1H), 0.85 (t, J = 7.5 Hz, 3H); LC-MS: m / z 907.5 [M+H] + .

[0327] 72. Synthesis of compound 72

[0328] [ka]

[0329] Compound A1 (300 mg, 0.4 mmol) and 2-bromo-5-fluoro- To a solution of 4-benzylamine (245 mg, 1.2 mmol), ZrCl4 (155 mg, 0.67 mmol) was added. The mixture was stirred at 80° C. overnight. The mixture was quenched with water and extracted with DCM. The organic layer was washed with water, dried over Na2SO4, filtered and concentrated. The residue was washed with flash (MeCN / H 2O = 50:50 to 95:5) to give crude compounds 72-1 and 72-2 (250 mg, The yield was 65%).

[0330] A solution of compounds 72-1 and 72-2 (250 mg, 0.26 mmol) in DCM (10 mL) was added to -78 under N2 pressure. At ℃, DAST (87.3 mg, 0.54 mmol) was added. The mixture was stirred at -78 ℃ under N2 pressure for 1 hour. The mixture was quenched with aqueous NaHCO3 (10 mL) and extracted with DCM (30 mL x 3). The combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by prep HPLC. Compound 72 was obtained as a yellow solid (25 mg, 10.3% yield). 1 H NMR (CDCl3, 3 00 MHz):δ7.48-7.43 (m, 2H), 6.90-6.83 (m, 1H), 6.73 (s, 1H), 4.87 (s, 1H), 4.75 -4.65 (m, 1H), 4.43 (d, J = 7.8 Hz, 1H), 4.34-4.28 (m, 1H), 3.32-3.06 (m, 4H), 2 .60-2.50 (m, 1H), 2.45-2.40 (m, 1H), 0.85 (t, J = 7.5 Hz, 3H); LC-MS: m / z 907.5 [M+H]+ .

[0331] 73. Synthesis of Compound 73

[0332] [ka]

[0333] Compound A1 (300 mg, 0.40 mmol) and 2-methoxy-4-methyl- To a solution of 164.6 mg, 1.2 mmol of phenylamine was added ZrCl4 (93.2 mg, 0.4 mmol). The mixture was stirred at 80° C. overnight. The mixture was quenched with water and extracted with DCM. The organic layer was washed with water, dried over Na2SO4, filtered and concentrated. The residue was washed with flash (MeCN / H2O = 50:50 to 95:5) to obtain crude compounds 73-1 and 73-2 (100 mg) as yellow solids. LC-MS: m / z 885.2 [M+H] + .

[0334] A solution of compounds 73-1 and 73-2 (100 mg, 0.11 mmol) in DCM (10 mL) was added to -78 under N2 pressure. At ℃, DAST (145.5 mg, 0.9 mmol) was added. The mixture was stirred at -78 ℃ under N2 pressure for 1 hour. The mixture was quenched with aqueous NaHCO3 (10 mL) and extracted with DCM (30 mL x 3). The combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by prep HPLC. Compound 73 was obtained as a yellow solid (16 mg, 8.4% yield). 1 H NMR (CDCl3, 30 0 MHz):δ7.31 (d, J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 6.72 (s, 1H), 4.85 (s, 1H), 4.75-4.65 (m, 1H), 4.45-4.38 (m, 1H), 4.31-4.24 (m, 1H), 3.80 (s, 3H), 3.68-3.03 (m, 21H), 2.54-2.45 (m, 1H), 2.41-2.33 (m, 1H), 0.84 (t, J = 7.2 Hz, 3 H); LC-MS: m / z 867.2 [M+H] + .

[0335] 74. Synthesis of Compound 74

[0336] [ka]

[0337] A solution of compound A1 (1.0 g, 1.3 mmol) in (S)-1-phenylethanamine (3 mL) was added to ZrC l4 (311 mg, 1.3 mmol) was added. The mixture was heated at 80 °C under N2 pressure in a microwave oven for 1 The mixture was purified by flash (MeCN / H2O = 50:50 to 95:5) to give a yellow solid The crude compounds 74-1 and 74-2 (600 mg, 53% yield) were obtained as LC-MS: m / z 869.2 [M+H] + .

[0338] A solution of compounds 74-1 and 74-2 (200 mg, 0.23 mmol) in DCM (10 mL) was added to -78 under N2 pressure. At ℃, DAST (111.1 mg, 0.7 mmol) was added. The mixture was stirred at -78 ℃ under N2 pressure for 1 hour. The mixture was quenched with aqueous NaHCO3 (10 mL) and extracted with DCM (30 mL x 3). The combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by prep HPLC. Compound 74 was obtained as a yellow solid (30 mg, 15.3% yield). 1 H NMR (CDCl3, 3 00 MHz):δ7.42-7.31 (m, 5H), 6.74 (s, 1H), 4.78 (s, 1H), 4.72-4.64 (m, 1H), 4.47 -4.41 (m, 1H), 4.25-4.20 (m, 1H), 3.69-3.62 (m, 1H), 3.57-3.41 (m, 4H), 3.34-3.2 4 (m, 3H), 3.16-3.06 (m, 2H), 2.59-2.42 (m, 3H), 2.15-1.81(m, 5H), 1.31-1.17(m, 12H), 0.85 (t, J = 7.8 Hz, 3H); LC-MS: m / z 851.2 [M+H] + .

[0339] 75. Synthesis of Compound 75

[0340] [ka]

[0341] A solution of compound A1 (0.5 g, 0.65 mmol) in (R)-1-phenylethanamine (4 mL) was added to the Zr Cl4 (153.1 mg, 0.65 mmol) was added. The mixture was stirred overnight at 80 °C under N2. The mixture was purified by flash (MeCN / HO = 50:50 to 95:5) to give the crude compound as a yellow solid. 75-1 and 75-2 (250 mg, 44% yield) were obtained. LC-MS: m / z 869.2 [M+H] + .

[0342] A solution of compounds 75-1 and 75-2 (250 mg, 0.28 mmol) in DCM (10 mL) was added to -78 under N2 pressure. At ℃, DAST (138.9 mg, 0.86 mmol) was added. The mixture was stirred at -78 ℃ under N2 pressure for 1 hour. The mixture was quenched with aqueous NaHCO3 (10 mL) and extracted with DCM (30 mL x 3). The combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by prep HPLC. Compound 75 was obtained as a yellow solid (40 mg, 16.7% yield). 1 H NMR (CDCl3, 3 00 MHz):δ7.44-7.30 (m, 4H), 7.25-7.18 (m, 1H), 6.68 (s, 1H), 4.88 (s, 1H), 4.73 -4.64 (m, 1H), 4.44-4.37 (m, 1H), 4.37-4.27 (m, 1H), 3.35-3.09 (m, 3H), 3.00-2.9 0 (m, 2H), 2.62-2.52 (m, 2H), 2.28-2.11 (m, 8H), 0.81 (t, J = 7.2 Hz, 3H); LC-MS : m / z 851.2 [M+H] + .

[0343] 76. Synthesis of Compound 76

[0344] [ka]

[0345] To a solution of compound A1 (0.5 g, 0.65 mmol) in 2-phenylpropan-2-amine (5 mL), rCl4 (153.1 mg, 0.65 mmol) was added, and the mixture was heated at 80 °C in a microwave under N2. The mixture was stirred for 4 hours. The mixture was purified by flash (MeCN / H2O = 50:50 to 95:5) to give a yellow solid. Crude compounds 76-1 and 76-2 (300 mg, 52% yield) were obtained as condensed forms. LC-MS: m / z 883.2 [M+H ] + .

[0346] A solution of compounds 76-1 and 76-2 (300 mg, 0.34 mmol) in DCM (10 mL) was added to -78 under N2 pressure. At ℃, DAST (164.0 mg, 1.0 mmol) was added. The mixture was stirred at -78 ℃ under N2 pressure for 1 hour. The mixture was quenched with aqueous NaHCO3 (10 mL) and extracted with DCM (30 mL x 3). The combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by prep HPLC. Compound 76 was obtained as a yellow solid (40 mg, 13.6% yield). 1 H NMR (CDCl3, 3 00 MHz):δ7.52-7.46 (m, 2H), 7.39-7.31 (m, 2H), 6.73 (s, 1H), 4.70 (s, 1H), 4.72 -4.64 (m, 1H), 4.46-4.39 (m, 1H), 4.31-4.23 (m, 1H), 3.31-2.97 (m, 5H), 2.59-2.5 0 (m, 1H), 0.85 (t, J = 7.8 Hz, 3H); LC-MS: m / z 865.2 [M+H] + .

[0347] 77. Synthesis of Compound 77

[0348] [ka]

[0349] Dissolve compound A3 (180 mg, 0.24 mmol) and TEA (73 mg, 0.72 mmol) in THF (13 mL). Benzoyl chloride (50 mg, 0.36 mmol) was added to the solution at 0° C. The mixture was stirred at room temperature for 2 hours. The reaction mixture was diluted with saturated NaHCO3 solution (30 mL) and extracted with DCM (50 mL). The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was The mixture was purified by HPLC to give compound 77 (43 mg, 21% yield) as a white solid. 1 HN MR (CDCl3, 400 MHz):δ8.12 (d, J = 7.2 Hz, 2H), 7.55 (t, J = 7.6 Hz, 1H), 7.46 ( t, J = 7.6 Hz, 2H), 6.74 (s, 1H), 4.88 (s, 1H), 4.75-4.71 (m, 1H), 4.43-4.41 (m, 1H), 4.36-4.31 (m, 1H), 3.76-3.71 (m, 1H), 3.66-3.62 (m, 1H), 3.32-3.25 (m, 1H) , 3.18-3.12 (m, 3H), 2.95-2.93 (m, 1H), 2.69-2.64 (m, 1H), 2.52 (d, J = 6.0 Hz, 1H), 0.85 (t, J = 7.2 Hz, 3H); LCMS: m / z 851.2 [M+H] + .

[0350] 78. Synthesis of compound 78

[0351] [ka]

[0352] Dissolve compound A3 (100 mg, 0.13 mmol) and TEA (68 mg, 0.67 mmol) in DCM (2 mL). To the solution was added tosyl chloride (51 mg, 0.26 mmol) at 0° C. The mixture was stirred at room temperature for 2 hours. The reaction mixture was diluted with saturated NaHCO3 solution (20 mL) and extracted with DCM (20 mL x 2 The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was prepped. Purification by HPLC gave compound 78 (49 mg, yield 65.5%). 1 H NMR (CDCl3, 300 M Hz):δ7.84 (d, J = 8.4 Hz, 2H), 7.35 (d, J = 7.5 Hz, 2H), 6.62 (s, 1H), 4.84 (s, 1H), 4.65-4.60 (m, 1H), 4.42-4.39 (m, 1H), 4.32-4.26 (m, 1H), 3.23-3.08 (m, 6H) , 2.70 (d, J= 7.8 Hz, 1H), 2.49-2.43 (m, 4H); LCMS: m / z 901.5 [M+H] + .

[0353] 79. Synthesis of Compound 79

[0354] [ka]

[0355] Compound A2 (310 mg, 0.4 mmol) and aniline (77 mg, 0.83 mmol) in toluene (5 mL) To a solution of 100 ml of 1,000 sulphuric acid was added ZrCl4 (578 mg, 2.5 mmol). The mixture was stirred at room temperature overnight. The mixture was quenched with aqueous NaHCO3 (30 mL) and extracted with EA (20 mL). The organic layer was washed with water. The residue was purified by silica gel chromatography ( Compounds 79-1 and 79-2 (170 mg, A mixture was obtained with a yield of 49%). LC-MS: m / z 841.2 [M+H] + .

[0356] A solution of compounds 79-1 and 79-2 (170 mg, 0.2 mmol) in DCM (10 mL) was heated to -78 °C under N2. DAST (33 mg, 0.2 mmol) was then added. The mixture was stirred at -78 °C under N2 pressure for 1 h. The reaction mixture was diluted with saturated NaHCO3 solution (10 mL) and extracted with DCM (15 mL x 2). The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by prep HPLC. Compound 79 was obtained as a yellow solid (20 mg, 12.1% yield). 1 H NMR (CDCl3, 400 MHz):δ7.21 (t, J = 7.6 Hz, 2H), 6.93 (t, J = 7.6 Hz, 1H), 6.83 (d, J = 7.2 Hz, 2H), 6.62 (s, 1H), 4.90 (s, 1H), 4.71-4.66 (m, 1H), 4.47 (d, J = 7.2 Hz, 1H), 4 .32-4.26 (m, 1H), 3.36-3.31 (m, 1H), 3.28-3.22 m, 1H), 3.12 (t, J = 9.2 Hz, 1H), 2.67-2.59 (m, 6H), 2.50 (s, 6H); LC-MS: m / z 823.2 [M+H] + .

[0357] 80. Synthesis of Compound 80

[0358] [ka]

[0359] 4-Biphenylboronic acid (60 mg, 0.3 mmol) and Cu(OAc)2(8. 0 mg, 0.04 mmol) was added to a solution of 2,6-lutidine (21.4 mg, 0.2 mmol), lauric acid (4.0 mg Compound A4 (150 mg, 0.2 mmol) was added to the mixture in an air atmosphere. The mixture was stirred at room temperature under air for 2 days. The mixture was concentrated, and the residue was subjected to column chromatography on silica gel. Compound 80 was obtained as a white solid by elution with HPLC (MeOH / DCM = 1 / 20) and purification by prep HPLC. (12 mg, 6.7% yield). 1 H NMR (CDCl3, 400 MHz):δ7.52 (d, J = 7.2 Hz , 2H), 7.46-7.38 (m, 4H), 7.32-7.26 (m, 1H), 6.90 (d, J = 8.4 Hz, 2H), 6.63 (s, 1H), 4.91 (s, 1H), 4.75-4.68 (m, 1H), 4.44-4.40 (m, 1H), 4.34-4.26 (m, 1H), 3.68 --3.62 (m, 1H), 3.41-3.34 (m, 2H), 3.29-3.21 (m, 1H), 3.16-3.11 (m, 1H), 2.74-2. 57 (m, 4H), 2.27-2.17 (m, 9H), 2.12-2.05 (m, 1H), 2.02-1.92 (m, 2H), 1.87-1.70 ( m, 3H), 0.85 (t, J = 7.6 Hz, 3H), LCMS: m / z 900.4 [M+H] + .

[0360] 81. Synthesis of Compound 81

[0361] [ka]

[0362] Indole-6-boronic acid (32 mg, 0.2 mmol) and Cu(OAc)2(5 A solution of 2,6-lutidine (13.3 mg, 0.013 mmol) and lauric acid (2. Compound A4 (100 mg, 0.13 mmol) was added to the mixture. The mixture was stirred at room temperature for 2 days under an atmosphere of air. The mixture was concentrated, and the residue was purified by column chromatography on silica gel. The compound was purified by chromatography (MeOH / DCM = 1 / 20) and prep HPLC to give a white solid. Compound 81 was obtained (10 mg, yield 8.9%). 1 H NMR (CDCl3, 400 MHz):δ7.58 (d, J = 2.0 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 7.18 (d, J = 2.4 Hz, 1H), 7.03 (dd, J = 8 .8, 2.4 Hz, 1H), 6.77 (s, 1H), 6.68 (d, J = 2.4 Hz, 1H), 4.90 (s, 1H), 4.76-4.66 (m, 1H), 4.45-4.41 (m, 1H), 4.37-4.28 (m, 1H), 3.68-3.62 (m, 1H), 3.34-3.25 (m, 2H), 3.17-3.06 (m, 2H), 2.62-2.51 (m, 2H), 2.44-2.39 (m, 1H), 2.02-1.96 (m, 1H) , 1.31-1.17 (m, 13H), 0.90-0.79 (m,4H). LCMS: m / z 863.4 [M+H] + .

[0363] 82. Synthesis of Compound 82

[0364] [ka]

[0365] A solution of compound A4 (45 mg, 0.06 mmol) and TEA (18 mg, 0.18 mmol) in THF (5 mL) Benzoyl chloride (12.5 mg, 0.09 mmol) was added to the mixture at 0° C. for 2 hours at room temperature. The reaction mixture was diluted with saturated NaHCO3 solution (10 mL) and extracted with DCM (20 mL). The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was The mixture was purified by HPLC to give compound 82 (15 mg, 29% yield) as a white solid. 1 HN MR (CDCl3, 400 MHz):δ7.89 (d, J = 7.2 Hz, 2H), 7.54 (t, J = 7.2 Hz, 1H), 7.42 ( t, J = 7.2 Hz, 2H), 6.62 (s, 1H), 4.87 (s, 1H), 4.70-4.65 (m, 1H), 4.43-4.41 (m, 1H), 4.37-4.32 (m, 1H), 3.67-3.62 (m, 1H), 3.31-3.29 (m, 1H), 3.29-3.12 (m, 3H) , 3.02 (d, J = 6.8 Hz, 1H), 2.71-2.66 (m, 1H), 2.54 (d, J = 13.2 Hz, 1H), 2.07-1 .92 (m, 3H), 1.87-1.74 (m, 3H), 0.82 (t, J = 7.2 Hz, 3H); LCMS: m / z 851.2 [M+H] + .

[0366] 83. Synthesis of Compound 83

[0367] [ka]

[0368] Solution of compound 1 (80 mg, 0.10 mmol) and TEA (54 mg, 0.53 mmol) in DCM (3 mL) To the mixture was added tosyl chloride (41 mg, 0.21 mmol). The mixture was stirred at room temperature for 2 hours. The reaction mixture was diluted with saturated NaHCO3 solution (20 mL) and extracted with DCM (20 mL x 2). The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by prep HPLC. Compound 83 (70 mg, 72.5% yield) was obtained as a white solid. 1 H NMR (CDCl3, 3 00 MHz):δ7.80 (d, J = 8.4 Hz, 2H), 7.35 (d, J = 8.1 Hz, 2H), 6.50 (s, 1H), 4.80 (s, 1H), 4.67-4.61 (m, 1H), 4.43-4.39 (m, 1H), 4.19-4.12 (m, 1H), 3.22-2.98 (m, 4H), 2.87-2.81 (m, 1H), 2.13-2.10 (m, 1H), 2.06-1.96 (m, 3H), 0.80 (t, J = 8.4 Hz, 3H); LCMS: m / z 901.5 [M+H] + .

[0369] 84. Synthesis of Compound 84

[0370] [ka]

[0371] A solution of Spinosyn J (2.15 g, 3.0 mmol) in ethyl bromide (15 mL). , powdered potassium hydroxide / tetra-n-butylammonium iodide (10:1, 1.0 g / 0.1 g) was added. The mixture was stirred at ambient temperature for 2 hours and then evaporated under reduced pressure. The residue was dissolved in water (60 mL) and extracted with EA (50 mL x 2). The combined organic layers were washed with brine. The mixture was washed, dried over Na2SO4, filtered and concentrated in vacuo to give an oil which was then precipitated on silica gel. Purification by column chromatography (DCM / MeOH = 50 / 1 to 20 / 1) gave a white solid. Compound J-1 (2.0 g, 90% yield) was obtained. LCMS: m / z 746.2 [M+H] + .

[0372] To a solution of compound J-1 (2.9 g, 3.8 mmol) in DCM (50 mL) was added m-CPBA (2.0 g, 11 0.6 mmol) was added. The mixture was stirred at room temperature overnight. The reaction was diluted with saturated Na2SO3 solution (30 mL After stirring for an additional 5 h, the organic solvent was removed under reduced pressure. The mixture was extracted with EA (50 mL x 3). The combined organic layers were washed with saturated NaHCO3 (30 mL x 2), water (30 mL). L), and brine, dried over anhydrous Na2SO4, filtered and concentrated. The residue was concentrated to silica gel The product was purified by column chromatography on gel (DCM / MeOH = 50 / 1 to 20 / 1) to give a yellow solid. Compound J-2 (2.5 g, yield 86%) was obtained as a compound. LCMS: m / z 761.2 [M+H] + .

[0373] A solution of compound J-2 (200 mg, 0.26 mmol) in aniline (2 mL) was treated with ZrCl4 (31 mg, 0.13 mmol). ol) was added. The mixture was stirred at 80° C. overnight. The mixture was subjected to column chromatography on silica gel. The compounds were purified by chromatography (DCM / MeOH = 20 / 1 to 10 / 1) to give compounds 84-1 and 84-2. (88 mg, 40% yield). LCMS: m / z 855.2 [M+H] + .

[0374] A solution of a mixture of compounds 84-1 and 84-2 (86 mg, 0.1 mmol) in DCM (3 mL) was added under N DAST (82 mg, 0.5 mmol) was added at -78°C. The mixture was stirred at -78°C for 0.5 h under N2 pressure. The reaction mixture was diluted with saturated NaHCO3 solution (50 mL) and extracted with EA (30 mL x 2). The combined organic phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by prep HPLC. The resulting mixture was purified by HPLC to give compound 84 (24 mg, 28% yield) as a white solid. 1 H NMR ( CDCl3, 300 MHz):δ7.23 (d, J = 8.1 Hz, 2H), 7.04 (d, J = 7.5 Hz, 2H), 6.97 (t, J = 6.9 Hz, 1H), 6.76 (s, 1H), 4.87 (s, 1H), 4.72-4.67 (m, 1H), 4.45-4.43 (m, 1H) , 4.35-4.30 (m, 1H), 3.76-3.71 (m, 1H), 3.67-3.62 (m, 1H), 3.33-3.27 (m, 2H), 3. 19-3.09 (m, 2H), 2.60-2.51 (m, 2H), 2.41-2.40 (m, 1H), 0.86 (t, J = 7.8 Hz, 3H). LCMS: m / z 837.2 [M+H] + .

[0375] 85. Synthesis of Compound 85

[0376] [ka]

[0377] Compound J-2 (1.0 g, 1.3 mmol) and trimethylsilyl azide in toluene (20 mL) (300 mg, 2.6 mmol) was added to a solution of Ti(Oi-Pr)4 (370 mg, 1.3 mmol). The mixture was stirred at 90 °C overnight. After cooling to room temperature, the mixture was quenched with H2O and extracted with DCM. (30 mL x 3). The combined organic layers were dried over potassium carbonate, filtered and concentrated. A mixture of compounds J-3-1 and J-3-2 (1.0 g) was obtained and carried to the next step without further purification. Used for LCMS: m / z 805.2 [M+H] + .

[0378] A solution of compounds J-3-1 and J-3-2 (1.0 g, 1.24 mmol) in THF (20 mL) was diluted with PPh3 (326 mg The mixture was heated to reflux for 2 hours. The mixture was concentrated to give a residue. The residue mixture was purified by column chromatography on silica gel (PE / EA = 3 / 1 followed by DCM / MeOH = 20 / 1) to give compound J-4 (506 mg, 53.5% yield) as a yellow solid. : m / z 761.2 [M+H] +

[0379] (4-Fluorophenyl)boronic acid (138 mg, 0.98 mmol) and Cu in toluene (10 mL) A solution of (OAc)2 (13 mg, 0.065 mmol) was added with 2,6-lutidine (70 mg, 0.53 mmol) and lauric acid. (26 mg, 0.13 mmol), and compound J-4 (500 mg, 0.65 mmol) were added to the mixture. The mixture was stirred under air for 3 days. The mixture was concentrated, and the residue was dissolved in 5% NH3.H2O (30 mL) and The mixture was diluted and extracted with EA (50 mL x 2). The combined organic layers were washed with 10% NaHCO3 (50 mL), water ( The mixture was washed with 50 mL) and brine, dried over anhydrous Na2SO4, filtered and concentrated. The product was purified by column chromatography on gel (MeOH / DCM = 1 / 20) and prep HPLC. Compound 85 was obtained as a white solid (260 mg, yield 47.1%). 1 H NMR (CDCl3, 40 0 MHz):δ6.98-6.89 (m, 4H), 6.75 (s, 1H), 4.85 (d, J = 1.6 Hz, 1H), 4.71-4.65 (m , 1H), 4.44-4.42 (m, 1H), 4.33-4.29 (m, 1H), 3.74-3.70 (m, 1H), 3.32-3.25 (m, 2H) ), 3.11 (t, J = 9.6 Hz, 1H), 2.56-2.47 (m, 2H), 2.37-2.35 (m, 1H), 2.24 (s, 6H), 0.85 (t, J = 7.6 Hz, 3H), 0.81-0.76 (m, 1H). LCMS: m / z 854.8 [M+H] + .

[0380] III. Preparations The compounds described herein or salts thereof may be provided in a formulation or composition. The spinosyn derivatives of the present invention may be formulated in compositions for the control of pests. may contain other active ingredients and / or plant or plant product treating compounds. Therefore, the formulation may include a contact-acting insecticide and / or acaricide. The active insecticides and / or acaricides are fatty acids, fatty acid esters, fatty acid sugar esters, and and fatty acid salts, pyrethrum extracts, vegetable oils and their salts, vegetable oils and their salts, essential oils, Contact-acting insecticides include those derived from mineral oil, pyrethrum extracts, and combinations thereof. And / or the acaricide may also include avermectins. The resulting spinosyn-containing compositions and formulations disclosed herein are effective as insecticides. Not only will it prove to be environmentally sound and safe for human use, but it will also prove to be Some ingredients and formulations do not leach from the bait and are easily washed off the leaves in the rain. It can remain in place in that it is not susceptible to insect and mite pests during and after rain. In some cases, the compositions and formulations may exhibit synergistic effects. and a better expected response than spinosyn or insecticide or acaricide treatments alone. This can result in the same results.

[0381] In some cases, the compounds of the present invention are used as ectoparasiticides (typically parasiticides that act against parasites external to their hosts). ("external") surface-attacking arthropod pests) The spinosyn compounds may be formulated for use as ectoparasiticides in a manner known to those of skill in the art. Representative ectoparasiticides include, but are not limited to: Bamectin, alphamethrin, amitraz, avermectin, coumaphos, cycloprotoxin Phosphorus, cyfluthrin, cyhalothrin, cypermethrin, cyromazine, deltamethrin, da Iazinon, diflubenzuron, dioxathion, doramectin, fanfur, fen Thione, fenvalerate, flucythrinate, flumethrin, hexaflumuron, ibex Rumectin, Lindane, Lufenuron, Malathion, Methoprene, Metrifonate, Mo Oxydectin, Permethrin, Fosme, Pirimiphos, Propetamphos, Propoxur, Tenon, Temephos, Tetrachlorvinphos, Trichlorfon, Zetacypermethrin, B .t.Biotoxins and boric acid.

[0382] Optionally, the compounds of the invention may be usefully combined with other ectoparasiticides or with anthelmintics. The latter are also known as endoparasiticides ("endo" = internal, typically (Control endoparasites of the phyla Ectozoa and Nematoda). Representative such endoparasites Pesticides include, but are not limited to: abamectin, albendazole, Avermectin, Bunamidine, Coumaphos, Dichlorvos, Doramectin, Epsiplante le, febantel, fenbendazole, flubendazole, ivermectin, levamizo methadone, mebendazole, milbemycin, morantel, moxidectin, netobimin, Closamide, nitroscanate, oxfendazole, oxibendazole, piperazine praziquantel, pyrantel, ricombendazole, tetramisole, thiabendazole ol, clorsulon, closantel, diamphenetide, nitroxynil, oxyclozapine Nido, rafoxanide, triclabendazole.

[0383] The formulations described herein may be used in combination with a spinosyn component to control One or more other compounds having activity against specific ectoparasites or endoparasites, e.g. For example, synthetic pyrethroids, natural pyrethrins, organophosphates, organochlorines, carbamate , phoramidine, avermectin, milbemycin, insect growth regulators (chitin synthesis inhibitors) , juvenile hormone analogs and juvenile hormones), nitromethylene, pyridine and pyridine In an exemplary embodiment, the composition further comprises an additional contact agent, such as a sorbitol. The composition may contain insecticides and / or acaricides. It can be available as a ready-to-use (RTU) liquid spray, dust or solid. The composition is applied to the pest itself, to the vicinity of the pest, and / or to the plants and plant products to be protected. It can be applied in the vicinity.

[0384] Generally, the formulations contain a compound as described herein and one or more The formulation will contain 0.5 mg of a physiologically acceptable adjuvant. It is present in concentrations ranging from 0.01 to 98.0 percent, with the remaining content being physiologically tolerable. Such formulations, particularly those containing less than 50 percent While the compounds of the present invention can sometimes be used directly, these formulations can also be used in other physiological applications. These may also be diluted with a commercially acceptable carrier to form a more dilute treatment formulation. The latter formulations may contain lower concentrations of the active agent, from 0.001 to 0.1 percent. do.

[0385] The compositions are prepared according to procedures and formulas that are conventional in the agricultural or pest control arts. The compositions may be concentrated and dispersed in water or in the form of dusts, baits or granular formulations. Dispersions may be used in a variety of applications, typically in the form of aqueous suspensions prepared from concentrated formulations of the compounds. The water-soluble or water-suspended or emulsified formulations are solids, wettable powders, or emulsions. or liquids known as emulsifiable concentrates or aqueous suspensions. These granules can be packed or compressed to form water-dispersible granules. The mixture includes a carrier and a surfactant. The concentration of the compound is typically about 0.1% by weight. The inert carrier is typically between about 90% by weight and about 100% by weight of attapulgite clay, momo Lilonite clay and diatomaceous earth or purified silicates.

[0386] The surfactant typically comprises from about 0.5% to about 10% of a hydrating agent. Sulfonated lignin, condensed naphthalene sulfonate, naphthalene sulfonate, alkyl benzenesulfonates, alkylsulfonates or non-ionic surfactants, e.g. The present invention includes the ethylene oxide adduct of alkylphenol, etc., and mixtures thereof. Emulsions of derivatives of are typically inert, which is a mixture of a water-immiscible solvent and an emulsifier. Dissolved in a carrier, equivalent to about 10% to about 50%, about 50 to about 10% per liter of liquid. It is a spinosyn derivative in the range of 500 grams. The organic solvent is an organic substance such as xylene, and petroleum fractions such as the high-boiling naphthenic and olefinic portions of petroleum, including heavy aromatic naphtha. Terpene-based solvents - Rosin derivatives, aliphatic ketones such as cyclohexanone, and Other organics, such as crude alcohols, may also be used. Emulsifiers for emulsions are typically: Mixed ionic and / or non-ionic compounds such as those mentioned herein or their equivalents. It is an ionic surfactant.

[0387] Aqueous suspensions may be prepared containing water-insoluble spinosyn derivatives, where the compound is dispersed in an aqueous vehicle, typically at a concentration ranging from about 5% to about 50% by weight. Suspensions are prepared by finely grinding the compound and vigorously dissolving it in a vehicle of water, surfactants and dispersants. The mixture is prepared by thoroughly mixing inert ingredients such as inorganic salts and synthetic or natural gums. may be used to increase the density and / or viscosity of the aqueous vehicle as desired.

[0388] The precipitated flowable material comprises at least one spinosyn derivative of the invention dissolved in a water-miscible solvent. and may be prepared by dissolving in a surfactant or surface active polymer. When these formulations are mixed with water, the active spinosyn derivatives precipitate along with the surfactant, resulting in The size of the crystallites depends on the specific polymer and interface. This can be controlled by the choice of the active agent mixture.

[0389] The spinosyn derivatives may be applied as a granular composition that is applied to the soil. Typically contains from about 0.5% to about 10% by weight of the derivative. The derivative is dispersed in an inert carrier, which is typically a clay or equivalent material. Granular compositions are prepared by dissolving a compound of the invention in a suitable solvent and preforming it to the desired particle size. The particles are typically prepared by applying them to a granular carrier. The granular composition forms a dough or paste of the carrier and compound, The combined mixture is dried and prepared by crushing the dough or paste to the desired particle size. It can also be manufactured.

[0390] The spinosyn derivative may be combined with a suitable organic solvent. The organic solvent is typically , and non-irritating petroleum oils that are widely used in the agricultural industry. These combinations are typically More typically, the spinosyn compound is administered as a spray in a liquid carrier. The compounds are applied as sprays, where the liquid carrier is water. The compound may be dissolved in an inert carrier which is a pressure-generating propellant mixture. The aerosol composition is packaged in a container, where the mixture is dispensed by an atomizing valve. The propellant mixture contains any of the low boiling halocarbons, which are inert Pressurized with gas or gaseous hydrocarbons, may be mixed with organic solvents or aqueous suspensions .

[0391] The compounds may be applied to any locus where insects or mites reside. , typically in cotton, soybean and vegetable crops, fruit and nut trees, grape vines, house and garden plants. The amount of spinosyn derivative to be applied to the locus of insects and mites is within the skill of the art. Generally, concentrations range from about 10 ppm to about 5,000 ppm. For crops such as soybeans and cotton, application rates are about 1000 mg / hectare. from about 0.01 to about 1 kilogram per hectare (kg / ha), wherein the spinosyn derivative is It is applied in a spray formulation at 5 to 50 gallons per acre (gal / A).

[0392] The compositions may be formulated in concentrate, ready-to-use (RTU) liquid spray, dust or solid form. The formulation chosen will depend on the use of the product.

[0393] The following general treatment methods are preferably used in accordance with the present invention for seed treatment or plant propagation material. Suitable for carrying out the material treatment: drying treatment (preferably with, for example, liquid paraffin or tar) Addition of adhesion promoters such as tallow, etc., and, if appropriate, colorants, slurry treatment (preferably or by the addition of wetting agents, dispersing agents, emulsifying agents, adhesives, inert fillers and colorants), Aqueous liquid treatment (preferably emulsifiers, dispersants, thickeners, antifreeze agents, polymers, adhesives and and colorant addition), solvent-based liquid processing (with solvent and colorant addition), Emulsion processing (by adding emulsifiers, solvents and colorants).

[0394] The total active spinosyn derivative in the treatment formulation is preferably from 0.01% by weight to 80% by weight. For example, the total active spinosyn compound may be 0.01%, 0.05%, 0.1% by weight, 0.5% by weight, 1% by weight, 5% by weight, 10% by weight, 20% by weight, 30% by weight %, 40% by weight, 50% by weight, 60% by weight, 70% by weight, or 80% by weight. Generally, about 1 to about 300 g of spinosyn per 100 kg of seed or plant propagation material. The derivatives are applied in the form of a treatment.

[0395] Those of skill in the art will appreciate that the specific dose level and frequency of dosing for any particular subject can be varied. the activity of the particular compound used, the metabolic stability and length of action of that compound, the species, age, weight, general health, sex and diet of the subject, mode and time of administration; Dependent on various factors, including rate of excretion, drug combination, and the severity of the particular condition It will be understood that the precise dose to be used in the formulation will depend on the route of administration and the nature of the infection. It will also depend on the severity of the condition and will be determined according to the judgment of the practitioner and the circumstances of each subject. It should be.

[0396] IV.How to use The spinosyn compounds described herein are useful in treating pests including insects, arachnids and nematodes. Thus, the compounds described herein have insecticidal and pesticidal activity against insects. The compounds and formulations as described herein are capable of controlling, inhibiting and / or inactivating the pest of interest. The spinosyn compounds described herein can be used to activate These substances and formulations provide the primary source of pesticide activity against crop pest species. In examples, the compounds and formulations can be used in animal health. The spinosyn compounds and formulations described in in an amount effective to control or inhibit the pest or condition being treated. The spinosyn compounds and formulations described herein are derived from naturally occurring spinosyns. Compared to one or more of the following characteristics: increased efficacy, reduced risk to non-target species , reduced potential for environmental damage, minimal cross-resistance to other pesticides currently available This may overcome existing pest resistance to certain spinosyn products.

[0397] The compounds and formulations described herein are useful for controlling or containing pest populations. The compounds and formulations are useful for preventing and controlling a number of commercially important insect pests. It exhibits strong and broad spectrum activity. The target insect spectrum includes planthoppers, leafhoppers, and grasshoppers. Lepidoptera and some members of several other insect orders, including mites and cockroaches. The compounds and formulations are effective against many of the problematic larval species of Lepidoptera. Insecticidal activity is generally seen on contact and ingestion uptake. This has been observed following administration of spinosyns by a variety of delivery methods, including sey

[0398] Those of skill in the art will be able to use the compounds, formulations and methods disclosed herein to produce a variety of Various home and garden insect and mite pests, including, but not limited to, the southern armyworm, Dring moth, armyworm, burr moth, Indian meal moth, tortrix, corn earworm, Tomato ball worm (also known as tomato fruit worm), European corn borer, Cabbage white butterfly, cabbage looper, red bollworm, American bollworm, tomato Hornworms, bagworms, eastern tent caterpillars, sod webworms, diamondback moths, tomato pinworms, Rapeberry Moss, Cotton Leafworm, Beet Armyworm and Fall Armyworm Members of the insect order Lepidoptera, including: aphids, leafhoppers, planthoppers, and two-spotted moths Members of the order Homoptera, including midges, scale insects, whiteflies, and spittlebugs; Members of the insect order Diptera, which includes house flies, stable flies, blow flies, and mosquitoes; mites; and It will be appreciated that the compounds described herein can be processed in various ways. The mixture and formulation are used to control thrips including melon thrips and western flower thrips. Members of the order Coleoptera, which includes the Colorado potato beetle; members of the order Orthoptera; and Lepidoptera. Pterygota (moths and butterflies), Hymenoptera (leaf-mining sawflies), Coleoptera (beetles) and Diptera (flies) Compounds and formulations can also be used to treat ants, green algae, and other insects. Control and / or treat beetles, adult houseflies, western tent caterpillar larvae, and two-spotted spider mites. Generally, the spinosyn compounds and preparations described herein The agent is active against a number of ectoparasites in a number of animals by multiple routes. The compounds and formulations of the present invention can be used to control a wide variety of arthropod pests. can.

[0399] Representative pests which may be controlled by the compounds and formulations of the present invention include, in addition, spiders, Am. blyomma americanum (Lone Star Tick), Amblyomma maculatum (Gulf Coast tick), Argas persicus (Poultry tick) ), Boophilus microplus (cattle tick), Chorioptes spp. (Demodex spp.), Demodex bovis (Bovine acne 2), Demodex canis (dog mite), Dermacentor a ndersoni (Rocky Mountain spotted fever tick), Dermacentor varia bilis (American dog tick), Dermanyssus gallinae (Northern Ixodes ricinus (the common sheep tick), Knemid okoptes gallinae (chicken scabies mite), Knemidokopt es mutans (tritium scaly mites), Otobius megnini (mites) (Scab mite), Psoroptes equi (Scab mite), Psoroptes o vis (scab mite), Rhipicephalus sanguineus (crustacean mite), Sarcoptes scabiei (Scabiei Scabiei) ), insects - Aedes (mosquito), Anopheles (mosquito), Culex (mosquito), Bovico la bovis (cattle louse), Callitroga homnivorax (black flies), Chrysops spp. (deer flies), Cimex lectu larius (bedbugs), Cochliomyia spp. (screwworm flies) ), Ctenocephalides canis (dog flea), Ctenoceph alides felis (cat flea), Culicoides spp. Mosquitoes, sandflies, Culicoides or midges), Damalinia ovis ( (warble fly), Dermatobia spp. ), Gasterophilus haemorrhoidalis (Atakaumaba D), Gasterophilus intestinalis (common botfly), Gasterophilus nasalis (jaw fly), Glossina s pp. (tsetse fly), Haematobia irritans (horn fly, buffalo fly), Haematopinus asini (horse blood louse), H aematopinus eurysternus (short-nosed cattle louse), Haemat opinus ovillus (body louse), Haematopinus suis (Pig lice), Hydrotaea irritans (Bite-biting house fly), Hy poderma bovis (bomb fly), Hypoderma Linognathus ovillus (Linognathus lineatum) (Body louse), Linognathus pedalis (Leg louse), Linog nathus vituli (long-nosed cattle louse), Lucilia spp. (maggots) Melophagus ovinus (sheep ked fly), Musca s pp. (house fly, face fly), Oestrus ovis (atakaumaba (lice), Pediculus spp. (lice), Phlebotomus spp. (Sandfly), Phormia regina (Blowfly), Psoroph ora spp. (mosquito), Pthirus spp. (lice), Reduvius spp. (Assassin bugs), Simulium spp. (Black flies), Solenopo tes capillatus (hairy lice), Stomoxys calci trans (stable flies), Tabanus spp. (horsey flies), Tenebrio spp. (mealworms), Triatoma spp. (assassin bugs) Similarly, spinosyn derivatives can be derived from the order Isopoda, e.g., Oniscus asellus , Armadillidium vulgare, Porcellio scaber; From the order of the Millipedes, for example, Blaniulus guttulatus; from the order of the Chilopoda, for example, et al., for example, Geophilus carpophagus, Scutigera sp. p; from the order Scutigerella, e.g., Scutigerella immaculata. From the order Mitomycetes, for example, Lepisma saccharina; from the order Collembola, for example, Onychiurus armatus; from the order Orthoptera, e.g., Blatta orie ntalis, Periplaneta americana, Leucophea maderae, Blattella germanica, Acheta domes ticus, Gryllotalpa spp., Locusta migratori a migratorioides, Melanoplus differential is, Schistocerca gregaria; from the order Dermaptera, e.g., Fo from the order Isoptera, e.g., Reticuli termes spp.; from the order Phthiraptera, e.g., Phylloxera vastat rix, Pemphigus spp., Pediculus humanus cor poris, Haematopinus spp., Linognathus spp; From the order Trichodectes, e.g., Trichodectes spp., Damalinea sp. p.; from the order Thripidae, e.g., Frankliniella occidental is, Hercinothrips femoralis, Thrips palmi, Thrips tabaci; from the order Heteroptera, e.g., Eurygaster spp., Dysdercus intermedius, Piesma quadrata, Ci mex lectularius, Rhodnius prolixus, Triato ma spp.; from the order Hemiptera, e.g., Aleurodes brassicae, Be misia tabaci, Trialeurodes vaporariorum, A phis gossypii, Brevicoryne brassicae, Cryp tomyzus ribis, Aphis fabae, Doralis pomi, E riosoma lanigerum, Hyalopterus arundinis, Macrosiphum avenae, Myzus spp., Phorodon h umuli、Rhopalosiphu padi、Empoasca spp.、E bilobate, Nephotettix cincticeps 、Lecanium corni、Saissetia oleae、Laodelph ax striatellus, Nilaparvata mourning, Aonidis ella aurantii, Aspidiotus hederae, Pseudodoc. occus spp., Psylla spp.; phora gossypiella、Bupalus piniarius、Chei matobia brumata、Lithocolletis blancardel la、Hyponomeuta padella、Plutella maculipe nnis, Malacosoma neustria, Euproctis chrys orrhoea、Lymantria spp.、Bucculatrix thurb eriella, Phyllocnistis citrella, Agrotis s pp., Euxoa spp., Feltia spp., Earias insula na、Heliothis spp.、Spodoptera exigua、Mame Brassicae, Panolis flammea, Prodenia litura、Spodoptera spp.、Trichoplusia ni、C arpocapsa pomonella、Pieris spp.、Chilo sp p., Pyrausta nubilalis, Ephestia kuehniell a、Galleria mellonella、Tineola bisselliel la、Tinea pellionella、Hofmannophila pseud ospretella、Cacoecia podana、Capua reticul ana、Choristoneura fumiferana、Clysia ambi guella, Homona magnanima, Tortrix viridana 、 Cnaphalocerus spp.; nctatum, Rhizopertha dominica, Acanthoscel ides obtectus, Acanthoscelides obtectus, H ylotrupes bajulus、Agelastica alni、Leptin otarsa ​​decemlineata、Phaedon cochleariae、 Diabrotica spp., Psylliodes chrysocephala 、Epilachna varivestis、Atomaria spp.、Oryz aephilus surinamensis, Antho nomus spp., S itophilus spp., Otiorrhynchus sulcatus, Co Smopolites sordidus、Ceuthorrhynchus assi milis, Hypera postica, Dermestes spp., Trog oderma spp.、Anthrenus spp.、Attagenus spp .、Lyctus spp.、Meligethes aeneus、Ptinus s pp. 、Niptus hololeucus、Gibbium psylloides Tribolium spp. Agriote s spp.、Conoderus spp tha、Amphimallon solstitialis、Costelytra zealandica、Oulema oryzae、Lissorhoptrus o ryzophilus;preservation of Diprion spp., Hoploc amp spp.、Lasius spp.、Monomorium pharaoh is, Vespa spp.; eles spp., Culex spp., Drosophila melanoga ster, Musca spp., Fannia spp., Calliphora e rythrocephala, Lucilia spp., Chrysomyia sp p.、Cuterabra spp.、Gastrophilus spp.、Hypp obosca spp., Liriomyza spp., Stomoxys spp. 、Oestrus spp.、Hypoderma spp.、Tabanus spp .、Tannia spp.、Bibio hortulanus、Oscinella frit、Phorbia spp.、Pegomyia hyoscyami、Ce ratitis capitata、Dacus oleae、Tipula palu dosa; Xenopsylla cheopis Cerato phyllus spp.; From the order of the Arachnida, for example, Scorpio maurus, Latrodectus m actans; from the order Acari, e.g., Acarus siro, Argas spp., Ornithodoros spp., Dermanyssus gallinae, E riophyes ribis, Phyllocoptruta oleivora, B oophilus spp., Rhipicephalus spp., Amblyom ma spp., Hyalomma spp., Ixodes spp., Psorop tes spp., Chorioptes spp., Sarcoptes spp., Tarsonemus spp., Bryobia praetiosa, Panony Useful against pests including Tetranychus spp., Tetranychus spp. .

[0400] Insects that can be controlled using the compounds and formulations described herein Insects include those from the following orders: Soil-dwelling insects: Diptera (e.g., burrowing moths, wheat bulb moths, etc.) D), Coleoptera (e.g., Diabrotica (wireworms)), Lepidoptera (e.g., Dartmoss ), Brattophtheroidea, Myriapoda. Leaf beetles: Aphidina, Coleoptera, Diptera, Lepidoptera, Hemiptera, Thripida, Aleurodinae, Cicadinae, Scleractinia, Coccinellidae , Heteroptera.

[0401] The method for controlling insect and acarid pests as described herein comprises: an effective amount of at least one spinosyn compound as described herein; At least one of the additional insecticides and acaricides, and at least one of the solvents or acceptable carriers. providing a formulation having at least one of the following properties: If the formulation is a liquid, the method may include administering an effective amount of the formulation to the pest, In contact with plants and plant products, in the vicinity of pests, and / or in the vicinity of plants and plant products. The method may further include administering an effective amount of the formulation to the subject so that the subject comes into contact with dust or solids. In the case of a pest, the step of administering an effective amount of the formulation comprises placing an effective amount of the composition in the vicinity of the pest. and / or placing an effective amount of the composition in the vicinity of the plants and plant products to be protected. The method may include the steps of:

[0402] An effective amount of a spinosyn compound or formulation as described herein can be used to treat a target The amount required to control or kill the pest. Application rates vary widely and are based on the target pest, Pest size and numbers, host crop and crop age, climate and economic thresholds or tolerances Generally, typical use rates are around 1 ppm (1 mg active It is set at 100 mg / ha for crop application. About 25 to about 200 grams per roll (0.023 to 0.184 lb per acre) ) of active ingredient is used. Turf rates are 88-450g ai / ha (0.0 78-0.4 lb ai / acre. The yield is 0.046-0.17 lb ai / acre. i / 100 gal or 55-204 ppm. Typically, higher temperatures are better. There is a positive temperature correlation that results in activity against some pests such as leaf miners and thrips. Performance is positively affected by the addition of a penetrating surfactant such as crop oil at the nominal rate.

[0403] All animals are susceptible to attack by such pests, but the problem lies among vertebrate hosts. Therefore, the spinosyn compounds and The products and preparations are intended for use in humans, livestock animals (cattle, sheep, pigs, goats, buffaloes, water buffaloes, horses, etc.) mosquitoes, rabbits, chickens, turkeys, ducks, geese, ostriches, etc.), horses and Other entertainment animals, minks and other animals raised for fur, rats, mice, laboratories and other animals used in research settings, companion animals such as dogs and cats. The present invention may be used for aquatic animals, fish, crustaceans, and other aquatic animals. The spinosyn compounds and formulations described herein are useful in treating a full range of animals.

[0404] Arthropod pests are treated on a host animal with an effective amount of a compound as described herein. The bacteria are inhibited or killed by contact with a spinosyn compound.

[0405] Techniques for delivering the compounds and formulations described herein are within the skill of the art. Generally, the formulations of the present invention, which include at least one spinosyn compound, are administered to animals. The formulation is applied to the exterior surface, whereby it attacks pests already present on the host and their host within an effective period. The spinosyn compounds are typically formulated in liquid formulations that come into contact with the insect pests that have arrived on the host's body. This is sprayed or poured onto the surface of the animal. The conventional treatment is a "soak", whereby the cow is soaked in a dilute solution containing the spinosyn compound. For some hosts and pests, the formulation is They may occur as dusts spread on the host or in shampoos or other liquids used to bathe the animal. The derivative may be a cream. Cat and dog collars are used to deliver the derivative directly to the surface of the animal. It can also be used as a modality.

[0406] The compounds and formulations described herein can be used in areas frequented by animals. Alternatively, the compound can be applied to the host in a manner similar to direct application to the host, whereby the compound comes into contact with the pest. Pet bedding and rug applications can be used. Bags can be used. These are positioned at doorways where the cows are forced to take the bags. The insect pests are then exposed to the compound of the present invention by rubbing the insect pests against the target.

[0407] In some cases, the compounds and formulations of the present invention can be used to reduce fecal contamination of cattle and other animals. The compounds and formulations can be administered orally to control insects and spiders. The compounds are transported via the intestinal tract and appear in the faeces. indirectly protects against pests.

[0408] The compounds and formulations described herein may be used to treat pests that may be preyed upon. In addition, the compounds may be administered orally to control animal pests. The composition may be applied intradermally or topically.

[0409] Oral administration may be achieved using tablets and animal feed. For animals, administration may be by direct administration or by addition to their food supply. This is best accomplished by using a liquid formulation that is well tolerated. A particularly useful method of administering orally is to administer the derivatives in the form of chewable tablets or treats and animal feed. This is achieved by administering the drug into the diet.

[0410] The spinosyn compounds and formulations described herein are useful in treating insect pests that are animal pests. They are also useful in the treatment of animals to control podoptera, i.e. insects and arachnids. Arthropod pests typically attack the external ("external") surfaces of their hosts, Agents that control various pests are called "ectoparasiticides."

[0411] Spinosyn compounds and formulations are used to treat soil, seeds or plant propagation material. It can be used for watering and irrigating plants. Various types of seeds and plant propagation materials can be treated: corn, grains (e.g. wheat, barley, oats, rye, etc.), rice, seed potatoes, cotton, rapeseed, sunflower, beet (e.g. (e.g. sugar beet, etc.), vegetable seeds (e.g. onion, cabbage, tomato, etc.), (for animal feed) Beans, peanuts, soybeans, sorghum, etc.

[0412] Applying granules containing the active compounds described herein into or onto the soil. Examples of suitable applications include seed, band, furrow and hole applications.

[0413] Spinosyns or their salts are emulsified or dissolved in water and used to irrigate plants. It is particularly advantageous to use the plant as a fertilizer. Suitable examples of application include spraying or irrigating the soil. and, i.e., irrigating the plant with a solution containing the active compound and drip irrigation, and Also of use in hydroponic systems, especially in the production of vegetables and ornamental plants.

[0414] The seed treatment is carried out to control animal pests, preferably arthropods, found in agriculture and in forests. and nematodes, especially insects and spiders. The treatment is effective against normally susceptible Effective against resistant and tolerant species, as well as against all or individual developmental stages .

[0415] In some embodiments, the spinosyn compounds and products described herein The agent comprises at least one spinosyn compound or a physiologically acceptable derivative thereof. The present invention relates to a method for promoting wound healing in a mammal, comprising administering a salt of the present invention to a mammal in need thereof. In this manner, spinosyn compounds and and the preparations are used in the manufacture of medicines for promoting or accelerating wound healing in animals, including humans. (see, e.g., U.S. Pat. No. 8,536,142) or in humans. It can be used in the treatment of

[0416] As used herein, the terms process, process, or process Such methods refer to a method of reducing one or more symptoms of a disease, infection or condition. The method includes the step of controlling, inhibiting and / or inactivating the pest. In the disclosed methods, the treatment is for the prevention and treatment of pests found in crops or animals, and and / or one or more of the diseases, infections or conditions associated with such pests. 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80% of the severity of symptoms This can refer to a %, 90%, or 100% reduction in the amount of pesticide used to control insects. The method includes determining whether or not a pest is present in one or more pests in a crop or in a subject compared to a control. A treatment is considered to be a 10% reduction in the number of infections. The method includes assessing a decrease in one or more symptoms or signs of infection in a subject compared to a control. A 10% reduction is considered to be a treatment. , control refers to the untreated condition. Thus, a reduction is greater than or equal to 10 compared to natural or control levels. %, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, or Or, any percentage reduction between 10% and 100%. Treatment is performed to achieve complete pest control. The total elimination or treatment of a disease, infection, condition, or the symptoms of a disease, infection, or condition; or It is understood that it does not necessarily refer to a complete resection.

[0417] As used herein, subject means both mammals and non-mammals. Mammals include, for example, humans, non-human primates, such as apes and monkeys, cows, horses, Non-mammals include, for example, fish and birds. Includes.

[0418] Non-limiting embodiments include: 1. Spinosyn compounds of the formula:

[0419] [ka] or its salt [In the formula,

[0420] [ka] is a single or double bond, A is a substituted or unsubstituted carbonyl, a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted Substituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heterocycloalkyl. aryl; B is a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl. R, C is O or NH, X 1 , X 2 , X 3 , X 4 , and X 5 are independent from N, NR, CR and CR2, respectively. where X 5 Alternatively, X may be a direct bond. 5 is a direct bond In some cases, X 1 , X 2 , X 3 , and X 4 One of the options is O or S. each R may be hydrogen, hydroxyl, substituted or unsubstituted amino, substituted or unsubstituted thio , substituted or unsubstituted alkoxy, substituted or unsubstituted aryloxy, substituted or unsubstituted a alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl.

[0421] 2.X 1 and X 2 is selected from NR, CR and CR2, X 1 and X 2 The R groups in combination form a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted cycloalkyl, Alkenyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted heterocycloa alkenyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl. The embodiment of paragraph 1.

[0422] 3.X 2 and X 3 is selected from NR, CR and CR2, X 2 and X 3 The R groups in combination form a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted cycloalkyl, Alkenyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted heterocycloa alkenyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl. The embodiment of paragraph 1.

[0423] 4. The embodiment of any of paragraphs 1-3, wherein A comprises forosamine.

[0424] 5. B is rhamnose or (2R,5S)-5-ethoxy-3,4-dimethoxy-6- The embodiment of any of paragraphs 1-4, comprising a methyloxan-2-yl group.

[0425] 6. A is forosamine, B is rhamnose, C is O, and X1 is N; The embodiment of any of paragraphs 1-5, wherein X2 is C(CH3) and X3 is S.

[0426] 7. The spinosyn compound is (1S, 2R, 8R, 10S, 12S, 13R, 17R, 1 8S,22S)-18-{[(2R,5S,6R)-5-(dimethylamino)-6-methyl 22-ethyl-5,17-dimethyl-10-{[(2 R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxane-2- yl]oxy}-23-oxa-6-thia-4-azapentacyclo[13.10.0.0 2 , 13 .0 3 , 7 .08 , 12 ]Pentacosa-3(7),4,14-triene-16, The embodiment of any of paragraphs 1-6, wherein the compound is 24-dione.

[0427] 8. A is forosamine, B is rhamnose, C is O, and X1 is N; The embodiment of any of paragraphs 1-5, wherein X2 is C(NH2) and X3 is S.

[0428] 9. The spinosyn compound is (1S, 2R, 8R, 10S, 12S, 13R, 17R, 1 8S,22S)-5-amino-18-{[(2R,5S,6R)-5-(dimethylamino )-6-methyloxan-2-yl]oxy}-22-ethyl-17-methyl-10-{ [(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxane -2-yl]oxy}-23-oxa-6-thia-4-azapentacyclo[13.10. 0.0 2 , 13 .0 3 , 7 .0 8 , 12 ]Pentacosa-3(7),4,14-triene- The embodiment of any of paragraphs 1-5 or 8, wherein the 16,24-dione.

[0429] 10. At least one spinosyn compound according to any one of paragraphs 1 to 9 and an acceptable and a carrier.

[0430] 11. The embodiment of paragraph 10, further comprising at least one additional active ingredient.

[0431] 12. The method according to paragraph 10 or 11, further comprising at least one plant or plant product treating compound. There are 11 embodiments.

[0432] 13. The composition of paragraph 11, in which at least one additional active ingredient comprises an insecticide or acaricide. Embodiment.

[0433] 14. The embodiment of paragraph 13, wherein the insecticide is a contact-acting insecticide.

[0434] 15. The embodiment of paragraph 13, wherein the acaricide is a contact-acting acaricide.

[0435] 16. A method for controlling pests, comprising administering an effective amount of any one of the compounds of paragraphs 1 to 9 to the pests. contacting the composition with a spinosyn compound or any of the formulations of paragraphs 10-15; method.

[0436] 17. The embodiment of paragraph 16, in which the pest is an insect.

[0437] 18. The embodiment of paragraph 16, in which the pest is a spider.

[0438] 19. The embodiment of paragraph 16, in which the pest is a nematode.

[0439] 20. A method for making a spinosyn compound, comprising: reacting the polybond to form a spinosyn compound according to paragraph 1, wherein the spinosyn compound is formed via an α-haloketone intermediate.

[0440] The following examples further illustrate certain aspects of the methods and compounds described herein. It is intended to further illustrate, but not to limit, the scope of the claims.

[0441] Intermediate 1: (1aR,1bR,3S,4aS,4bR,7R,8S,12S,15aS,15bR,15cS)-8-(((2R,5S,6R)-5-(dimethylamino )-6-Methyltetrahydro-2H-pyran-2-yl)oxy)-12-ethyl-7-methyl-3-(((2R,3R,4R ,5S,6S)-3,4,5-trimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,3,4,4 a,7,8,9,10,11,12,15,15a,15b,15c-Tetradecahydro-1aH-oxireno[2',3':4,5]-as-iso Ndaceno[3,2-d][1]oxacyclododecine-6,14(1bH,4bH)-dione (1)

[0442] [ka]

[0443] To a solution of Spinosyn A (3.0 g, 4.1 mmol) in DCM (100 mL) was added m-CPBA (2.18 g, 12.3 mmol) was added. The mixture was stirred at 0° C. for 1 h and at room temperature for 1.5 h. A saturated aqueous solution of NaHSO3 (100 mL) was added to the mixture, and the resulting mixture was stirred at room temperature for 2 hours. The organic layer was separated and the aqueous layer was extracted with DCM (100 mL x 2). The combined organic phase Wash with brine (300 mL), dry over anhydrous Na2SO4, filter and concentrate to give a residue. This was purified by column chromatography on silica gel (DCM / methanol = 40 / 1). This gave the title compound 1 (2.35 g, 76%) as a white solid. 1 H NMR (400 MHz, C DCl3,):δ6.58 (s, 1H), 4.85 (1H, s), 4.67-4.65 (m, 1H), 4.43-4.41 (m, 1H), 4.26- 4.21 (m, 1H), 3.64-3.52 (m, 1H), 3.27-3.18 (m, 2H), 3.12 (t, J = 9.6 Hz, 1H), 2. 61-2.56 (m, 1H), 2.43 (dd, J = 13.6, 2.4 Hz, 1H), 0.82 (t, J = 7.2 Hz, 3H). LCMS : m / z 748.5 [M+H] + .

[0444] Intermediates 2a and 2b: (2S,3aR,4R,5R,5aR,5bS,9S,13S,14R,16aR,16bS)-13-(((2R,5S,6R)-5-(dimethylamino) -6-Methyltetrahydro-2H-pyran-2-yl)oxy)-9-ethyl-4-hydroxy-14-methyl-5 -(phenylamino)-2-(((2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyltetrahydro-2 H-pyran-2-yl)oxy)-2,3,3a,4,5,5a,5b,6,9,10,11,12,13,14-tetradecahydro-1H- as-Indaceno[3,2-d][1]oxacyclododecine-7,15(16aH,16bH)-dione (2a) and (2S,3aR,4S,5S,5aR,5bS,9S,13S,14R,16aR,16bS)-13-(((2R,5S,6R)-5-(dimethyl Amino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-9-ethyl-5-hydroxy-14- Methyl-4-(phenylamino)-2-(((2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyltetramethyl Hydro-2H-pyran-2-yl)oxy)-2,3,3a,4,5,5a,5b,6,9,10,11,12,13,14-tetradecahydro 1H-as-indaceno[3,2-d][1]oxacyclododecine-7,15(16aH,16bH)-dione ( 2b)

[0445] [ka]

[0446] A solution of compound 1 (1.0 g, 1.3 mmol) in aniline (3 mL) in a microwave tube To the mixture was added ZrCl4 (15 mg, 0.066 mmol) under N2. The reaction mixture was heated at 80 °C in a microwave oven. The mixture was stirred under irradiation for 1 h. After cooling to room temperature, it was purified by silica gel column (DCM:MeOH = 20:1 to 10:1) to obtain a mixture of 2a and 2b, which was then subjected to chiral prep HPLC. Further purification afforded the title compounds 2a (110 mg, 10.1% yield) and 2b (65 mg, 10.2% yield) as white solids. g, yield 6.0%). Partial 1 H NMR (CDCl3, 400 MHz) for 2a:δ7.17 (t, J = 7.6 Hz, 2H), 6.78 (s, 1H), 6.70 (t, J = 7.6 Hz, 1H), 6.66 (d, J = 7.6 Hz, 2H), 4.83 (d, J = 0.8 Hz, 1H), 4 .64-4.62 (m, 1H), 4.42-4.40 (m, 1H), 4.27-4.25 (m, 1H), 4.10 (s, 1H), 3.66-3.61 (m, 2H), 3.56-3.44 (m, 16H), 3.31-3.27 (m, 1H), 3.11 (t, J = 9.6 Hz, 1H), 3.04 ( dd, J1= 4.8 Hz, J2= 13.6 Hz, 1H ), 2.90-2.87 (m, 2H), 2.23 (s,7H),0.79 (t, J = 7.6 Hz, 3H). LCMS: m / z 841.2 [M+H] + . Partial 1 H NMR (CDCl3, 400 MHz) for 2b:δ7.18 (t, J =7.2 Hz, 2H), 6.82 (s, 1H), 6.76-6.70 (m, 3H), 4.73(s, 1H), 4.70-4.66 (m, 1H), 4.43-4.42 (m, 1H), 4.20-4.18 (m, 1H), 3.87(t, J = 6.4 Hz, 1H), 3.65-3.63 (m, 1H), 3.54-3.38 (m, 17H), 3.31-3 .23 (m, 2H), 3.13-3.07 (m, 2H), 2.90 (dd, J1= 3.2 Hz, J2= 14.0 Hz, 1H ), 2.26 (s, 9H), 1.40-1.17 (m, 15H), 0.81 (t, J = 7.2 Hz, 3H). LCMS: m / z 841.2 [M+H] + .

[0447] Example 1: (1aS,1bR,3S,4aS,4bR,7R,8S,12S,15aS,15bR,15cR)-8-(((2R,5S,6R)-5-(dimethylamino )-6-Methyltetrahydro-2H-pyran-2-yl)oxy)-12-ethyl-7-methyl-1-phenyl-3- (((2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy C)-1,2,3,4,4a,4b,7,8,9,10,11,12,15,15a,15b,15c-Hexadecahydro-[1]oxacyclo Dodecyno[5',4':2,3]-as-indaceno[4,5-b]azirine-6,14(1aH,1bH)-dione (3)

[0448] [ka]

[0449] A solution of a mixture of compounds 2a and 2b (150 mg, 0.18 mmol) in DCM (10 mL) was added under N Diethylaminosulfur trifluoride (86.1 mg, 0.54 mmol) was added at 78°C. The mixture was stirred at -78 °C for 0.5 h. The reaction mixture was quenched with saturated NaHCO3 solution (5 mL). The combined organic phase was dried over anhydrous Na2SO4 and filtered. The residue was purified by prep HPLC to give title compound 3 (30 mg, The yield was 21%). 1 H NMR (CDCl3, 400 MHz):δ7.23 (d, J = 7.6 Hz, 2H), 7.0 3 (d, J = 7.2 Hz, 2H), 6.96 (t, J = 7.2 Hz, 1H), 6.76 (s, 1H), 4.89 (s, 1H), 4.7 3-4.68 (m, 1H), 4.44-4.42 (m, 1H), 4.34-4.32 (m, 1H), 3.67-3.62 (m, 1H), 3.32-3. 26 (m, 2H), 3.14-3.10 (m, 2H), 2.58-2.50 (m, 2H), 2.41-2.39 (m, 1H), 0.81 (t, J = 7.2 Hz, 3H). LCMS: m / z 823.2 [M+H] + .

[0450] Example 2: Testing Compounds for Insecticidal and Acaricidal Utility The compounds prepared by the above-mentioned methods were tested for their activity against several insects and mites. More specifically, the cotton plant, a member of the insect order Homoptera, is tested for its Compounds are tested against melon aphids. Other members of the order Lepidoptera include Leafhoppers, planthoppers, pear psylla, Apple sucker, scale insects, whiteflies, foxtails Thrips include spittle bugs, and many other host-specific aphid species. It is also active against greenhouse thrips, members of the Thysanoptera order. The southern armyworm, a member of the Lepidoptera order of insects, is Compounds are also tested against the genus Orm. Other representative members of this order include codlin, Codling moth, cutworm, Indianmeal moth , corn earworm, European corn borer ), cabbage worm, cabbage looper, Cotton bollworm, bagworm, eastern tent caterpillar rn tent caterpillar, sod webworm, and fall armyworm Examples include fall armyworm.

[0451] The active compounds are useful for reducing insect and mite populations, After applying an effective insect-inactivating or mite-inactivating amount of the compound to the locus, the insect or mite The present invention is used in a method for suppressing the population of

[0452] To evaluate insecticidal activity, each test compound was formulated as a 400 ppm solution and then This solution is diluted with water to a lower concentration. The 400 ppm solution is made with 0.05% Tween 20 (Polymer) in water. Add 19.2 mL of trioxyethylene 5 (20) sorbitan monolaurate solution to 0.8 mL of acetone / It is prepared by combining with a solution of 8 mg of the compound in ethanol (9 / 1).

[0453] Activity against aster leafhoppers (Macrosteles tascifrons) was tested as follows: Tests are performed using test compounds at concentrations of 400 ppm and 50 ppm. Using a nozzle, dispense 0.4 mL of formulated material into a 1 oz plastic cup containing a cotton wick. Allow excess water to evaporate. Then, fill each cup with a horizontal plate anesthetized with carbon dioxide. Add 5-10 adult mosquitoes to the cup. Cover the cup and keep it at room temperature for 24 hours. Measures cent mortality.

[0454] Activity against beet armyworm (Spodoptera exiqua) was evaluated as follows: Tests are conducted using test compounds at concentrations of 400 ppm and 50 ppm. The material is diluted to half strength with 5% non-nutrient agar. Add this food material (8 mL) to 1 oz of food. Dispense into cups. One hour before treatment, place 35-40 eggs on the bait surface. Then, The cups are sprayed with the formulated material using a rat fan nozzle. After drying in air, the cup is sealed with a plastic lid. The cup is kept at room temperature for 6 days. The survival rate is then determined based on the total number of live and dead larvae, and the size of the live larvae. Evaluate gender.

[0455] Against cotton aphid (Aphis gossypii) and two-spotted spider mite (Tetranychus urticae) The activity of the compound is evaluated as follows: Golden Crookneck Squash plants are placed in a Grow to the expanded cotyledon stage (approximately 6-8 days). Excised from stock colonies Cotton abrasions were inoculated by transferring infected leaves 16 to 24 hours before application of the test substance. The plants are infested with spider mites and two-spotted spider mites. Immediately prior to spray application of the test substance, the infested plants are The infested leaves were removed from the squash plants. The test compounds were administered at concentrations of 400 ppm and 50 ppm. Tests are conducted using a nebulizer sprayer at 17 psi to spray the plants with the test solution. Cover both surfaces of the leaves until they run off, then allow to dry. After 1 day, the activity of each compound is determined. Activity is measured by the number of mites present on plants sprayed with solvent only. Evaluate as a percentage based on aphids.

[0456] Activity against root-knot nematodes (Meloidogyne arenaria) was tested as follows: Place 5 untreated cucumber seeds in the bottom of a clear 1 oz cup and cover with 20 g of clean white sand. and spraying 1.0 mL of the 400 ppm solution onto the sand by adding 1.0 mL of the 400 ppm solution into the cup while it rotates on the pedestal. Into each cup, dispense 2.5 mL–3.0 mL of deionized water containing 300–500 nematodes. The cups are kept in an environmental incubation chamber at a temperature of 76-85°F and an ambient humidity of 50%-60% for 10-12 days. After 10-12 days, each cup was inverted and observed for nematode mortality and feeding damage to the cucumber plants. The cup is evaluated by:

[0457] Active against the 18-spotted melon leaf beetle (Diabrocica undecimpuccaca bowardi Barber) The toxicity was determined by injecting 1 mL of test solution containing a given concentration of the test compound into 16 g of sterile soil on maize plants. This is evaluated by adding 24 ppm of soil to a cup containing granules. After drying for ~2 hours, add five 4th instar cucumber beetle nymphs to each cup. On the 3rd-4th day Mortality was measured by pouring the contents of the cup onto an iron plate and examining the soil for live cucumber beetles. Measure.

[0458] Activity against Heliotbis virescens was evaluated as follows: The general-purpose artificial lepidopteran bait material is diluted to half its concentration with 5% non-nutrient agar. Dispense 8 mL of food into each 1 oz. food cup. One hour prior to treatment, apply 18-20 mL of water to the food surface. Then, using a flat fan nozzle, spray the formulated material into the cup. Tests are performed using test compounds at concentrations of 400 ppm and 50 ppm. The cup is dried in air and then sealed with a plastic lid. The cup is then stored at room temperature for 6 After that, the total number of live and dead larvae, as well as the size of the live larvae, were counted. Activity is assessed based on this.

[0459] Activity against the German cockroach (Blattella germanicus) was evaluated as follows: Place 8 mL of alfalfa-based green insect bait material into a 1-ounce bait cup. Then, spray the formulated material into the cup using a flat fan nozzle. Test compounds are tested at concentrations of 0.5 and 50 ppm. Treated cups are then incubated in air for 24 h. The cups were then dried for 1 hour and infested with 5 late third or early fourth instar German cockroaches. The containers are then covered and kept in an environmental incubation chamber at a temperature of 76-85°F for 10 days. Activity is assessed based on the total number of live and dead insects.

[0460] The terminology used herein is for the purpose of describing particular embodiments only. It is understood that the terminology used is not intended to be limiting. The scope of the invention is defined by the appended claims. Unless otherwise defined, all techniques used herein are limited only by the Technical and scientific terms are commonly understood by those skilled in the art to which this invention belongs. If a range of values ​​is provided, the context must clearly indicate otherwise. Each intervening unit between the upper and lower limits of a range, to one-tenth of the unit of the lower limit, unless The values, as well as any other stated or intervening values ​​in a stated range, are within the scope of the present invention. It is understood that the upper and lower limits of these smaller ranges are encompassed within the respective Subranges may be included independently and are also encompassed within the present invention. The stated range is subject to any specifically excluded limits. Where any of the following limits is included, ranges excluding either or both of those included limits are also included within the invention. Certain ranges are presented herein with numerical values ​​preceded by the term "about." The term "about" is used herein to refer to the exact number that follows the term as well as the number that follows the term. Used to provide textual support for numbers that are close or approximate to the number that follows. In determining whether a number listed is close or approximate to a number specifically recited, An unenumerated number whose proximity or approximation is not relevant to the context in which it is presented. In the above, the numerals may be numbers that provide substantial equivalents to the numerals specifically recited.

[0461] All publications, patents and patent applications cited herein are the property of their respective owners. All publications, patents, or patent applications are specifically and individually indicated to be incorporated by reference. Each cited reference is incorporated herein by reference to the same extent as if each cited reference were filed under the same patent application. The publications, patents, or patent applications cited in this document disclose the subject matter in relation to which the publications are cited. The present application is incorporated by reference to illustrate and describe the present invention. The disclosures herein are based on prior invention and are hereby expressly incorporated by reference in their entirety. should not be construed as an admission that the claimed invention is not authorized to antedate such publication. Furthermore, the publication dates provided may differ from the actual publication dates and may be subject to change without notice. It may be necessary to stand up and check.

[0462] It is noted that the claims may be drafted to exclude any optional element. As such, this specification does not provide any explicit or explicit statement of the nature of the claims that relate to the recitation of claim elements. It can serve as an antecedent for the use of exclusive terms such as "exclusive" or "negative" qualifications. As will be apparent to one of skill in the art upon reading this disclosure, Each of the individual embodiments described and illustrated may deviate from the scope or spirit of the present invention. It can also be easily separated from any of the features of other embodiments without Any of the listed compounds have distinctive components and characteristics that can be combined with any of the listed compounds. The method requires that events occur in the order listed, or in any other order that is logically possible. Any methods and methods similar or equivalent to those described herein may be used. Although the materials may be used in the practice or testing of the present invention, representative illustrative methods are described herein. and the materials.

Claims

1. Spinosyn compounds of the formula: 【Chemistry 1】 or its salt [In the formula, 【Chemistry 2】 A is forosamine, B is selected from the group consisting of rhamnose, tri-O-methyl rhamnose and the (2R,5S)-5-ethoxy-3,4-dimethoxy-6-methyloxan-2-yl group; C is O; 【Chemistry 3】 represents a substituent composed of an aromatic ring or a derivative thereof, 1 , X 2 , X 3 , X 4 , and X 5 are N, NR, CR and CR 2 where X is independently selected from 5 may alternatively be a direct bond, X 5 When is a direct bond, X 1 , X 2 , X 3 , and X 4 may further be selected from O or S, each R is selected from hydrogen, hydroxyl, substituted or unsubstituted amino, substituted or unsubstituted thio, substituted or unsubstituted alkoxy, substituted or unsubstituted aryloxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; 1 , X 2 , X 3 , X 4 , and X 5 are each CR or CH, and when B is tri-O-methyl rhamnose, R may be fluorine or chlorine; X 1 and X 2 NR, CR and CR 2 In the case where X is selected from 1 and X 2 R groups may combine to form substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted heterocycloalkenyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; X 2 and X 3 However, NR, CR and CR 2 In the case where X is selected from 2 and X 3 The R groups may combine to form substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted heterocycloalkenyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl.

2. The substituent A-C- is represented by the following formula: 【Chemistry 4】 The spinosyn compound of claim 1 ,

3. 2. The spinosyn compound of claim 1, wherein B is rhamnose forming a glycosidic bond or a (2R,5S)-5-ethoxy-3,4-dimethoxy-6-methyloxan-2-yl group.

4. 13. A formulation comprising at least one spinosyn compound of claim 1 and an acceptable carrier.

5. 5. The formulation of claim 4 further comprising at least one additional active ingredient.

6. 6. The formulation of claim 4 or 5, further comprising at least one plant or plant product treating compound.

7. 7. The formulation of claim 6, wherein the at least one additional active ingredient comprises an insecticide or acaricide.

8. 8. The formulation of claim 7, wherein the insecticide is a contact acting insecticide.

9. 8. The formulation of claim 7, wherein the acaricide is a contact acaricide.

10. 13. A method for making a spinosyn compound according to claim 1, comprising reacting the C-5,6 double bond of spinosyn A to form a spinosyn compound according to claim 1, wherein the spinosyn compound is formed via an epoxide or 1,2-dihalo intermediate, or directly via nitrene insertion into said double bond.

11. The following groups: 【Chemistry 7】 【Chemistry 8】 【Chemistry 9】 A compound selected from: